10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10 – Q

x QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2015

¨ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 000-53488

PROPELL TECHNOLOGIES GROUP, INC.

(Exact name of registrant as specified in its charter)

Delaware	26-1856569
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification Number)

1701 Commerce Street, Houston, Texas 77002

(Address of principal executive offices including zip code)

(713) 227 - 0480

(Registrant’s telephone number, including area code)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every interactive data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer ¨ Accelerated Filer ¨ Non-Accelerated Filer ¨ Smaller Reporting Company x

Number of shares outstanding of the issuer’s common stock as of the latest practicable date: 268, 558,931 shares of common stock, $.001 par value per share, as of November 18, 2015.

PROPELL TECHNOLOGIES GROUP, INC.

Index

		Page
PART I. FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Financial Statements	F-1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1
Item 3.	Quantitative and Qualitative Disclosures About Market Risks	5
Item 4.	Controls and Procedures	5
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	6
Item 1A.	Risk factors	6
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	15
Item 3.	Defaults Upon Senior Securities	15
Item 4.	Mine Safety Disclosures	15
Item 5.	Other Information	15
Item 6.	Exhibits	15

Item 1.

PROPELL TECHNOLOGIES GROUP, INC.

TABLE OF CONTENTS

September 30, 2015

Condensed Consolidated Balance Sheets as of  September 30, 2015 (unaudited) and December 31, 2014	F-2
Condensed Consolidated Statements of Operations for the three months and nine months ended September 30, 2015 and 2014, (Unaudited)	F-3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) as of January 1, 2015 to September 30, 2015, (Unaudited)	F-4
Condensed Consolidated Statements of Cash Flows for the nine months ended September  30, 2015 and 2014, (Unaudited)	F-5
Notes to the unaudited Condensed Consolidated Financial Statements	F-6–F-25

F-1

PROPELL TECHNOLOGIES GROUP, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30, 2015			December 31, 2014
	Unaudited
Assets
Current Assets
Cash	$	12,568,839		$	40,844
Accounts receivable		9,391			5,892
Prepaid expenses and other current assets		132,579			13,031
Total Current Assets		12,710,809			59,767
Non-Current assets
Plant and Equipment, net		701,090			319,574
Intangibles, net		245,000			297,500
Deposits		2,200			2,200
Total non-current assets		948,290			619,274
Total Assets	$	13,659,099		$	679,041
Liabilities and Stockholders' Equity (Deficit)
Current Liabilities
Accounts payable	$	254,208		$	347,437
Accounts payable – related parties		159,676			-
Accrued liabilities and other payables		256,970			240,426
Notes payable		3,000			117,489
Short-term convertible notes payable, net		-			183,109
Derivative financial liabilities		-			18,455
Total Current Liabilities		673,854			906,916
Long Term Liabilities
Convertible notes payable, net		-			6,220
Total Long Term Liabilities		-			6,220
Total Liabilities		673,854			913,136
Stockholders' Equity (Deficit)
Preferred stock, $0.001 par value, 10,000,000 authorized shares, 0 shares and 4,500,000 shares undesignated.					-
Series A-1 Convertible Preferred stock, $0.001 par value; 5,000,000 shares designated, 3,137,500 and 3,512,500 shares issued and outstanding, respectively. (liquidation preference $251,000 and $281,000, respectively)		3,138			3,513
Series B Convertible, Redeemable Preferred Stock, $0.001 par value; 500,000 shares designated; 40,000 and 75,000 issued and outstanding, respectively (liquidation preference $480,000 and $900,000)		40			75
Series C Convertible, Preferred Stock, $0.001 par value; 4,500,000 shares designated; 4,500,000 and 0 issued and outstanding (liquidation preference $14,750,000 and $0)		4,500			-
Common stock, $0.001 par value; 500,000,000 shares authorized, 268,558,931 and 260,169,499 shares issued and outstanding, respectively		268,559			260,169
Additional paid-in capital		25,458,468			9,914,303
Accumulated deficit		(12,845,919	)		(10,412,155	)
Total stockholder’s equity  - controlling interest		12,888,786			(234,095	)-
Non-controlling interest		96,459			-
Total Stockholders' Equity (Deficit)		12,985,245			(234,095	)
Total Liabilities and Stockholders' Equity (Deficit)	$	13,659,099		$	679,041

See notes to the unaudited condensed consolidated financial statements

F-2

PROPELL TECHNOLOGIES GROUP, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

	Three months ended, September 30, 2015			Three months ended September 30, 2014			Nine months ended, September 30, 2015			Nine months ended September 30, 2014
Net Revenues	$	-		$	-		$	91,000		$	85,008
Cost of Goods Sold		40,275			34,620			140,245			136,645
Gross Profit (Loss)		(40,275	)		(34,620	)		(49,245	)		(51,637	)
Consulting fees		90,229			53,181			309,896			140,405
Stock based compensation		311,284			619,125			793,856			1,741,849
Sales and Marketing		2,541			1,943			5,232			6,026
Professional Fees		243,635			65,898			625,699			200,931
General and administrative		309,561			228,455			600,557			574,844
Depreciation and amortization		33,833			23,959			103,149			49,308
Total Expenses		991,083			992,561			2,438,389			2,713,363
Loss from Operations		(1,031,358	)		(1,027,181	)		(2,487,634	)		(2,765,000	)
Other income		-			150,000			-			150,000
Amortization of debt discount and finance costs		(54	)		(8,309	)		(53,154	)		(503,991	)
Change in fair value of derivative liabilities		-			(33,345	)		18,455			(430,956	)
		(54	)		108,346			(34,699	)		(784,947	)
Loss before Provision for Income Taxes		(1,031,412	)		(918,835	)		(2,522,333	)		(3,549,947	)
Provision for Income Taxes		-			-			-			-
Net Loss		(1,031,412	)		(918,835	)		(2,522,333	)		(3,549,947	)
Net loss attributable to non-controlling interest		88,569			-			88,569			-
Net Loss Attributable to Controlling Interest		(942,843	)		(918,835	)		(2,433,764	)		(3,549,947	)
Deemed preferred stock dividend		-			-			(2,456,781	)		(1,604,335	)
Undeclared Series B and Series C Preferred dividends		(157,786	)		-			(302,948	)		-
Net loss to common stockholders	$	(1,100,629	)	$	(918,835	)	$	(5,193,493	)	$	(5,154,282	)
Net Loss Per Share – Basic and Diluted	$	(0.00	)	$	(0.00	)	$	(0.02	)	$	(0.02	)
Weighted Average Number of Shares Outstanding – Basic and Diluted		261,037,172			239,473,781			257,867,561			225,460,411

See notes to the unaudited condensed consolidated financial statements

F-3

PROPELL TECHNOLOGIES GROUP, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN

STOCKHOLDERS' EQUITY (DEFICIT)

FOR THE PERIOD JANUARY 1, 2015 TO SEPTEMBER 30, 2015

	Preferred Stock																Common stock										Total
	Series A-1						Series B						Series C														Stockholders’
	Shares			Amount			Shares			Amount			Shares		Amount		Shares		Amount		Additional Paid in Capital			Accumulated deficit			Equity (Deficit) - Controlling Interest			Non– Controlling Interest			Total Stockholders’ Equity (Deficit)
Balance as of January 1, 2015		3,512,500		$	3,513			75,000		$	75			-	$	-		260,169,499	$	260,169	$	9,914,303		$	(10,412,155	)	$	(234,095	)	$	-		$	(234,095	)
Conversion of notes and accrued interest thereon to common stock		-			-			-			-			-		-		639,432		640		12,149			-			12,789						12,789
Subscription for Series C Convertible Preferred Stock		-			-			-			-			4,500,000		4,500		-		-		14,745,500			-			14,750,000						14,750,000
Conversion of Series A-1 preferred stock to common		(375,000	)		(375	)		-			-			-		-		3,750,000		3,750		(3,375	)		-			-						-
Conversion of Series B preferred stock to common		-			-			(35,000	)		(35	)		-		-		3,500,000		3,500		(3,465	)		-			-						-
Restricted stock awards		-			-			-			-			-		-		-		-		723,856			-			723,856						723,856
Shares issued for services		-			-			-			-			-		-		500,000		500		69,500			-			70,000						70,000
Contribution by joint venture partner		-			-			-			-			-		-		-		-		-			-			-			185,028			185,028
Net loss for the nine months ended September 30, 2015		-			-			-			-			-		-		-		-		-			(2,433,764	)		(2,433,764	)		(88,569	)		(2,522,333	)
Balance as of September 30, 2015		3,137,500		$	3,138			40,000		$	40			4,500,000	$	4,500		268,558,931	$	268,559	$	25,458,468		$	(12,845,919	)	$	(12,888,786	)	$	96,459		$	12,985,245

See notes to the unaudited condensed consolidated financial statements

F-4

PROPELL TECHNOLOGIES GROUP, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	Nine Months ended,  September 30,  2015			Nine Months ended,  September 30,  2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss attributable to the company	$	(2,433,764	)	$	(3,549,947	)
Less: loss attributable to non-controlling interest		(88,569	)		-
Net loss		(2,522,333	)		(3,549,947	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		50,649			14,308
Amortization expense		52,500			35,000
Amortization of debt discount		16,233			333,404
Equity based compensation		723,856			1,439,502
Stock issued for services rendered		70,000			302,347
Derivative financial liability		(18,455	)		430,956
Gain on forgiveness of debt by issuer		-			(150,000	)
Changes in Assets and Liabilities
Accounts receivable		(3,500	)		(891	)
Prepaid expenses and other current assets		(119,549	)		(11,352	)
Accounts payable		(93,229	)		(19,981	)
Accounts payable -  related parties		159,676			-
Accrued liabilities		16,545			(14,547	)
Accrued interest		(11,261	)		39,834
Cash Used in Operating Activities		(1,678,868	)		(1,151,367	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of plant and equipment		(432,165	)		(139,227	)
NET CASH USED IN INVESTING ACTIVITIES		(432,165	)		(139,227	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds on issuance of Series C Preferred stock		14,750,000			-
Proceeds on issuance of Series B Preferred stock		-			750,000
Proceeds on common stock issued, net of expenses		-			946,110
Contribution from joint venture partner		185,028			-
Proceeds from notes payable and advances		125,000			160,000
Repayment of notes payable and advances		(421,000	)		(461,948	)
NET CASH PROVIDED BY FINANCING ACTIVITIES		14,639,028			1,394,162
NET INCREASE IN CASH		12,527,995			103,568
CASH AT BEGINNING OF PERIOD		40,844			28,423
CASH AT END OF PERIOD	$	12,568,839		$	131,991
CASH PAID FOR INTEREST AND TAXES:
Cash paid for income taxes	$	-		$	-
Cash paid for interest	$	48,130		$	130,753
NON-CASH INVESTING AND FINANCING ACTIVITIES
Licenses acquired not yet paid for	$	-		$	200,000
Conversion of debt to equity	$	12,789		$	794,150
Conversion of interest on debt to equity	$	-		$	102,397

See notes to the unaudited condensed consolidated financial statements

F-5

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1 ORGANIZATION AND DESCRIPTION OF BUSINESS

a) Organization

Propell Technologies Group, Inc. (formerly known as Propell Corporation) (the “Company”), is a Delaware corporation originally formed on January 29, 2008 as CA Photo Acquisition Corp. On April 10, 2008 Crystal Magic, Inc. (“CMI”), a Florida Corporation, merged with an acquisition subsidiary of Propell’s, and the Company issued an aggregate of 180,000 shares to the former shareholders of CMI. On May 6, 2008, the Company acquired both Mountain Capital, LLC (doing business as Arrow Media Solutions) (“AMS”) and Auleron 2005, LLC (doing business as Auleron Technologies) (“AUL”) and made each a wholly owned subsidiary and issued a total of 41,897 shares of the Company’s common stock to the members of Mountain Capital, LLC and a total of 2,722 shares of the Company’s common stock to the members of AUL. In 2010 AUL and AMS were dissolved and the operations of CMI were discontinued. On February 4, 2013, the Company entered into a Share Exchange Agreement with Novas Energy (USA), Inc. (“Novas”) whereby the Company exchanged 100,000,000 shares of its common stock for 100,000,000 shares of common stock in Novas. After the consummation of the share exchange, Novas became a wholly owned subsidiary of the Company. As a result of the share exchange the shareholders of Novas obtained the majority of the outstanding shares of the Company. As such, the exchange is accounted for as a reverse merger or recapitalization of the Company and Novas was considered the acquirer for accounting purposes.

b) Description of the business

The Company, through its wholly owned subsidiary, Novas, is an innovative technology and services company whose aim is to radically improve oil production by introducing modern and innovative technologies. Novas has a unique Plasma-Pulse Treatment (“PPT”) technology, which is a new Enhanced Oil Recovery methodology and process that has been developed to be environmentally friendly, mobile, time efficient and extremely cost effective. We filed for patent protection of the PPT technology which is still pending. PPT has the potential to drive new and renewed revenue for energy producers and become a new standard for the entire petroleum industry.

On October 22, 2015, Novas Energy USA, Inc. (“Novas”), a wholly owned subsidiary of Propell Technologies Group, Inc. (the “Company”), entered into an operating agreement with Technovita Technologies USA, Inc. (the “Joint Venture Agreement”) through a newly formed Delaware limited liability company, Novas Energy North America, LLC (“NENA”), whereby Novas agreed to contribute $1,200,000 ($600,000 to be delivered on the effective date (October 22, 2015) of the Joint Venture Agreement, $300,000 on November 1, 2015 and $300,000 on the two month anniversary of the Effective Date) to the capital of NENA for 60% of the membership interests of NENA and Technovita agreed to contribute an aggregate of $800,000 to the capital of NENA for 40% of the membership interests of NENA. In terms of a side agreement entered into on November 18, 2015, the revenue and expenses incurred by Technovita prior to entering into the operating agreement, have been included in the joint venture and consolidated into the Company’s results effective September 1, 2015.

Subject to certain exceptions and pursuant to the terms of a sublicense agreement (the “Novas Sublicense Agreement”) that was entered into between Novas, NENA and Novas Energy Group Inc. (the “Licensor”), the licensor of Plasma Pulse Technology currently used by Novas and Technovita, NENA will be the exclusive provider of the Vertical Technology (as defined in the Joint Venture Agreement) to third parties in the United States. Subject to certain exceptions and pursuant to the terms of Sublicense Agreements (the “Technovita Sublicense Agreement”) that was entered into between Technovita, NENA and Licensor, NENA is the exclusive provider of the Vertical Technology to third parties in Canada. Notwithstanding the foregoing, both Novas and Technovita will retain the right to deploy the Vertical Technology on wells owned by Novas or Technovita in the United States or Canada, respectively. If either Novas or Technovita terminates the Sublicense Agreement with NENA and Licensor, the non- terminating party will receive 100% of the terminating member’s membership interest in NENA.

The business and affairs of NENA are to be managed by or under the direction of the Board of Directors, consisting of five (5) members, three (3) of whom shall be appointed by Novas and two (2) of whom shall be appointed by Technovita. Board approval is required to: (i) incur any indebtedness, pledge or grant liens on any assets or guarantee, assume, endorse or otherwise become responsible for the obligations of any other person, except to the extent approved or authorized in NENA’s budget; (ii) make any loan, advance or capital contribution in any person, except to the extent approved or authorized in the budget; (iii) transfer any equipment necessary in the deployment of the Vertical Technology to any third party; (iv) enter into or effect any transaction or series of related transactions involving the sale of NENA or the sale, lease, license, exchange or other disposition (including by merger, consolidation, sale of assets or similar business transaction) by NENA of any assets in excess of $300,000; (v) appoint or remove NENA’s auditors or make any changes in the accounting methods or policies of NENA (other than as required by GAAP); (vi) enter into or effect any transaction or series of related transactions involving the purchase, lease, license, exchange or other acquisition (including by merger, consolidation, acquisition of stock or acquisition of assets) by NENA of any assets and/or equity interests of any person and/ or assets in excess of $300,000; or (v) enter into or effect any commercial transaction or series of related commercial transactions involving anticipated liabilities or revenues of NENA in excess of $500,000 or that materially vary from NENA’s existing strategy or business plan.

The Joint Venture will provide NENA with access to Technovita’s experienced team, the ability to build one North American brand, the ability to leverage the strength of the combined entity expanding the Company’s geographic reach beyond the United States and into Canada.

F-6

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2 ACCOUNTING POLICIES AND ESTIMATES

a) Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which we consider necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months and nine months ended September 30, 2015 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this quarterly report on Form 10-Q should be read in conjunction with our audited financial statements included in our annual report on Form 10-K as of and for the year ended December 31, 2014 as filed with the Securities and Exchange Commission (the “SEC”).

Significant accounting policies are described in Note 2 to the consolidated financial statements included in Item 8 of our annual report on Form 10-K as of December 31, 2014.

The preparation of unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to: the estimated useful lives for plant and equipment, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses, those related to revenue recognition and the allowance for doubtful accounts.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

All amounts referred to in the notes to the unaudited consolidated financial statements are in United States Dollars ($) unless stated otherwise.

b) Principles of Consolidation

The unaudited consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited consolidated financial statements. The entities included in these unaudited consolidated financial statements are as follows:

Propell Technologies Group, Inc. – Parent Company

Nova Energy USA Inc. (wholly owned)

Novas Energy North America, LLC (60% owned)

F-7

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

c) Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed. 

d) Fair Value of Financial Instruments

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. 

The carrying amounts reported in the balance sheets for cash, accounts receivable, prepaid expenses, deposits, accounts payable, accrued liabilities, notes payable, and convertible notes payable approximate fair value due to the relatively short period to maturity for these instruments. The recorded derivative liabilities during the years ended December 31, 2014 was noted as subject to level III fair value measurements. The Company did not identify any other assets or liabilities that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance. 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.

e) Risks and Uncertainties

The Company's operations will be subject to significant risk and uncertainties including financial, operational, regulatory and other associated risks, including the potential risk of business failure. The recent global economic crisis has caused a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

The Company’s operations are carried out in the USA and Mexico. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environment in the USA and Mexico and by the general state of those economies. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

F-8

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

f) Recent Accounting Pronouncements

In August 2015, FASB issued Accounting Standards Update (“ASU”) No.2015-14, “Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date” defers the effective date ASU No. 2014-09 for all entities by one year. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in Update 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities should apply the guidance in Update 2014-09 to annual reporting periods beginning after December 15, 2018, and interim reporting periods within annual reporting periods beginning after December 15, 2019. All other entities may apply the guidance in ASU No. 2014-09 earlier as of an annual reporting period beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities also may apply the guidance in Update 2014-09 earlier as of an annual reporting period beginning after December 15, 2016, and interim reporting periods within annual reporting periods beginning one year after the annual reporting period in which the entity first applies the guidance in ASU No. 2014-09. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition.

In April 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs, to simplify presentation of debt issuance costs by requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The ASU does not affect the recognition and measurement guidance for debt issuance costs. For public companies, the ASU is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early application is permitted. This updated guidance is not expected to have a material impact on our results of operations, cash flows or financial condition.

Any new accounting standards, not disclosed above, that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

g) Reporting by Segment

No segmental information is presented as the Company has disposed of its historical virtual trading store business which had minimal revenues. The Company is focusing on developing its Novas Energy, Plasma Pulse Technology for the petroleum industry.

Revenues to date are insignificant.

h) Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2015 and December 31, 2014, respectively, the Company had no cash equivalents.

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. At September 30, 2015, the Company had cash balances of $12,568,839 which exceeded the federally insured limits by $11,717,660. At December 31, 2014, the balance did not exceed the federally insured limit.

F-9

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

i) Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the nine months ended September 30, 2015 and the year ended December 31, 2014.

j) Inventory

The Company had no inventory as of September 30, 2015 or December 31, 2014.

k) Plant and Equipment

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

Description	Estimated Useful Life
Office equipment and furniture	2 years
Leasehold improvements and fixtures	Lesser of estimated useful life or life of lease
Plant and equipment	2 to 3 years
Plasma pulse tools	5 years

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

l) Intangibles

All of our intangible assets are subject to amortization. We evaluate the recoverability of intangible assets periodically by taking into account events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired. Where intangibles are deemed to be impaired we recognize an impairment loss measured as the difference between the estimated fair value of the intangible and its book value.

i) License Agreements

License agreements acquired by the Company are reported at acquisition value less accumulated amortization and impairments.

ii) Amortization

Amortization is reported in the income statement on a straight-line basis over the estimated useful life of the intangible assets, unless the useful life is indefinite. Amortizable intangible assets are amortized from the date that they are available for use. The estimated useful life of the license agreement is five years which is the expected period for which we expect to derive a benefit from the underlying license agreements

F-10

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

m) Long-Term  Assets

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

n) Revenue Recognition

The Company records revenue when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the service is completed without further obligation, (3) the sales price to the customer is fixed or determinable, and (4) collectability is reasonably assured.

o) Share-Based Payment Arrangements

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the unaudited consolidated statement of operations.

p) Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2015, there have been no interest or penalties incurred on income taxes.

q) Net Loss per Share

Basic net loss per share is computed on the basis of the weighted average number of common shares outstanding during the period.

Diluted net loss per share is computed on the basis of the weighted average number of common shares and common share equivalents outstanding. Dilutive securities having an anti-dilutive effect on diluted net loss per share are excluded from the calculation (See Note 14, below).

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common shares at the average market price during the period.

Dilution is computed by applying the if-converted method for convertible preferred shares. Under this method, convertible preferred stock is assumed to be converted at the beginning of the period (or at the time of issuance, if later), and preferred dividends (if any) will be added back to determine income applicable to common stock. The shares issuable upon conversion will be added to weighted average number of common shares outstanding. Conversion will be assumed only if it reduces earnings per share (or increases loss per share).

Any common shares issued as a result of the issue of stock options and warrants would come from newly issued common shares from our remaining authorized shares.

F-11

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

r) Comprehensive income

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. For the Company, comprehensive income for the periods presented includes net loss.

s) Related parties

Parties are considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company, or own in aggregate, on a fully diluted basis 5% or more of the Company’s stock. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company shall disclose all related party transactions. All transactions shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a distribution to related party.

3 PREPAID EXPENSES

Prepaid expenses consisted of the following as of September 30, 2015 and December 31, 2014:

	September 30, 2015		December  31, 2014
Prepaid insurance	$	23,125	$	8,144
Expenses in excess of billings		72,308
Prepaid professional fees		36,286		4,417
Other		860		470
	$	132,579	$	13,031

4 PLANT AND EQUIPMENT

Plant and Equipment consisted of the following as of September 30, 2015 and December 31, 2014:

	September 30, 2015			December 31, 2014
Capital work in progress	$	447,669		$	18,482
Plasma pulse tool		310,374			310,374
Furniture and equipment		29,621			26,643
Field equipment		19,627			19,627
Computer equipment		1,500			1,500
Total cost		808,791			376,626
Less: accumulated depreciation		(107,701	)		(57,052	)
Plant and equipment, net	$	701,090		$	319,574

Depreciation expense was $50,649 and $14,308 for the nine months ended September 30, 2015 and 2014, respectively.

F-12

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

5 INTANGIBLES

Licenses

Novas licenses the “Plasma-Pulse Technology” (“the Technology”) from Novas Energy Group Limited, the Licensor, pursuant to the terms of an exclusive perpetual royalty bearing license it entered into in January 2013, which was amended on March, 2014 and further amended on December 23, 2014. The amended license agreement provides Novas with the exclusive right to develop, use, market and commercialize the Technology for itself and/or third parties, sublicense and provide services to third parties related to the Technology in the United States and Mexico including all of its states, districts, territories, possessions and protectorates. The amended license agreement also provides Novas with the right to design and have manufactured the apparatus and to make modifications and improvements to the Technology provided that the Licensor is provided a non-exclusive license to any such improvements and modifications and any patent rights of Novas related to the Technology. The license is limited to the United States and Mexico. It also provides that Novas will pay the Licensor royalties equal to seven and a half percent (7.5%) of Net Service Sales (as defined in the second amendment to the license agreement) and Non-Royalty Sublicensing Consideration (as defined in the second amendment to the license agreement) and provides for a minimum royalty payment of $500,000 per year from United States operations and $500,000 per year from Mexican operations; however, no minimum royalty payment is due prior to the three year anniversary of the license agreement for revenue derived from the United States operations and no minimum royalty is due prior to December 31, 2015 for revenue derived from Mexico. Revenue derived from operations in one territory can be used to satisfy obligations for minimum royalty payments in the other territory. All royalty payments made by Novas as well as sublicensing revenue paid by Novas to the Licensor are credited towards the minimum royalty payment. If the minimum royalty is not timely paid, the Licensor has the right to terminate the license with respect to a particular territory and if the minimum royalty payment for both territories is not paid, to terminate the license agreement. Novas was obligated to pay an initial license fee of $150,000 on or prior to June 30, 2014, this fee was subsequently waived by the Licensor with effect from July 30, 2014, an additional $200,000 was due to the Licensor on June 30, 2015, this amount, together with the minimum annual royalty amounts due in terms of the licensing agreement are currently under renegotiation with the Licensor, we expect the $200,000 to be waived and the minimum royalty payments to be amended and deferred. The Licensor is responsible for the cost of filing prosecuting and maintaining the patents and Novas is responsible for costs of obtaining marketing approvals. The Licensor has the right to terminate the license agreement upon Novas’ breach or default. If the Licensor dissolves, becomes insolvent or engages in or is the subject of any other bankruptcy proceeding then the technology and patent rights in the United States shall become our property.

Subject to certain exceptions and pursuant to the terms of the Novas Sublicense Agreement that was entered into on October 22, 2015, between Novas, NENA and the Licensor of the Plasma Pulse Technology currently used by Novas and Technovita, NENA will be the exclusive provider of the Vertical Technology (as defined in the Joint Venture Agreement entered into on October 22, 2015) to third parties in the United States. Subject to certain exceptions and pursuant to the terms of Sublicense Agreements (the “Technovita Sublicense Agreement”) that was entered into between Technovita, NENA and Licensor, NENA is the exclusive provider of the Vertical Technology to third parties in Canada. Notwithstanding the foregoing, both Novas and Technovita will retain the right to deploy the Vertical Technology on wells owned by Novas or Technovita in the United States or Canada, respectively. If either Novas or Technovita terminates the Sublicense Agreement with NENA and Licensor, the non- terminating party will receive 100% of the terminating member’s membership interest in NENA.

Intangibles consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	September 30, 2015			December 31, 2014
License agreements	$	350,000		$	350,000
Website development		8,000			8,000
Total cost		358,000			358,000
Less: accumulated amortization		(113,000	)		(60,500	)
Intangibles, net	$	245,000		$	297,500

Amortization expense was $52,500 and $35,000 for the nine months ended September 30, 2015 and 2014, respectively.

The minimum commitments due under the license agreement for the next five years are summarized as follows:

	Amount
2015	$	700,000
2016		1,000,000
2017		1,000,000
2018		1,000,000
2019		1,000,000
	$	4,700,000

6 ACCOUNTS PAYABLE – RELATED PARTIES

Accounts payable to related parties includes the following:

	September 30, 2015		December 31, 2014
Technovita Technologies Corp.	$	108,510	$	-
Energy Conservation Management		47,610		-
Other		3,556		-
	$	159,676	$	-

Technovita Technologies Corp., is the 40% shareholder in the NENA joint venture which the Company entered into. This payable represents expenses paid on behalf of the joint venture by Technovita.

Energy Conservation Corp is a third party contractor associated with the joint venture.

F-13

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

7 ACCRUED LIABILITIES AND OTHER PAYABLES

Accrued liabilities consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	September 30, 2015		December 31, 2014
Payroll liabilities	$	42,317	$	35,823
Accrued Royalties		14,653		4,603
License fees payable		200,000		200,000
	$	256,970	$	240,426

8 NOTES PAYABLE

Notes payable consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

Description	Interest Rate			Maturity	September 30, 2015		December 31, 2014
Short-Term
Owl Holdings		-		-	$	3,000	$	3,000
JAZ-CEH Holdings, LLC		7.5	%	October 31, 2015		-		105,000
Accrued interest						-		9,489
Total JAZ-CEH holdings, LLC						-		114,489
Total Notes Payable					$	3,000	$	117,489

Owl Holdings

The note payable advanced by Owl Holdings to the Company has no interest rate and is repayable on demand.

JAZ-CEH Holdings, LLC

In October 2013, Navies Energy USA, Inc., entered into an unsecured promissory note with JAZ-CEH Holdings LLC with a face value of $105,000. The note bore interest at 7.5% per annum and was due to mature on October 31, 2015.

On February 20, 2015, the note to JAZ-CEH Holdings, LLC, including interest thereon was repaid for a total amount of $115,590.

F-14

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

9 SHORT-TERM CONVERTIBLE NOTES PAYABLE

Short Term Convertible Notes payable consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	Interest Rate	Maturity	September 30, 2015		December 31, 2014
LG Capital Funding, LLC	8%	October 30, 2015		-		107,000
Unamortized debt discount and interest expense				-		(4,379	)
Total LG Capital Funding, LLC				-		102,621
KBM Worldwide, Inc.	8%	September 12, 2015		-		84,000
Unamortized debt discount and interest expense				-		(3,512	)
Total KBM Worldwide, Inc.				-		80,488
Total Short-Term Convertible Notes Payable			$	-	$	183,109

LG Capital Funding, LLC

On October 31, 2014, the Company issued a note in the principal amount of $107,000 to LG Capital Funding, LLC (“LG”) upon receipt of $100,000 from LG. The terms of the note provided for an original issue discount of 7% amounting to $7,000 which was added to the face value of the note. The note carried an interest charge of 8% per annum. The note was convertible into common stock at any time, at the holder’s option, in whole or in part, at a conversion price equal to 62% of the lowest bid prices in the 10 trading days prior to conversion. The note had a maturity date of October 30, 2015. The holder was not entitled to exercise any conversion right that would result in the holder owning more than 9.9% of the Company’s common stock. The Convertible Note was redeemable by the Company within 180 days of the issuance date, after a 3 day notice period, in which notice period the holder could elect to exercise the conversion feature of the note, at a premium over the principal amount due of 10%, plus any interest earned thereon, subject to the holders approval. The conversion price of the note had anti-dilutive provisions which would increase the redemption penalty of the note to 150% of the principal outstanding plus accrued and unpaid interest thereon, or allow conversion immediately prior to the dilutive event taking place.

On February 20, 2015, the unsecured promissory note issued to LG in the principal amount of $107,000 was repaid for $125,677, inclusive of interest, original issue discounts and early settlement penalty accrued thereon. The Company has no further obligations under this note.

KBM Worldwide, Inc.

On December 10, 2014, the Company issued an unsecured convertible note to KBM Worldwide, Inc. (“KBM”) with a face value of $84,000, in exchange for $80,000 in cash, including an original issue discount of $4,000. The note was convertible into common stock of the Company and bore interest at the rate of 8% per annum, which interest was payable in cash or common stock, at the election of the holder, and had a maturity date of September 12, 2015. The conversion price, as well as the formula for determining the number of shares needed to repay the note and any interest thereon was 58% of the average of the lowest closing price for any three trading days during the last ten day trading period prior to conversion or payment of interest. The holder could only convert the note following the expiration of 180 days from the date of issuance, December 10, 2014. The holder was not entitled to any conversion right that would result in the holder owning more than 4.99% of the Company’s common stock. This note could be prepaid by the Company from the date of issuance to 180 days after issuance date at a prepayment penalty ranging from 110% to 135% of the balance outstanding, including interest thereon, dependent upon the age of the note.

On February 20, 2015, the unsecured promissory note issued to KBM on December 10, 2014 with a face value of $84,000 was repaid for $102,107, inclusive of interest, fees and an early settlement penalty accrued thereon. The Company has no further obligations under this note.

F-15

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

10 DERIVATIVE FINANCIAL LIABILITY

Certain of the short-term convertible notes disclosed in note 9 above, had variable priced conversion rights with no fixed floor price and would re-price dependent on the share price performance over varying periods of time. This gave rise to a derivative financial liability, which was valued at $224,442 at inception of the convertible notes using a Black-Scholes valuation model. The value of this derivative financial liability is re-assessed at each financial reporting period, with any movement thereon recorded in the statement of operations in the period in which it is incurred or the convertible debt is converted into equity.

Upon repayment or conversion of the outstanding notes, the derivative financial liability is no longer required.

The movement in derivative liabilities is as follows:

	September 30, 2015			December 31,  2014
Opening balance	$	18,455		$	237,799
Derivative financial liability arising on short-term notes with variable conversion prices		-			23,060
Conversion of derivative liability for stock issued at a discount		-			(668,756	)
Fair value adjustments to derivative financial liability		(18,455	)		426,352
	$	-		$	18,455

The following assumptions were used in the Black-Scholes valuation model:

	Year ended December 31, 2014
Stock price over the period	$	0.17 – $0.23
Risk free interest rate		0.13% to 0.25	%
Expected life of short-term notes payable		9 to 14 months
Expected volatility		95.24% - 119.45	%
Expected dividend rate		0	%

11 LONG-TERM CONVERTIBLE NOTES PAYABLE

Long Term Convertible Notes payable consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

Description	Interest Rate		Maturity	September 30, 2015		December 31, 2014
Notes payable		6%	November 19, 2017	$	-	$	11,250
Accrued interest					-		1,470
Unamortized debt discount					-		(6,500	)
Total long-Term Convertible Notes Payable				$	-	$	6,220

The convertible notes payable consisted of notes issued to a number of private principals (“the Notes”). The Notes bore interest at the rate of 6% per annum and were due on November 19, 2017. The Notes were convertible into common stock at a fixed conversion price of $0.02 per share.

On February 6, 2015, the remaining convertible note with an aggregate principal amount of $11,250, inclusive of interest of $1,539, totaling $12,789 was converted into 639,432 common shares at a conversion price of $0.02 per share.

F-16

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

12 STOCKHOLDERS’ EQUITY (DEFICIT)

a) Common Stock

The Company has authorized 500,000,000 common shares with a par value of $0.001 each, and issued and outstanding 268,558,931 shares of common stock as of September 30, 2015.

The following common shares were issued by the Company during the nine months ended September 30, 2015:

i) an aggregate of 639,432 shares of Common Stock to convertible note holders upon conversion of an aggregate of $12,789 of long-term convertible notes, inclusive of interest thereon, at a share price of $0.02 per share;

ii) an aggregate of 3,750,000 shares of Common Stock were issued upon the conversion of 375,000 shares of Series A-1 Preferred stock in terms of a conversion notice received from a Series A-1 stockholder at a conversion factor of 10 Common shares for one Series A-1Preferred share.

iii)	an aggregate of 3,500,000 shares of Common Stock were issued upon the conversion of 35,000 shares of Series B Preferred stock in terms of a conversion notice received from the Series B stockholder at a conversion factor of 100 Common shares for one Series B Preferred share.
iv)	an aggregate of 500,000 shares of Common Stock were issued for consulting services which were valued at a fair market price of $70.000.

Included in the Common stock outstanding are 13,000,000 restricted shares of common stock issued as follows:

(a) An aggregate of 10,000,000 shares of restricted common stock were issued to our Chief Executive Officer in terms of an employment agreement entered into with him. These shares are restricted. As of September 30, 2015, 3,750,000 shares have already vested and a further 1,250,000 shares vested on October 1, 2015 with further vesting per quarter thereafter, these shares will be fully vested on October 1, 2016. These restricted shares were valued at the closing price of the common stock on February 4, 2015, the date of approval of the amended and restated employment agreement with our Chief Executive officer. Refer to the related party disclosure in note 15 below.

(b) An aggregate of 3,000,000 shares of restricted common stock were issued to our Director, John Zotos, in terms of a consulting agreement entered into with him. These shares are restricted and vested as to 1,000,000 shares on March 31, 2015, 1,000,000 on September 30, 2015 with the remaining 1,000,000 vesting on March 31, 2016. These restricted shares were valued at the closing price of the common stock on December 5, 2014, the date of approval of the consulting agreement with John Zotos. Refer to the related party disclosure in note 15 below.

Our Chief Executive Officer is also entitled to 1,500,000 shares of restricted common stock which has not been issued as yet. These shares will be issued upon vesting in two equal tranches of 750,000 shares of common stock on January 1, 2016 and January 1, 2017.

The restricted stock granted and exercisable at September 30, 2015 is as follows: 

		Restricted Stock Granted				Restricted Stock Vested
Grant date Price		Number Granted		Weighted Average Fair Value per Share		Number Vested		Weighted Average Fair Value per Share
$	0.15		11,500,000	$			3,750,000	$
$	0.18		3,000,000	$			2,000,000	$
			14,500,000	$	0.16		5,750,000	$	0.16

The Company has recorded an expense of $723,856 and $0 for the nine months ended September 30, 2015 and 2014, relating to the restricted stock awards and a further $920,714 will be expensed over the vesting period of the stock which takes place over the next fifteen months.

F-17

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

12 STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

b) Preferred Stock

The Company has 10,000,000 authorized preferred shares with a par value of $0.001 each with 5,000,000 preferred shares designated as Series A-1 Convertible Preferred Stock (“Series A-1 Shares”), 500,000 preferred shares designated as Series B Preferred Stock and on February 19, 2015, the Company amended its articles of incorporation, designating the remaining 4,500,000 preferred shares as Series C Preferred Stock.

i) Series A-1 Convertible Preferred Stock

The Company has designated 5,000,000 preferred shares as Series A-1 Convertible Preferred Stock (“Series A-1 Shares”), with 3,137,500 Series A-1 Shares issued and outstanding which are convertible into 31,375,000 shares of common stock.

During the nine months ended September 30, 2015, holders of 375,000 Series A-1 shares converted their holdings into 3,750,000 shares of the Company’s Common Stock at a conversion ratio of 10 common shares to 1 Series A-1 Share.

The rights, privileges and preferences of the Series A-1 Shares are summarized as follows;

Conversion

Each Series A-1 Share has the following conversion rights:

(a) Each share of the Series A-1Shares is convertible into ten shares of Common Stock.

(b) There shall be no adjustment made to the conversion ratio of the Series A-1 Shares for any stock split, stock dividend, combination, reclassification or other similar event.

Company Redemption

The Series A-1 Shares are non-redeemable by the Company.

Voting Rights

Each holder of Series A-1 Shares is entitled to vote on all matters submitted to a vote of the stockholders of the Company and shall be entitled to that number of votes equal to the number of shares of Common Stock into which such holder’s shares of Series A-1 Shares could then be converted.

Dividends

Until such time that any dividend is paid to the holders of Common Stock, the holders of Series A-1 Shares shall be entitled to a dividend in an amount per share equal to that which such holders would have been entitled to receive had they converted all of the shares of Series A-1 Shares into Common Stock immediately prior to the payment of such dividend

Liquidation Preference

Each share of Series A-1 Shares is entitled to a liquidation preference of $0.08 per share

No Circumvention

The approval of the holders of at least 2/3 (66.6%) of the outstanding shares of the Series A-1 Shares, voting together separately as a class, is required for:

(a) the merger, sale of all, or substantially all of the assets or intellectual property, recapitalization, or reorganization of the Company;

(b) the authorization or issuance of any equity security having any right, preference or priority superior to or on a parity with the Series A-1 Shares;

(c) the redemption, repurchase or acquisition of any of the Company’s equity securities or the payment of any dividends or distributions thereon;

(d) any amendment or repeal of the Company’s Articles of Incorporation or Bylaws that would have an adverse effect on the rights, preferences or privileges of the Series A-1 Shares; and

(e) the making of any loan or advance to any person except in the ordinary course of business.

F-18

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

12 STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

b) Preferred Stock (continued)

ii) Series B Convertible Preferred Stock

The Company has designated 500,000 preferred shares as Series B Convertible Preferred Stock (“Series B Shares”), with 40,000 Series B Shares issued and outstanding which are convertible into 4,000,000 shares of common stock.

The Company issued 75,000 Series B shares in March 2014 for gross proceeds of $750,000.

During the nine months ended September 30, 2015, the holder of 35,000 Series B shares converted his holding into 3,500,000 shares of the Company’s Common Stock at a conversion ratio of 100 common shares per Series B Share.

The rights, privileges and preferences of the Series B Shares are summarized as follows:

Conversion

The holders of the Series B Preferred Shares shall have conversion rights as follows:

(a) Each share of the Series B Shares is convertible at any time prior to the issuance of a redemption notice by the Company into such number of shares of Common Stock by dividing the Stated value ($10) of the Series B Shares by $0.10 and is subject to adjustment for dividends or distributions made in common stock, the issue of securities convertible into common stock, stock splits, reverse stock splits, or reclassifications of common stock. No adjustments will be made to the conversion rights or conversion price for any reorganization other than to be entitled to receive the same benefits as if the shares were converted immediately prior to such reorganization. No conversion will take place if the holder of the Series B Shares will beneficially own in excess of 4.99% of the shares of Common Stock outstanding immediately after conversion. As of the date hereof, each Series B Share converts into 100 shares of common stock.

(b) The conversion right of the holders of Series B Shares are exercised by the surrender of the certificates representing shares to be converted to the Company, accompanied by written notice electing conversion.

(c) No fractional shares of Common Stock or script will be issued upon conversion of Series B Shares. The Company will pay a cash adjustment in respect to such fractional interest based upon the fair value of a share of Common Stock, as determined in good faith by the Company’s Board of Directors.

(d) All shares of Common Stock issued upon conversion of Series B Shares will upon issuance be validly issued, fully paid and non-assessable. All certificates representing Series B Shares surrendered for conversion shall be appropriately canceled on the books of the Company and the shares so converted represented by such certificates shall be restored to the status of authorized but unissued shares of preferred stock of the Company.

Company Redemption

The Company has the right, at any time after the date the Series B Shares have been issued, to redeem all or a portion of any Holder's Series B Shares at a price per Series B Share equal to the issue price per Series B Share multiplied by 120%

Voting Rights

Each holder of Series B Shares is entitled to vote on all matters submitted to a vote of the stockholders of the Company and is entitled to votes equal to the number of shares of Common Stock into which Series B Shares could be converted, and the holders of shares of Series B Shares and Common Stock shall vote together as a single class on all matters submitted to the stockholders of the Company. 

Dividends

(a) The holders of the Series B Shares are entitled to receive cumulative dividends at the rate of eight percent per annum of the issue price per share, accrued daily and payable annually in arrears on December 31st of each year (“Dividend Date”). Such dividends accrue on any given share from the day of original issuance of such share. Such dividends are cumulative, whether or not declared by the Board of Directors, but are non-compounding.

(b) Any dividend payable on a dividend payment date may be paid, at the option of the Company, either (i) in cash or (ii) in shares of common stock at an issue price of $0.10 per common share.

(c) Nothing contained herein is deemed to establish or require any payment or other charges in excess of the maximum permitted by applicable law.

(d) In the event that pursuant to applicable law or contract the Company is prohibited or restricted from paying in cash the full dividends to which the holders of the Series B Shares are entitled, the cash amount available pursuant to applicable law or contract will be distributed among the holders of the Series B Shares ratably in proportion to the full amounts to which they would otherwise be entitled and any remaining amount due to holders of the Series B Shares will be payable in cash.

F-19

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

12 STOCKHOLDERS’ EQUITY DEFICIT (continued)

b) Preferred Stock (continued)

ii) Series B Convertible Preferred Stock (continued)

Liquidation Preference

In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of the Series B Shares are entitled to receive, prior and in preference to any distribution of any assets of the Company to the holders of any other preferred stock of the Company and subordinate to any distribution to the Series A-1 Shares, and prior and in preference to any distribution of any assets of the Company to the holders of the Common Stock, the amount of 120% of the issue price per share. In addition, the Series B holder has agreed to vote to subordinate the series B Preferred stock liquidation preferences to the Series C Preferred stock preferences.

No Circumvention

The Company may not amend its certificate of incorporation, or participate in any reorganization, sale or transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action for the purpose of avoiding or seeking to avoid the observance or performance of any of the terms to be observed or performed by the Company.

We have undeclared dividends on the Series B Preferred stock amounting to $82,455 as of September 30, 2015. If the dividends are paid in stock, the beneficial conversion feature of these undeclared dividends will be recorded upon the declaration of these dividends. The computation of loss per common share for the three months and nine months ended September 30, 2015 takes into account these undeclared dividends.

iii) Series C Convertible Preferred Stock

The Company has designated 4,500,000 preferred shares as Series C Convertible Preferred Stock (“Series C Shares”), with 4,500,000 Series C Shares issued and outstanding which are convertible into 120,000,000 shares of common stock (a conversion price of $0.12291665 per share).

On February 19, 2015, the Company entered into a Series C Preferred Stock Purchase Agreement (the “Purchase Agreement”) with Ervington Investment Limited, an entity organized under the laws of the Republic of Cyprus who is wholly owned by Greenleas International Holdings Ltd., which in turn is wholly owned by Harmony Trust Settlement, and closed the first tranche of a private placement offering under the Purchase Agreement, raising $5,000,000 in gross proceeds from the sale of 1,525,424 shares of our Series C Preferred Stock (“Series C Preferred Stock”) at a purchase price of $3.277777778 per share. The Company agreed to use the net proceeds of the offering for research and development, commercialization of new products, sales and marketing, repayment of debt, accounts payable and administrative expenses.

In terms of the Purchase Agreement, the Company sold to Ervington an additional 2,974,576 shares of Series C Preferred Stock for additional gross proceeds to us of $9,750,000 on June 30, 2015. The proceeds of the second closing are to be used by us for the acquisition, enhancement and maintenance of an oil field for deployment of our Plasma Pulse Technology.

We valued the beneficial conversion rights of the first tranche of Series C Convertible Preferred Stock issued on February 19, 2015 to be the right to the additional effective common shares as converted utilizing the opening market price of the common stock of $0.15 per share. Such computation valued the beneficial conversion rights to be $1,101,696 for purposes of presenting the net loss to common stock holders. We valued the beneficial conversion rights of the second tranche of Series C Convertible Preferred Stock issued on June 30, 2015, to be the right to the additional effective common shares as converted utilizing the open market price of the common stock of $.014 per share. Such computation valued the beneficial conversion rights to be $1,355,085 for purposes of presenting the net loss to common stockholders.

In connection with the Purchase Agreement, the Company also entered into an Investors’ Rights Agreement with Ervington (the “Investors’ Rights Agreement”). The Investors’ Rights’ Agreement provides that the Holders (as defined in the Investors’ Rights Agreement) of a majority of the outstanding Registerable Securities (defined therein as the shares of common stock and Series A-1 Convertible Preferred Stock (“Series A-1 Preferred Stock”) issued pursuant to the Secondary Stock Purchase Agreement (as defined below), the shares of Series C Preferred Stock issued pursuant to the Purchase Agreement and any common stock issued as dividends thereon or in exchange for such) are entitled to demand registration rights under certain circumstances and piggyback registration rights. In addition, the Investors’ Rights Agreement provides that Ervington (or its assignee) has the right to designate a person to be appointed as the Company’s Chief Executive Officer, a board observer right if a representative of Ervington or its affiliate is not a member of our board of directors and certain consultation rights if a representative of Ervington or its affiliate is not a member of our board of directors so long as it holds a majority of the Registerable Securities and at least 36,000,000 shares of our common stock on an “as converted” basis. Ervington and its affiliates also have a right of first refusal to acquire their pro rata share of any New Securities (as defined in the Investors’ Rights Agreement) which we propose to issue and sell.

In connection with the Purchase Agreement, Ervington also entered into a stock purchase agreement (the “Secondary Purchase Agreement”) with certain of our stockholders (the “Selling Stockholders”), pursuant to which the Selling Stockholders sold to Ervington an aggregate of 7,624,990 shares of our common stock and 2,437,500 shares of our Series A-1 Preferred Stock (representing 24,375,000 shares of our common stock on an as converted basis) at a purchase price of $.001 per share on the closing of the first tranche on February 19, 2015. In terms of the Secondary Purchase Agreement the Selling Stockholders also sold to Ervington on July 6, 2015, after the second closing an additional 56,677,477 shares of our common stock and 700,000 shares of our Series A-1 Preferred Stock (representing 7,000,000 shares of our common stock on an as converted basis) on the closing of the second tranche on July 6, 2015.

The Company also entered into a Stockholders Agreement with the Selling Stockholders and Ervington (the “Stockholders Agreement”) providing that until a Change of Control Transaction (as defined in the Stockholders Agreement), each person a party thereto shall vote all of such person’s shares of our common stock in favor of the designees appointed by Ervington and two additional directors appointed by two of the Selling Stockholders and Ervington agreed to vote its shares in favor of the two designees appointed by the two Selling Stockholders provided that the certain Selling Stockholders continue to own a certain threshold number of shares of our common stock or preferred stock convertible into our common stock. In addition, the Selling Stockholders granted Ervington certain drag along rights in the event of a Change of Control Transaction (as defined in the Stockholders Agreement) and Ervington and its affiliates were granted certain rights of first refusal.

F-20

PROPELL TECHNOLOGIES GROUP, INC. 

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

12 STOCKHOLDERS’ EQUITY DEFICIT (continued)

b) Preferred Stock (continued)

iii) Series C Convertible Preferred Stock (continued)

In accordance with the terms of the Series C Preferred Stock Certificate of Designations (the “Series C Certificate of Designations”), Ervington appointed Ivan Persiyanov to serve as a director, holding two votes and Maria Damianou was appointed to serve as a director during July 2015, holding one vote.. In addition, James Fuller, Mark Kalow and Dan Steffens resigned from the Board of Directors effective upon the closing. In terms of the Series C Certificate of Designation.

In addition, as a condition to the consummation of the Purchase Agreement, the Company filed a Certificate of Designations to our Certificate of Incorporation with the Secretary of State of the State of Delaware setting forth the rights, preferences and privileges of the Series C Preferred Stock, our Bylaws were amended and restated and we entered into an Indemnification Agreement with Ivan Persiyanov.

The terms attached to the Series C Preferred Stock (“Series C Share”) are summarized below:

Conversion

Subject to adjustment for stock splits, stock dividends, reorganizations and recapitalizations and similar transactions, each Series C Share is currently convertible at the option of the holder into 26.67 shares of common stock.

Company Redemption

The Series C Shares are not subject to redemption by the Company.

Voting Rights

Generally, holders of Series C Shares will, on an as-converted basis, vote together with the common stock as a single class.  

Upon the issuance of at least 1,500,000 shares of Series C Preferred Stock the holders of the Series C Preferred Stock, as a class, are entitled to elect either two directors holding one vote or one director holding two votes. Upon the issuance of an aggregate of 4,500,000 shares of Series C Preferred Stock, the holders of the Series C Preferred Stock are entitled to elect either three directors holding one vote each, one director holding three votes or two directors with one director holding two votes and another director holding one vote.

Dividends

The Series C Shares accrue dividends at the rate per annum equal to 4% of the stated price (which initially is $3.277777778) payable annually in arrears on December 31 of each year in preference and priority to any payment of any dividend on our common stock, or any other class of preferred stock.

Liquidation Preference

In the event of our liquidation, dissolution or winding up and other liquidation events (as defined in the Series C Certificate of Designations), holders of Series C Shares are entitled to receive from proceeds remaining after distribution to our creditors and prior to the distribution to holders of common stock or any other class of preferred stockthe (x) stated value (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) held by such holder and (y) all accrued but unpaid dividends on such shares.

Anti-Dilution 

The Series C Shares are entitled to certain weighted average anti-dilution protection as specified in the Series C Certificate of Designations.

F-21

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

12 STOCKHOLDERS’ EQUITY DEFICIT (continued)

b) Preferred Stock (continued)

iii) Series C Convertible Preferred Stock (continued)

No Circumvention

The approval by holders of a majority of the Series C Shares, voting separately as a class, will be required for the following:

(i) merger, sale of substantially all of our assets or our recapitalization, reorganization, liquidation, dissolution or winding up;

(ii) redemption or acquisition of shares of our common stock other than in limited circumstances;

(iii) declaration or payment of a dividend or distribution with respect to our capital stock;

(iv) making any loan or advance;

(v) amending our Certificate of Incorporation or Bylaws;

(vi) authorizing or creating any new class or series of equity security;

(vii) increasing the number of authorized shares for issuance under any existing stock or option plan;

(viii) materially changing the nature of the business

(ix) incurring any indebtedness;

(x) engaging in or making investments not authorized by our board of directors;

(xi) acquiring or divesting a material amount of assets;

(xii) selling, assigning, licensing, pledging or encumbering our material technology or intellectual property;

(xiii) entering into any corporate strategic relationship involving payment, contribution or assignment by us or to us of any assets.

We have undeclared dividends on the Series C Preferred stock amounting to $220,493 as of September 30, 2015. The computation of loss per common share for the three and nine months ended September 30, 2015 takes into account these undeclared dividends.

c) Stock Options

i) Plan options

The Company’s Board of Directors approved the Company’s 2008 Stock Option Plan (the “Stock Plan”) for the issuance of up to 5,000,000 shares of common stock to be granted through incentive stock options, nonqualified stock options, stock appreciation rights, dividend equivalent rights, restricted stock, restricted stock units and other stock-based awards to officers, other employees, directors and consultants of the Company and its subsidiaries. After the reverse stock split in August 2012, a total of 100,000 shares were available for grant. Subsequent to the reverse split the Board of Directors approved an increase in the number of awards available for grant to 2,100,000 shares. The exercise price of stock options under the Stock Plan is determined by the Board of Directors, and may be equal to or greater than the fair market value of the Company’s common stock on the date the option is granted. Options become exercisable over various periods from the date of grant, and generally expire ten years after the grant date.

At September 30, 2015 and December 31, 2014, there were 380,950 Plan options issued and outstanding, respectively, under the Stock Option Plan.

The vesting provisions for these stock options are determined by the board of directors at the time of grant, there are no unvested options outstanding as of September 30, 2015. 

No options were issued during the nine months ended September 30, 2015.

In the event of the employees’ termination, the Company will cease to recognize compensation expense.

F-22

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

12 STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

c) Stock Options (continued)

A summary of all of our option activity during the period January 1, 2014 to September 30, 2015 is as follows: 

	Shares			Exercise price per share		Weighted average exercise price
Outstanding January 1, 2014		11,452,960		$	0.25 to 25.00	$	0.30
Granted		-			-		-
Forfeited/Cancelled		(11,072,010	)		0.25 to 25.00		0.25
Exercised		-			-		-
Outstanding December 31, 2014		380,950		$	0.51 to 13.50	$	0.90
Granted		-			-		-
Forfeited/Cancelled		-			-		-
Exercised		-			-		-
Outstanding September 30, 2015		380,950			0.51 to 13.50		0.90

Stock options outstanding as of September 30, 2015 and December 31, 2014 as disclosed in the above table, have an intrinsic value of $0 and $0, respectively.

The options outstanding and exercisable at September 30, 2015 are as follows:

		Options Outstanding						Options Exercisable
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual life in years		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price		Weighted Average Remaining Contractual life in years
$	13.50		3,480		3.71	$			3,480	$			3.71
$	12.50		2,000		5.04	$			2,000	$			5.04
$	8.50		500		5.75	$			500	$			5.75
$	5.00		14,800		6.04	$			14,800	$			6.04
$	0.65		36,924		7.50	$			36,924	$			7.50
$	0.63		38,096		2.75	$			38,096	$			2.75
$	0.51		285,150		4.54	$			285,150	$			4.54
			380,950		4.70	$	0.90		380,950	$	0.90		4.70

The Company has applied fair value accounting for all share based payment awards since inception. The fair value of each option or warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model. There is no deferred compensation recorded upon initial grant date, instead, for employees, the fair value of the share-based payment is recognized ratably over the stated vesting period. For consultants, the fair value is recognized as expense immediately.

All options are fully vested and have been fully amortized as of September 30, 2015. The Company has recorded an expense of $0 and $1,439,502 for the nine months ended September 30, 2015 and 2014 relating to options issued.

F-23

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

12 STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

(d) Warrants

A summary of all of our warrant activity during the period January 1, 2014 to September 30, 2015 is as follows: 

	Shares		Exercise price per share		Weighted average exercise price
Outstanding January 1, 2014		375,000	$	0.30	$	0.30
Granted		5,964,498		0.15 to 0.25		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding December 31, 2014		6,339,498	$	0.15 to 0.30	$	0.24
Granted		-		-		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding September, 2015		6,339,498	$	0.15 to 0.30	$	0.24

The warrants outstanding and exercisable at September 30, 2015 are as follows:

		Warrants Outstanding						Warrants Exercisable
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual life in years		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price		Weighted Average Remaining Contractual life in years
$	0.30		375,000		3.08	$	0.30		375,000	$	0.30		3.08
$	0.25		1,751,667		3.74	$	0.25		1,751,667	$	0.25		3.74
$	0.15		525,500		3.74	$	0.15		525,500	$	0.15		3.74
$	0.25		1,508,333		3.84	$	0.25		1,508,333	$	0.25		3.84
$	0.15		577,499		3.85	$	0.15		577,499	$	0.15		3.85
$	0.25		968,166		3.85	$	0.25		968,166	$	0.25		3.85
$	0.25		633,333		3.90	$	0.25		633,333	$	0.25		3.90
			6,339,498		3.77	$	0.24		6,339,498	$	0.24		3.77

The warrants outstanding have an intrinsic value of $0 as of September 30, 2015 and December 31, 2014, respectively.

13 EQUITY BASED COMPENSATION

Equity based compensation is made up of the following:

	Nine months ended September 30, 2015		Nine months ended September 30, 2014
Stock option compensation charge	$	-	$	1,439,502
Restricted stock award compensation charge		723,856		-
Stock issued for services rendered		70,000		302,347
	$	793,856	$	1,741,849

F-24

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

14 NET LOSS PER SHARE

Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus common stock equivalents, including convertible preferred shares and convertible notes as well as the incremental shares that would be issued upon the assumed exercise of in-the-money stock options using the treasury stock method. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the nine months ended September 30, 2015 and 2014, all stock options, unvested restricted stock awards, warrants, convertible preferred stock and convertible notes were excluded from the computation of diluted net loss per share. Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:

	Nine Months ended September 30, 2015 (Shares)		Nine months ended September 30, 2014 (Shares)
Options to purchase shares of common stock		380,950		11,452,960
Restricted stock awards – unvested		8,750,000		-
Warrants to purchase shares of common stock		6,339,498		6,339,498
Series A-1 convertible preferred shares		31,375,000		38,875,000
Series B convertible preferred shares		4,000,000		7,500,000
Series C convertible preferred shares		120,000,000		-
Convertible long term notes		-		1,968,750
Convertible short term notes*		-		-
		170,845,448		66,136,208

* In the prior year convertible short term notes have variable conversion pricing dependent upon share prices prior to conversion

15 RELATED PARTY TRANSACTIONS

On February 4, 2015, we entered into an Amended and Restated Employment Agreement (the “Employment Agreement”) with John Huemoeller II, that superseded the Company’s prior Employment Agreement with Mr. Huemoeller that was previously entered into on December 5, 2014 (the “Prior Agreement”).

Under the Employment Agreement, which has a stated term of three (3) years, for his continued service as the Chief Executive Officer and President of the Company, Mr. Huemoeller will continue to receive the same annual base salary of $180,000 provided for under the Prior Agreement and will be entitled to bonuses at the discretion of the Company based on performance. The new Employment Agreement restated a previous grant to Mr. Huemoeller of 10,000,000 shares of the Company’s restricted stock. As of September 30, 2015, 3,750,000 shares have already vested and a further 1,250,000 vested on October 1, 2015, with further vesting taking place on each quarter anniversary commencing January 1, 2016 for another four (4) quarters. The restricted stock grant was in lieu of the options that had previously been granted to Mr. Huemoeller, which options were canceled on December 5, 2014. The Employment Agreement also provides that Mr. Huemoeller will receive a restricted stock grant of 750,000 shares of stock on an annual basis commencing January 1, 2016, which will vest upon issuance. In the event of a Change of Control (as defined in the Employment Agreement), termination without Cause (as defined in the Employment Agreement), termination due to disability (as defined in the Employment Agreement), death or termination by Mr. Huemoeller for Good Reason (as defined in the Employment Agreement), Mr. Huemoeller will receive: (i) a severance payment equal to two (2) months base salary together with payment of medical insurance or COBRA payments for two (2) months after termination; and (ii) all restricted stock grants that have been issued to Mr. Huemoeller will immediately vest. If Mr. Huemoeller terminates his employment at any time prior to January 1, 2016 Without Good Reason (as defined in the Employment Agreement) or is terminated for Cause (as defined in the Employment Agreement) then 5,000,000 of any restricted stock grants will immediately vest. The Employment Agreement also includes customary confidentiality obligations and inventions assignments by Mr. Huemoeller.

On December 5, 2014, the Company entered into a consulting agreement with John Zotos (“Zotos”), our director for a two year period. In terms of the agreement, Zotos will provide consulting services to the Company for a consideration of $5,000 per month and the grant of 3,000,000 restricted shares of which 1,000,000 vested on March 31, 2015, a further 1,000,000 vested on September 30, 2015 and the remaining 1,000,000 will vest on March 31, 2016. Early termination of the agreement by either party will result in immediate vesting of the remaining unvested shares. The Company will also reimburse the consultant for all out of pocket expenses incurred whilst performing his duties. The consulting agreement also includes customary confidentiality obligations and invention assignments by Mr. Zotos.

F-25

PROPELL TECHNOLOGIES GROUP, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

16 COMMITMENTS AND CONTINGENCIES

The Company disposed of its Crystal Magic, Inc. subsidiary effective December 31, 2013. In terms of the sale agreement entered into by the Company, the purchaser has been indemnified against all liabilities whether contingent or otherwise, claimed by third parties, this includes claims by creditors of the Company amounting to $372,090 and claims against long-term liabilities of $848,916. Management does not consider it likely that these claims will materialize and accordingly no provision has been made for these contingent liabilities.

The Company leases approximately 2,300 square feet of office space in Houston, Texas, the original term of the lease agreement terminated on January 31, 2014 with automatic renewals for six month periods unless 60 days written notice is given prior to renewal. The rental is $2,200 per month.

The future minimum lease installments under this agreement as of September 30, 2015 for the period October 1, 2015 to January 31, 2016 (the automatic renewal period) is $8,800.

The Company leases a loft space in Houston, Texas from a related party in terms of a lease agreement entered into on September 1, 2015 and expiring on May 31, 2016. The lease provides for automatic renewal on a month to month basis unless 60 days written notice is given to terminate the lease. The monthly rental is $3,260 per month.

The future minimum lease installments under this agreement as of September 30, 2015 for the period October 1, 2015 to May 31, 2016 is $26,080.

The future minimum operating lease commitments are as follows:

	Amount
2015		16,380
2016		18,500
	$	34,880

In terms of the license agreement commitments disclosed in note 5 above, the minimum commitments due under the amended license agreement entered into on January 30, 2013, for the next five years, are summarized as follows:

	Amount
2015	$	700,000
2016		1,000,000
2017		1,000,000
2018		1,000,000
2019		1,000,000
	$	4,700,000

We are currently in negotiation with the Licensor to waive the $200,000 license fee which was due on June 30, 2015, we are also renegotiating the terms of the minimum royalty payments due and expect these payments to be deferred and amended.

17 JOINT VENTURE

On October 22, 2015, Novas Energy USA, Inc. (“Novas”), a wholly owned subsidiary of Propell Technologies Group, Inc. (the “Company”), entered into an operating agreement with Technovita Technologies USA, Inc. (the “Joint Venture Agreement”) through a newly formed Delaware limited liability company, Novas Energy North America, LLC (“NENA”), whereby Novas agreed to contribute $1,200,000 ($600,000 to be delivered on the effective date (October 22, 2015) of the Joint Venture Agreement, $300,000 on November 1, 2015 and $300,000 on the two month anniversary of the Effective Date) to the capital of NENA for 60% of the membership interests of NENA and Technovita agreed to contribute an aggregate of $800,000 to the capital of NENA for 40% of the membership interests of NENA. In terms of a side agreement entered into on November 18, 2015, the revenue and expenses incurred by Technovita and the Company prior to entering into the operating agreement, have been included in the joint venture and consolidated into the Company’s results effective September 1, 2015.

Subject to certain exceptions and pursuant to the terms of a sublicense agreement (the “Novas Sublicense Agreement”) that was entered into between Novas, NENA and Novas Energy Group Inc. (the “Licensor”), the licensor of Plasma Pulse Technology currently used by Novas and Technovita, NENA will be the exclusive provider of the Vertical Technology (as defined in the Joint Venture Agreement) to third parties in the United States. Subject to certain exceptions and pursuant to the terms of Sublicense Agreements (the “Technovita Sublicense Agreement”) that was entered into between Technovita, NENA and Licensor, NENA is the exclusive provider of the Vertical Technology to third parties in Canada. Notwithstanding the foregoing, both Novas and Technovita will retain the right to deploy the Vertical Technology on wells owned by Novas or Technovita in the United States or Canada, respectively. If either Novas or Technovita terminates the Sublicense Agreement with NENA and Licensor, the non- terminating party will receive 100% of the terminating member’s membership interest in NENA.

The business and affairs of NENA are to be managed by or under the direction of the Board of Directors, consisting of five (5) members, three (3) of whom shall be appointed by Novas and two (2) of whom shall be appointed by Technovita. Board approval is required to: (i) incur any indebtedness, pledge or grant liens on any assets or guarantee, assume, endorse or otherwise become responsible for the obligations of any other person, except to the extent approved or authorized in NENA’s budget; (ii) make any loan, advance or capital contribution in any person, except to the extent approved or authorized in the budget; (iii) transfer any equipment necessary in the deployment of the Vertical Technology to any third party; (iv) enter into or effect any transaction or series of related transactions involving the sale of NENA or the sale, lease, license, exchange or other disposition (including by merger, consolidation, sale of assets or similar business transaction) by NENA of any assets in excess of $300,000; (v) appoint or remove NENA’s auditors or make any changes in the accounting methods or policies of NENA (other than as required by GAAP); (vi) enter into or effect any transaction or series of related transactions involving the purchase, lease, license, exchange or other acquisition (including by merger, consolidation, acquisition of stock or acquisition of assets) by NENA of any assets and/or equity interests of any person and/ or assets in excess of $300,000; or (v) enter into or effect any commercial transaction or series of related commercial transactions involving anticipated liabilities or revenues of NENA in excess of $500,000 or that materially vary from NENA’s existing strategy or business plan.

18 SUBSEQUENT EVENTS

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to September 30, 2015 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements. 

F-26

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis is intended as a review of significant factors affecting our financial condition and results of operations for the periods indicated.  The discussion should be read in conjunction with our consolidated financial statements and the notes presented herein and the risk factors and the financial statements and the other information set forth in our Annual Report on Form 10-K for the year ended December 31, 2014. In addition to historical information, the following Management's Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements that involve risks and uncertainties. Our actual results could differ significantly from those anticipated in these forward-looking statements as a result of certain factors discussed herein and any other periodic reports filed and to be filed with the SEC.

Cautionary Note Regarding Forward-Looking Statements

This report and other documents that we file with the SEC contain forward-looking statements that are based on current expectations, estimates, forecasts and projections about our future performance, our business, our beliefs and our management’s assumptions.  Statements that are not historical facts are forward-looking statements.  Words such as “expect,” “outlook,” “forecast,” “would,” “could,” “should,” “project,” “intend,” “plan,” “continue,” “sustain”, “on track”, “believe,” “seek,” “estimate,” “anticipate,” “may,” “assume,” and variations of such words and similar expressions are often used to identify such forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, those described in this Quarterly Report on Form 10-Q and other reports that we file or furnish with the SEC.  Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements.  Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made.  Except to the extent required by law, we undertake no obligation to update publicly any forward-looking statements after the date they are made, whether as a result of new information, future events, changes in assumptions or otherwise.

Overview and Financial Condition

Our Company

We are a Delaware corporation with principal offices located at 1701 Commerce Street, Houston, Texas 77002. We are engaged in the commercial application of a proprietary Plasma Pulse Technology to enhance the recovery of oil in the United States and Mexico.  We began introducing the Plasma Pulse Technology in the United States on a limited basis in March 2013. Prior to this, all of our revenue had been derived from our e-commerce and other lines of business, which we discontinued, effective December 31, 2014, to enable us to focus all of our attention to our oil recovery business.

Since February 4, 2013, following the closing of the Share Exchange Agreement with the shareholders of Novas, under which we acquired all of the outstanding equity securities of Novas in exchange for 100,000,000 shares of our common stock, our primary focus has been to the further development of our licensed oil recovery technology. The Plasma Pulse Technology used by Novas is based on an exclusive, perpetual royalty-bearing license to engage in the commercial application of the proprietary Plasma Pulse Technology entered into on January 30, 2013, as amended in March 2014 and December 23, 2014 with Novas Energy Group Limited, as licensor which granted Novas the right to use the Plasma Pulse Technology in the United States to enhance oil production.  The License Agreement provides Novas with the right to practice the licensed process and to utilize the Plasma Pulse Technology to provide services to third parties and for ourselves as well, and to sublicense the Plasma Pulse Technology in the United States. In March 2014, the License Agreement was amended to, among other things, increase the territory in which Novas can practice the licensed process and utilize the Plasma Pulse Technology to include Mexico. Although new to the United States and Mexico, the Plasma Pulse Technology has been successfully utilized outside of the United States and Mexico for several years. The Licensor filed for patent protection of the Plasma Pulse Technology in the United States, this patent is still pending.  The process utilizes a down-hole tool that is lowered into vertical wellbores to the perforated oil producing zone.  When initiated, the tool delivers metallic plasma-generated, directed, non-linear, wide-band elastic oscillations at resonance frequencies to enhance oil production using the tool developed by the Licensor and enhanced by Novas.  The Plasma Pulse Technology is suitable for oil wells as deep as 12,000 feet. By optimizing production efficiency combined with the resulting increased oil production we expect to extend the economic life of mature oil fields and to recover previously unrecoverable oil efficiently.

Since March 19, 2013, we have used the Plasma Pulse Technology to treat over forty oil and injector wells located in eight states; Louisiana, Oklahoma, Kansas, Texas, California, Tennessee, Colorado and Wyoming. The Plasma Pulse Technology has been shown to increase oil production or injection rates in many of the wells that we have treated. The initial results of this treatment have been very encouraging, however the results on the wells treated may not be indicative of the results of treatment on additional wells. We currently have six tools that we use to perform the treatments, of which four only work in vertical wells with a minimum of 5 ½-inch casings and not in horizontal wells. We developed U.S. made prototype tools to treat 4 ½-inch cased wells and treated 4 wells with the new tools. 

On October 22, 2015, Novas Energy USA, Inc. (“Novas”), a wholly owned subsidiary of Propell Technologies Group, Inc. (the “Company”), entered into an operating agreement with Technovita Technologies USA, Inc. (the “Joint Venture Agreement”) through a newly formed Delaware limited liability company, Novas Energy North America, LLC (“NENA”), whereby Novas agreed to contribute $1,200,000 ($600,000 to be delivered on the effective date (October 22, 2015) of the Joint Venture Agreement, $300,000 on November 1, 2015 and $300,000 on the two month anniversary of the Effective Date) to the capital of NENA for 60% of the membership interests of NENA and Technovita agreed to contribute an aggregate of $800,000 to the capital of NENA for 40% of the membership interests of NENA.

Subject to certain exceptions and pursuant to the terms of a sublicense agreement (the “Novas Sublicense Agreement”) that was entered into between Novas, NENA and Novas Energy Group Inc. (the “Licensor”), the licensor of Plasma Pulse Technology currently used by Novas and Technovita, NENA will be the exclusive provider of the Vertical Technology (as defined in the Joint Venture Agreement) to third parties in the United States. Subject to certain exceptions and pursuant to the terms of Sublicense Agreements (the “Technovita Sublicense Agreement”) that was entered into between Technovita, NENA and Licensor, NENA is the exclusive provider of the Vertical Technology to third parties in Canada. Notwithstanding the foregoing, both Novas and Technovita will retain the right to deploy the Vertical Technology on wells owned by Novas or Technovita in the United States or Canada, respectively. If either Novas or Technovita terminates the Sublicense Agreement with NENA and Licensor, the non- terminating party will receive 100% of the terminating member’s membership interest in NENA.

To date we have financed our operations, from sales of our securities, both debt and equity, and revenue from operations and we expect to continue to obtain required capital in a similar manner. We have incurred an accumulated deficit of $12,815,903 through September 30, 2015 and there can be no assurance that we will be able to achieve profitability.

Our fiscal year end is December 31.

1

History

Propell Technologies Group, Inc. (f/k/a Propell Corporation) is a Delaware corporation originally formed on January 29, 2008 as CA Photo Acquisition Corp. On April 10, 2008 Crystal Magic, Inc. (“CMI”), a Florida Corporation, merged with an acquisition subsidiary of Propell’s, and we issued an aggregate of 108,000 shares to the former shareholders of CMI. On May 6, 2008, we acquired both Mountain Capital, LLC (d/b/a Arrow Media Solutions) (“AMS”) and Auleron 2005, LLC (d/b/a Auleron Technologies) (“AUL”) and made each a wholly owned subsidiary and issued a total of 41,987 shares of our Common Stock to the members of Mountain Capital, LLC and a total of 2,721 shares of our Common Stock to the members of AUL (the shares referenced above are in pre-split amounts, that is prior to our 50-to-1 reverse split in August 2012). In 2010 AUL and AMS were dissolved. In September 2010, CMI’s assets were foreclosed upon by its largest creditor and these assets were liquidated and effective December 31, 2013, we disposed of our interest in CMI for nominal consideration. On July 6, 2012, we filed a Certificate of Designations, Rights and Preferences with the Secretary of State of the State of Delaware designating 5,000,000 Preferred shares as Series A-1 Preferred Stock. On August 17, 2012, we filed an amendment to our Certificate of Incorporation, which increased the number of shares of our authorized Common Stock to 500,000,000 shares, effectuated a 50:1 reverse split of the number of shares of our outstanding common stock and changed our name to Propell Technologies Group, Inc. On February 4, 2013, we acquired all of the outstanding shares of Novas and Novas became our wholly owned subsidiary. Effective December 31, 2013, we disposed of our ecommerce line of business. On March 14, 2014, we filed a Certificate of Designations, Rights and Preferences with the Secretary of State of the State of Delaware designating 500,000 preferred shares as Series B Preferred Stock. On February 17, 2015, we filed a Certificate of Designations, Rights and Preferences with the Secretary of State of the State of Delaware designating 4,500,000 preferred shares as Series C Preferred Stock. On February 19, 2015, we entered into a Purchase Agreement with Ervington Investments Limited, an entity organized under the laws of the Republic of Cyprus who is wholly owned by Greenleas International Holdings Ltd., which in turn is wholly owned by Harmony Trust Settlement, and closed the first tranche of a private placement offering under the Purchase Agreement, raising $5,000,000 in gross proceeds from the sale of 1,525,424 shares of our Series C Preferred Stock at a purchase price of $3.277777778 per share. We have agreed to use the net proceeds of the offering for research and development, commercialization of new products, sales and marketing, repayment of debt, accounts payable and administrative expenses. On June 30, 2015, Ervington Investments closed the second tranche of a private placement offering under the purchase agreement raising an additional $9,750,000 in gross proceeds from the sale of 2,974,576 shares of our Series C Preferred Stock at a purchase price of $3.277777778. We have agreed to use the proceeds for the acquisition, enhancement and maintenance of an oil field for deployment of our Plasma Pulse Technology.

Until recently, we offered our services on a fee based model and charge a service fee for use of the Plasma Pulse Technology.

In addition, we intend to acquire wells and use the Plasma Pulse Technology on our acquired wells to increase their production.

Management Discussion and Analysis of financial condition

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements as of September 30, 2015 and September 30, 2014, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of any contingent liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. On an on-going basis we review our estimates and assumptions. Our estimates are based on our historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results are likely to differ from those estimates under different assumptions or conditions.

Results of Operations for the three months ended September 30, 2015 and September 30, 2014

Net revenues

Net revenues were $0 for the three months ended September 30, 2015 and 2014 respectively. We did not generate any revenues in Novas as we were not applying the Plasma Pulse technology to treat any wells while we were revising our business model and awaiting requisite approvals to enter into the joint venture agreement with Technovita Technologies USA, Inc. (“Technovita”), through a newly formed company, NENA pursuant to which NENA will be the entity applying the Plasma Pulse Technology to oil wells in the United States and Canada. Technovita has significant commercial experience which will assist in developing the US and Canadian market for the benefit of the Company.

2

Cost of goods sold

Cost of goods sold was $40,275 and $34,620 for the three months ended September 30, 2015 and 2014, respectively, an increase of $5,655 or 16.3%. Cost of goods sold during the current year, primarily represents engineering services provided by third party contractors to Novas which is contracted on a monthly basis and is not correlated to the revenues earned, while cost of goods sold in the prior year represents non-recoverable set up fees including engineering costs and travel costs incurred on the Mexico project, offset by cost recovery fees charged to our customer.

Gross loss

Gross loss was $(40,275) and ($34,620) for the three months ended September 30, 2015 and 2014, respectively, an increase of $5,655. This increase is described under cost of sales above.

Total expenses

Total expenses were $991,083 and $992,561 for the three months ended September 30, 2015 and 2014, respectively, a decrease of $1,478 or 0.5%. Total expenses consisted primarily of the following:

· Stock based compensation expense was $311,284 and $619,125 for the three months ended September 30, 2015 and 2014, respectively, a decrease of $307,841. The current year charge includes a charge of $241,284 for restricted stock issued to our Chief Executive Officer, John Huemoeller and one of our directors, John Zotos, which vest over the next fifteen months and a $70,000 charge for common stock issued to our engineering contractor for services rendered, the prior year charge included a charge of $458,708 which represents a charge for the amortization of stock option compensation expense for options issued to John Zotos, our director and John Huemoeller, our CEO, which options were cancelled and replaced with restricted stock in December 2014 and $160,417 for common stock issued to consultants for services rendered during the prior year..

· General and administrative expenditure was $309,561 and $228,455 for the three months ended September 30, 2015 and 2014, respectively, an increase of $81,106 or 35.5%. This increase is due to expenses incurred in NENA, including contractors’ fees of $71,492, salaries and wages of $26,524, travel expenses of $22,513 and training expenses of $29,164 offset by a reduction in travel expenditure and investor and public relations expenditure in Propell during the current year.

· Professional fees were $243,635 and $65,898 for the three months ended September 30, 2015 and 2014, respectively, an increase of $177,737 or 269.7%. The increase is primarily due to an increase in; i) legal fees which increased by $57,465 due non-recurring work performed on the joint venture agreements by our legal counsel and ii) recruiting fees of $110,348 incurred on the search for appropriate executives for the group and joint venture.

· Consulting fees were $90,229 and $53,181 for the three months ended September 30, 2015 and 2014, respectively, an increase of $37,048 or 69.7%, primarily due to consulting fees incurred by NENA primarily management fees from Technovita and Energy Conservation Management personnel.

· Depreciation and amortization expense was $33,833 and $23,959 for the three months ended September 30, 2015 and 2014, respectively, an increase of $9,874. This is primarily due to additional depreciation expense incurred on the capitalization and deprecation on our US developed down-hole tool.

Amortization of debt discount and finance costs

Amortization of debt discount and finance costs was $54 and $8,309 for the three months ended September 30, 2015 and 2014, respectively. All debt was repaid during the first quarter of the current year. In the prior year, the charge represented the period amortization of debt discount and interest costs on the remaining debt.

Change in fair value of derivatives

The change in fair value of derivative liabilities was $0 and $33,345 for the three months ended September 30, 2015 and 2014 respectively, a decrease of $33,345 or 100.0%. In the prior year the derivative liability movement reflected the mark-to-market of equities issued to short-term note holders who converted their debt to equity at deeply discounted prices based on variable priced conversion rates which was offset by a mark-to-market credits on the remaining short-term convertible notes.

Net loss

We incurred a net loss of $1,031,412 and $918,835 for the three months ended September 30, 2015 and 2014, an increase of $112,577 or 12.3%, respectively and which consists of the various expense items discussed above.

Net loss attributable to non-controlling interest

The net loss attributable to non-controlling interest represents 40% of the loss reported by NENA for the period since inception to September 31, 2015.

A deemed dividend of $157,786 has been disclosed in the statement of operations for the three months ended September 30, 2015. This amount represents the dividends that are due, but remain undeclared, to Series B and Series C preferred stock holders for the three months ended September 30, 2015.

Results of Operations for the nine months ended September 30, 2015 and September 30, 2014

Net revenues

Net revenues were $91,000 and $85,008 for the nine months ended September 30, 2015 and 2014 respectively, an increase of $5,992 or 7.0%. The revenues consist of $91,000 earned on the treatment of several wells in the USA. The revenue from the prior year represented amortization of a once off licensing fee and initial set up revenues for a well treatment project undertaken in Mexico of $40,000, which has subsequently been terminated and renegotiated with another vendor and revenue from the treatment of several wells in the USA amounting to $45,000. Revenue has been sporadic as the business is being developed and comparison to prior periods during this development stage has limited value to business analysis.

3

Cost of goods sold

Cost of goods sold was $140,245 and $136,645 for the nine months ended September 30, 2015 and 2014, respectively, an increase of $3,600 or 2.6%. Cost of goods sold during the current year, primarily represents engineering services provided by third party contractors to Novas which is contracted on a monthly basis and is not correlated to the revenues earned, while cost of goods sold in the prior year represents non-recoverable set up fees including engineering costs and travel costs incurred on the Mexico project, offset by cost recovery fees charged to our customer.

Gross loss

Gross loss was $(49,245) and $(51,637) for the nine months ended September 30, 2015 and 2014, respectively, a decrease of $2,392 or 4.6%. The decrease is due to higher revenues earned in the current year, offset by slightly higher expenses in the current year, as described above.

Total expenses

Total expenses were $2,438,389 and $2,713,363 for the nine months ended September 30, 2015 and 2014, respectively, a decrease of $274,974 or 10.1%. Total expenses consisted primarily of the following:

· Stock based compensation expense was $793,856 and $1,741,849 for the nine months ended September 30, 2015 and 2014, respectively, a decrease of $947,993. The current year charge includes a charge of $723,856 for restricted stock issued to our Chief Executive Officer, John Huemoeller and one of our directors, John Zotos, which vest over the next fifteen months and $70,000 for common stock issued to our engineering contractor for services rendered, the prior year charge included a charge of $302,347 for shares issued to certain consultants and advisors and a charge of $1,439,502 which represents a charge for the amortization of stock option compensation expense for options issued to John Zotos, our director and John Huemoeller, our CEO, which options were cancelled and replaced with restricted stock in December 2014.

· General and administrative expenditure was $600,557 and $574,844 for the nine months ended September 30, 2015 and 2014, respectively, an increase of $25,713 or 4.5%. This increase is due to expenses incurred in NENA, including contractors’ fees of $71,492, salaries and wages of $26,524, travel expenses of $22,513 and training expenses of $29,164 offset by  a reduction in travel expenditure, investor relations expenses and directors’ fees during the current year.

· Professional fees were $625,699 and $200,931 for the nine months ended September 30, 2015 and 2014, respectively, an increase of $424,768 or 211.4%. The increase is primarily due to an increase in; i) legal expenditure which increased by $240,222 over the prior year due to additional time spent on the joint venture arrangements and the second tranche investment into the Company by Ervington Investments and legal fees incurred on patents for our improvements to the down-hole too; an increase in recruitment fees of $110,348 as we searched for appropriate executives for the Company and an increase in corporate secretarial fees of $21,000 which was introduced in April 2014.

· Consulting fees were $309,896 and $140,405 for the nine months ended September 30, 2015 and 2014, respectively, an increase of $169,491 or 120.7%, primarily due to consulting fees due to a third party of $110,090 for recruiting services while we attempt to increase the depth of our management skills in the Company and for the newly formed joint venture; fees payable to an individual of $15,000 assist with sales, field work and administration before the joint venture comes into operation and management consulting fees paid to Technovita and Energy Conservation Management incurred by NENA.

· Depreciation and amortization expense was $103,149 and $49,308 for the nine months ended September 30, 2015 and 2014, respectively, an increase of $53,841, this is primarily due to the increase in depreciation expense of $36,340 primarily due to the capitalization and deprecation on our US developed down-hole tool and an increase in the amortization of our licensed technology of $17,500 which amortization only commenced in April 2014.

Amortization of debt discount and finance costs

Amortization of debt discount and finance costs was $53,154 and $503,991 for the nine months ended September 30, 2015 and 2014, respectively. All debt was repaid during the first quarter of the current year. In the prior year, the amortization of debt and finance costs, included the accelerated amortization of debt discount on notes that were repaid or converted into equity and normal amortization on the remaining notes.

Change in fair value of derivatives

The change in fair value of derivative liabilities was $18,455 and $(430,956) for the nine months ended September 30, 2015 and 2014 respectively, a decrease of $449,411. In the prior year the derivative liability movement reflected a mark-to-market of equities issued to short-term note holders who converted their debt to equity at deeply discounted prices based on variable priced conversion rates which was offset by a mark-to-market credits on the remaining short-term convertible notes and a new derivative liabilities raised on short term debt issued in the prior year.

Net loss

We incurred a net loss of $(2,522,333) and $(3,549,947) for the nine months ended September 30, 2015 and 2014, a decrease of $1,027,614 or 28.9%, respectively and which consists of the various revenue and expense items discussed above.

Net loss attributable to non-controlling interest

The net loss attributable to non-controlling interest represents 40% of the loss reported by NENA for the period since inception to September 31, 2015

A deemed preferred stock dividend of $2,456,781 and $1,604,335 has been disclosed in the statement of operations for the nine months ended September 30, 2015 and 2014, respectively. This amount represents the in-the-money value of the conversion feature of the Series C and the Series B Preferred Stock as of the date of issue. These shares of Series C and Series B Preferred Stock are convertible into common stock at an exercise price of $0.12291665 and $0.10 per share, respectively.

A deemed dividend of 302,948 has been disclosed in the statement of operations for the nine months ended September 30, 2015 and 2014, respectively. This amount represents the dividends that are due, but remain undeclared, to Series B and Series C preferred stock holders for the nine months ended September 30, 2015.

4

Liquidity and Capital Resources.

To date, our primary sources of cash have been funds raised from the sale of our securities and the issuance of convertible and non-convertible debt. We raised gross proceeds of $14,750,000 from the sale of our Series C Preferred Stock in February 2015 and June 2015. In addition, we also raised temporary debt in the aggregate principal amount of $125,000 from the sale of our debt securities, this debt together will all other outstanding interest bearing debt in the aggregate principal amount of $296,000, including interest and early settlement penalty interest thereon was repaid on February 20, 2015 out of the proceeds raised from the sale of the Series C Preferred Stock.

We have spent $432,165 on plant and equipment for the nine months ended September 30, 2015, primarily on improvements to the down-hole tool and the development of seven new down-hole tools suitable for the smaller cased American wells.

We have incurred an accumulated deficit of $12,845,919 through September 30, 2015 and incurred negative cash flow from operations of $1,678,868 for the nine months ended September 30, 2015. We have spent, and need to continue to spend, substantial amounts in connection with implementing our business strategy, including our planned product development effort.

Our primary commitments include the minimum commitments under the license agreements and our commitment to invest $1,200,000 into the joint venture based on their cash flow needs, commencing once the agreements have been finalized.

Our minimum commitments under the License Agreement for the next five years is summarized as follows: 

	Amount
2015	$	700,000
2016		1,000,000
2017		1,000,000
2018		1,000,000
2019		1,000,000
	$	4,700,000

As of September 30, 2015 we had notes, in the principal amount outstanding of $3,000, this note is non-interest bearing and has no fixed repayment terms.

Off Balance Sheet Arrangements

There are no off balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures About Market Risks

None.

Item 4. Controls and Procedures

(a) Evaluation of disclosure controls and procedures

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer (“CEO”), who also serves as our principal financial and accounting officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s CEO who also serves as our principal financial and accounting officer concluded that due to a lack of segregation of duties and insufficient controls over review and accounting for certain complex transactions, that the Company’s disclosure controls and procedures as of September 30, 2015 were not effective to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, was recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Company’s CEO, as appropriate, to allow timely decisions regarding required disclosure. The Company intends to retain additional individuals to remedy the ineffective controls. We have begun to take actions that we believe will substantially remediate the material weaknesses identified. In response to the identification of our material weaknesses, we are in the process of expanding our finance and accounting staff. However, we cannot assure you that our internal control over financial reporting, as modified, will enable us to identify or avoid material weaknesses in the future.

(b) Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our fiscal quarter ended September 30, 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

5

Part II. OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

Investing in our Company involves a high degree of risk. In addition to the risks related to our business set forth in this Form 10-Q, you should carefully consider the risks described below before investing in our Company. Additional risks, uncertainties and other factors not presently known to us or that we currently deem immaterial may also impair our business operations.

Risks Relating to Our Company

Our business is difficult to evaluate because we are currently focused on a new line of business and a new business strategy and have very limited operating history and limited information.

We have recently engaged in a new business line involving our Plasma Pulse Technology. We have also recently switched our business model with our entry into a joint venture agreement with Technovita. There is a risk that the joint venture will be unable to successfully operate this new line of business or be able to successfully integrate it with Technovita’s management and structure. The joint venture estimates of capital, personnel and equipment required for our new line of business are based on the experience of management and businesses they are familiar with. The joint venture management has limited direct experience in this new line of business. The joint venture is subject to the risks such as their ability to implement their business plan, market acceptance of the proposed business and services, under-capitalization, cash shortages, limitations with respect to personnel, financing and other resources, competition from better funded and experienced companies, and uncertainty of their ability to generate revenues. There is no assurance that the joint venture activities will be successful or will result in any revenues or profit, and the likelihood of their success must be considered in light of the stage of development. Even if the joint venture generates revenue, there can be no assurance that it will be profitable. In addition, no assurance can be given that the joint venture will be able to consummate its business strategy and plans, as described herein, or that financial, technological, market, or other limitations may force the joint venture to modify, alter, significantly delay, or significantly impede the implementation of such plans. The joint venture has insufficient results for investors to use to identify historical trends or even to make quarter to quarter comparisons of its operating results. You should consider our prospects in light of the risk, expenses and difficulties we will encounter as an early stage company. Our revenue and income potential is unproven and our business model is continually evolving. We are subject to the risks inherent to the operation of a new business enterprise, and cannot assure you that we will be able to successfully address these risks.

We currently have limited revenues from our Plasma Pulse Technology and may not generate any revenue in the near future, if at all, from the use of our technology.

We currently have generated limited revenues from the use of our Plasma Pulse Technology. The majority of the wells that were treated were treated as sample wells to demonstrate the ability of the Plasma Pulse Technology at no cost to the well owner. Therefore there can be no assurance that well owners will determine that the price to be paid by the joint venture customers for their services, whether in the form of a cash payment or profit sharing arrangement, will be deemed to be reasonable and that customers will be willing to pay such prices.

We may not be profitable.

We expect to incur operating losses for the foreseeable future.   For the nine months ended September 30, 2015 and the year ended December 31, 2014, we had net revenues of $91,000 and $190,035, respectively, from our oil recovery business. For the nine months ended September 30, 2015 and the year ended December 31, 2014, we sustained a net loss of $2,522,333 and $5,018,483, respectively.  To date, we have not generated significant revenue from our Plasma Pulse Technology. Our ability to become profitable depends on our ability to have successful operations and generate and sustain sales, while maintaining reasonable expense levels, all of which are uncertain in light of our limited operating history in our current line of business and our recent changes in business strategy.

Our future plans and operations may require that we raise additional capital.

To date, we have not generated enough revenue from operations to pay all of our expenses. During the nine months ended September 30, 2015 and the year ended December 31, 2014 we raised a total of $14,750,000 from our private placement of Series C Preferred stock to Ervington consummated during February 2015 and $1,103,000 during the period June to August of 2014 and an additional $750,000 from the sale of our Series B Preferred Stock in March 2014. We have used the funds raised in our financings for working capital purposes and intend to acquire an oil well with the funds that were recently raised. However there can be no assurance that we will be able to achieve our goals with the cash on hand or the cash generated from operations.

The joint venture may not be able to service customers with the five tools that we currently have.

The Joint ventures ability to continue to service customers and expand its business is dependent upon us acquiring additional apparatuses to be utilized with the Plasma Pulse Technology. We currently have four down-hole tools that can treat 5 ½ inch cased wells and one new tool that treats 4 ½-inch cased wells and horizontal wells. If the tools should require repair the joint venture may be unable to service customers. In addition, with only five tools, the joint venture can only treat a limited number of wells at a time and are unable to treat wells on days when the tools are in transit from one customer’s well to another well. In addition, only one of the tools can treat the 4 ½-inch cased wells and horizontal wells.

6

There is no guarantee that the planned joint venture will be successful.

To date, Technovita has treated very limited wells with the Plasma Pulse Technology and therefore there is no guarantee that the Technovita team will be successful in meeting its milestones. Due to limited data about well treatment it is difficult to assess the revenue to be derived from the Canadian wells, which may not perform as expected and may contribute less than 40% to the revenue of the planned joint venture. We will only have a 60% interest in revenue derived from treatment of U.S. wells instead of our current 100% interest. Although Novas has the right to terminate the joint venture if certain milestones are not met, if the milestones are met there can be no assurance that the revenue derived from U.S. wells will not exceed 60% of the revenue of the joint venture. We have not received a valuation or fairness opinion regarding the planned joint venture and its percent ownership in the joint venture. We are required to contribute $1,200,000 to the joint venture that may not be recovered in the event that the joint venture dissolves. In addition, the joint venture will bear the additional costs associated with the additional Technovita management team.

There is uncertainty as to market acceptance of the Plasma Pulse Technology and products.

The Plasma Pulse Technology that we license has been utilized in the United States on a limited basis. We have not yet generated significant revenue from the Plasma Pulse Technology that we license and there can be no assurance that the Plasma Pulse Technology will be accepted in the market or that our commercialization efforts or those of the joint venture will be successful.

The results of our the application of our technology for initial well treatments may not support future well treatments and are not necessarily predictive of future long term results on the wells for which the initial data is favorable.

To date, we have applied our licensed Plasma Pulse Technology to treat over forty wells, which treatments were performed fairly recently, and we do not have long terms results on the wells that were treated. Of such wells, we have seen improvement results in many wells. Favorable results in our early treatments may not last and may not be repeated in later treatments of other wells. Success in early treatments does not ensure that wells treated at a later date will be successful. Additionally, collecting treatment data results is not always possible as operators that pay for the service are not required to deliver data or we are required to work under non-disclosure agreements.

We rely on a license to use the Plasma Pulse Technology that is material to our business and if the agreement were to be terminated, it would halt our ability to market our technology, as well as have an immediate material adverse effect on our business, operating results and financial condition.

We have a License Agreement with Novas Energy Group Limited granting us the right to use certain critical intellectual property which we have sub-licensed to NENA. If we or NENA breach the terms of this agreement, including any failure to make minimum royalty payments required thereunder, the Licensor has the right to terminate the license. If we or NENA were to lose or otherwise be unable to maintain this license on acceptable terms, or find that it is necessary or appropriate to secure new licenses from other third parties, it would halt our ability or that of NENA to market the Plasma Pulse Technology, which would have an immediate material adverse effect on our business, operating results and financial condition.

We may be unable to generate sufficient revenues to meet the minimum royalties under our license agreement,

The License Agreement with Novas Energy Group Limited requires us to pay aggregate minimum royalty payments of $1,000,000 per year; however, no minimum royalty payment is due prior to (i) December 31, 2015 with respect to Mexican operations and (ii) the three year anniversary of the license agreement with respect to the United States operations. If the minimum royalty is not timely paid, the Licensor has the right to terminate the license agreement with respect to a certain territory under certain circumstances and in certain other circumstances has the right to terminate the entire agreement. In addition, we are currently renegotiating the waiver of the $200,000 due with respect to our rights in Mexico and we are simultaneously renegotiating the terms of the minimum annual royalty requirements. To date, we have not generated enough revenue to pay minimum royalty payments. No assurance can be given that we or the joint venture will generate sufficient revenue to make these minimum royalty payments. Any failure to make the payments would permit the Licensor to terminate the license. If we were to lose or otherwise be unable to maintain this license, it would halt our ability to market our technology, which would have an immediate material adverse effect on our business, operating results and financial condition.

The beneficial ownership of a significant percentage of our common stock gives Ervington effective control of us, and limits the influence of other shareholders on important policy and management issues.

Ervington currently beneficially owns approximately 50.9% of our voting shares on a fully diluted basis (including outstanding options, warrants and convertible instruments). In addition, Ervington currently has the right to three votes on our board of directors and has appointed two members with an aggregate of three votes which constitutes a majority of the votes on our board of directors. As a result of these appointment rights and its voting control of our company, Ervington has the power to control the outcome of all matters submitted to our shareholders for approval, including the election of our directors, our business strategy, our day-to-day operations and any proposed merger, consolidation or sale of all or substantially all of our assets. Ervington’s control of our company could discourage the acquisition of our common stock by potential investors and could have an anti-takeover effect, preventing a change in control of our company that might be otherwise beneficial to our shareholders, and possibly depress the trading price of our common stock. There can be no assurance that conflicts of interest will not arise with respect to Ervington’s ownership and control of our company or that any conflicts will be resolved in a manner favorable to the other shareholders of our company.

7

Trends in oil and natural gas prices affect the level of exploration, development, and production activity of our customers and the demand for our services and products which could have a material adverse effect on our business, consolidated results of operations, and consolidated financial condition.

Demand for the services and products of the joint venture or oil derived from wells we acquire is particularly sensitive to the level of exploration, development, and production activity of, and the corresponding capital spending by, oil and natural gas companies, including national oil companies. The level of exploration, development, and production activity is directly affected by trends in oil and natural gas prices, which historically have been volatile and are likely to continue to be volatile.

Prices for oil and natural gas are subject to large fluctuations in response to relatively minor changes in the supply of and demand for oil and natural gas, market uncertainty, and a variety of other economic factors that are beyond our control. The recent decline in oil prices from $80 per barrel in December 2014 to $45 per barrel in March 2015 has resulted in a decline in oil drilling rigs which has depressed the immediate level of exploration, development, and production activity which could have a material adverse effect on our business, consolidated results of operations, and consolidated financial condition. Even the perception of longer-term lower oil and natural gas prices by oil and natural gas companies can similarly reduce or defer major expenditures given the long-term nature of many large-scale development projects. Factors affecting the prices of oil and natural gas include:

· the level of supply and demand for oil and natural gas, especially demand for natural gas in the United States;

· governmental regulations, including the policies of governments regarding the exploration for and production and development of their oil and natural gas reserves;

· weather conditions and natural disasters;

· worldwide political, military, and economic conditions;

· the level of oil production by non-OPEC countries and the available excess production capacity within OPEC;

· oil refining capacity and shifts in end-customer preferences toward fuel efficiency and the use of natural gas;

· the cost of producing and delivering oil and natural gas; and

· potential acceleration of development of alternative fuels.

Legislative and regulatory changes affecting the environment and the oil industry could adversely affect our business

Political, economic and regulatory influences are subjecting oil recovery efforts to potential fundamental changes that could substantially affect our results of operations. State and local governments, for example, continue to propose and pass legislation designed to reduce the impact of oil recovery efforts on the environment. We cannot predict the effect any legislation may have on our business and we can offer no assurances they will not have a material adverse effect on our business.

Various federal legislative and regulatory initiatives have been undertaken which could result in additional requirements or restrictions being imposed on hydraulic fracturing operations and possibly our operations. For example, the Department of Interior has issued proposed regulations that would apply to hydraulic fracturing operations on wells that are subject to federal oil and gas leases and that would impose requirements regarding the disclosure of chemicals used in the hydraulic fracturing process as well as requirements to obtain certain federal approvals before proceeding with hydraulic fracturing at a well site. These regulations, if adopted, could also be applicable to our operations and would establish additional levels of regulation at the federal level that could lead to operational delays and increased operating costs. At the same time, legislation and/or regulations have been adopted in several states that require additional disclosure regarding chemicals used in the hydraulic fracturing process but that include protections for proprietary information. Legislation and/or regulations are being considered at the state and local level that could impose further chemical disclosure or other regulatory requirements (such as restrictions on the use of certain types of chemicals or prohibitions on hydraulic fracturing operations and competitive operations in certain areas) that could affect our operations.

The adoption of any future federal, state, local, or foreign laws or implementing regulations imposing reporting obligations on, or limiting or banning, the hydraulic fracturing process if applicable to competitive processes such as ours, could make it more difficult to complete natural gas and oil wells and could have a material adverse effect on our liquidity, consolidated results of operations, and consolidated financial condition.

Liability for cleanup costs, natural resource damages, and other damages arising as a result of environmental laws could be substantial and could have a material adverse effect on our liquidity, consolidated results of operations, and consolidated financial condition.

We will be exposed to claims under environmental requirements for wells we acquire and treat and the joint venture will be exposed to claims under environmental requirements for wells it treats. In the United States, environmental requirements and regulations typically impose strict liability. Strict liability means that in some situations we or the joint venture could be exposed to liability for cleanup costs, natural resource damages, and other damages as a result of our or the joint ventures conduct that was lawful at the time it occurred or the conduct of prior operators or other third parties. Liability for damages arising as a result of environmental laws could be substantial and could have a material adverse effect on our liquidity, consolidated results of operations, and consolidated financial condition.

8

Existing or future laws, regulations, related to greenhouse gases and climate change could have a negative impact on our business and may result in additional compliance obligations with respect to the release, capture, and use of carbon dioxide that could have a material adverse effect on our liquidity, consolidated results of operations, and consolidated financial condition.

Changes in environmental requirements related to greenhouse gases and climate change may negatively impact demand for the services of the joint venture. For example, oil and natural gas exploration and production may decline as a result of environmental requirements (including land use policies responsive to environmental concerns). State, national, and international governments and agencies have been evaluating climate-related legislation and other regulatory initiatives that would restrict emissions of greenhouse gases in areas in which we conduct business. Because our business depends on the level of activity in the oil and natural gas industry, existing or future laws, regulations, treaties, or international agreements related to greenhouse gases and climate change, including incentives to conserve energy or use alternative energy sources, could have a negative impact on our business if such laws, regulations, treaties, or international agreements reduce the worldwide demand for oil and natural gas. Likewise, such restrictions may result in additional compliance obligations with respect to the release, capture, sequestration, and use of carbon dioxide that could have a material adverse effect on our liquidity, consolidated results of operations, and consolidated financial condition.

Our failure to protect our proprietary information and any successful intellectual property challenges or infringement proceedings against us could materially and adversely affect our competitive position.

We rely on a variety of intellectual property rights that the joint venture uses in its services and products. We may not be able to successfully preserve these intellectual property rights in the future, and these rights could be invalidated, circumvented, or challenged. In addition, the laws of some foreign countries in which our services and products may be sold do not protect intellectual property rights to the same extent as the laws of the United States. Our failure to protect our proprietary information and any successful intellectual property challenges or infringement proceedings against us could materially and adversely affect our competitive position and that of the joint venture.

9

Any future recompletion activities engaged upon by us on wells that we acquire may not be productive.

We may acquire properties upon which we believe recompletion activity will be successful. Recompletion or workovers on oil and natural gas wells involves numerous risks, including the risk that we will not encounter commercially productive oil or natural-gas reservoirs. The costs of recompleting, and operating wells are often uncertain, and operations may be curtailed, delayed, or canceled as a result of a variety of factors, including the following unexpected drilling conditions:

· pressure or irregularities in formations;

· equipment failures or accidents;

· fires, explosions, blowouts, and surface cratering;

· difficulty identifying and retaining qualified personnel;

· title problems;

· other adverse weather conditions; and

· shortages or delays in the delivery of equipment

Certain of our future activities may not be successful and, if unsuccessful, this failure could have an adverse effect on our future results of operations and financial condition.

We intend to become an exploration stage company.

We intend to use the proceeds from the sale of our Series C Preferred Stock to acquire oil fields and intend to become an exploration stage company which will face a high risk of business failure because of the unique difficulties and uncertainties inherent in oil and gas exploration ventures. Potential investors should be aware of the risks and uncertainties normally encountered by oil and gas exploration companies and the high rate of failure of such companies. The likelihood of our success must be considered in light of the problems, expenses, difficulties, complications and delays that could be encountered in connection with our planned exploration and followed drilling. These potential problems include, but are not limited to, possible problems relating to exploration and additional costs and expenses that may reduce our current forecast of income and asset value. Additional expenditures related to exploration may not result in the confirmation of anticipated oil and gas reserves. Problems such as unusual or unexpected formations and other conditions are involved in mineral exploration and often result in unsuccessful exploration efforts. If the results of our exploration do not reveal viable oil and gas reserves beyond the reserves that have been proven with historically drilled wells, we may decide to acquire additional exploration and production assets, modify our current leases agreements into deeper horizons or terminate our activities all together. The acquisition of additional fields will be dependent upon us possessing capital resources at that time in order to purchase and/or maintain such concessions. If no funding is available, we may be forced to cease our operations.

Our anticipated future oil drilling and producing operations will involve various risks.

Once we acquire wells and commence oil drilling activities, we will be subject to all the risks normally incident to the operation and development of oil and natural gas properties, including:

· well blowouts, cratering, explosions and human related accidents

· mechanical, equipment and pipe failures

· adverse weather conditions and natural disasters

· civil disturbances and terrorist activities

· oil and natural gas price reductions

· environmental risks stemming from the use, production, handling and disposal of water, waste materials, hydrocarbons and other substances into the air, soil or water title problems

· limited availability of financing

· marketing related infrastructure, transportation and processing limitations

· regulatory compliance issues

We intend to maintain insurance against many potential losses or liabilities arising from well operations in accordance with customary industry practices and in amounts believed by management to be prudent. However, insurance will not protect us against all risks.

10

Uncertainty of economic conditions, worldwide and in the United States, may have a significant negative effect on operating results, liquidity and financial condition.

Effects of change in domestic and international economic conditions could include a decline in demand for oil and natural gas resulting in decreased oil, and natural gas reserves due to curtailed drilling activity; A decline in reserves would lead to a decline in production, and either a production decline, or a decrease in oil, and natural gas prices, would have a negative impact on our cash flow, profitability and value.

There is competition in the oil and gas industry for acquisition of oil wells and we have limited financial and personnel resources with which to compete.

Competition in the oil and gas industry is extremely intense in all aspects, including but not limited to raising investment capital for exploration and obtaining qualified managerial and technical employees. We are an insignificant participant in the oil and gas industry due to our limited financial and personnel resources. Our competition includes large established oil and gas companies, with substantial capabilities and with greater financial and technical resources than we have, as well as the myriad of other exploration stage companies These companies are able to pay more for development prospects and productive oil and natural gas properties and are able to define, evaluate, bid for, purchase and subsequently drill a greater number of properties and prospects than our financial or human resources permit. As a result of this competition, we may be unable to attract the necessary funding or qualified personnel. If we are unable to successfully compete for funding or for qualified personnel, our activities may be slowed, suspended or terminated, any of which would have a material adverse effect on our ability to continue operations.

Shortages of oil field equipment, services, qualified personnel and resulting cost increases could adversely affect results of operations.

 The demand for qualified and experienced field personnel, geologists, geophysicists, engineers and other professionals in the oil and natural gas industry can fluctuate significantly, often in correlation with oil and natural gas prices, resulting in periodic shortages. When demand for rigs and equipment increases due to an increase in the number of wells being drilled, there have been shortages of drilling rigs, hydraulic fracturing equipment and personnel and other oilfield equipment. Higher oil and natural gas prices generally stimulate increased demand for, and result in increased prices of, drilling rigs, crews and associated supplies, equipment and services. These shortages or price increases could negatively affect the ability to drill wells and conduct ordinary operations by the operators of the Company’s wells, resulting in an adverse effect on the Company’s financial condition, cash flow and operating results.

Our operations will be subject to permitting requirements.

Oil drilling operations will be subject to permitting requirements which could require us to delay, suspend or terminate our operations. Our operations, including but not limited to any exploitation program, require permits from the U.S. government. We may be unable to obtain these permits in a timely manner, on reasonable terms, or at all. If we cannot obtain or maintain the necessary permits, or if there is a delay in receiving these permits, our timetable and business plan for exploration and/or exploitation, may be materially and adversely affected.

International expansion of our business exposes us to business, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States.

Our amended license agreement grants us a license, which has been sub-licensed to NENA, to utilize the Plasma Pulse Technology in Mexico and the joint venture is anticipated to conduct business in Canada. Doing business internationally involves a number of risks, including:

· multiple, conflicting and changing laws and regulations such as tax laws, export and import restrictions, employment laws, regulatory requirements and other governmental approvals, permits and licenses;

· failure by us to obtain regulatory approvals for the sale or use of our technology in various countries;

· difficulties in managing foreign operations;

· financial risks, such as longer payment cycles, difficulty enforcing contracts and collecting accounts receivable and exposure to foreign currency exchange rate fluctuations;·

· reduced protection for intellectual property rights;

· natural disasters, political and economic instability, including wars, terrorism and political unrest, outbreak of disease, boycotts, curtailment of trade and other business restrictions; and

· failure to comply with the Foreign Corrupt Practices Act, including its books and records provisions and its anti-bribery provisions, by maintaining accurate information and control over activities.

Any of these risks, if encountered, could significantly harm the future international expansion and operations of the joint venture and, consequently, have a material adverse effect on our financial condition, results of operations and cash flows.

We will have limited control over the activities on properties for which we own an interest but we do not operate.

We may acquire interests in oil wells that will be operated by other companies. We will have limited ability to influence or control the operation or future development of these non-operated properties or the amount of capital expenditures that we are required to fund with respect to them. Our dependence on the operator and other working interest owners for these projects and our limited ability to influence or control the operation and future development of these properties could materially adversely affect the realization of our targeted returns on capital and lead to unexpected future costs.

11

The loss of key personnel and an inability to attract and retain additional personnel could affect our ability to successfully grow our business.

We are highly dependent upon the continued service and performance of our senior management. The loss of any key employees may significantly delay or prevent the achievement of our business objectives. We believe that our future success will also depend in part on our and their continued ability to identify, hire, train and motivate qualified personnel. We face intense competition for qualified individuals. We may not be able to attract and retain suitably qualified individuals who are capable of meeting our growing operational and managerial requirements, or we may be required to pay increased compensation in order to do so. Our failure to attract and retain qualified personnel could impair our ability to implement our business plan.

We may be adversely affected by actions of our competitors.

The market in the oil and gas recovery industry is highly competitive. Many of our competitors have substantially greater financial, technical and other resources than we have. We face competition from owners of oil wells as well as large oil and gas companies The ability of the joint venture to compete effectively depends in part on market acceptance of our technology, the environmental impact of our technology and the joint ventures ability to service its customers in a timely manner. There can be no assurance that the joint venture will be able to compete effectively or that it will respond appropriately to industry trends or to activities of competitors.

Most of the potential customers of the joint venture are owners of oil wells and are subject to risks faced by those industries.

We expect the joint venture to derive a significant portion of our future revenues from the implementation of the Plasma Pulse Technology. As a result, it will be subject to risks and uncertainties that affect the oil industry, such as availability of capital, weather and environmental issues, government regulation, and the uncertainty resulting from technological change.

We have no separate independent audit committee. Our full Board of Directors functions as our audit committee and is composed of four directors, none of whom are considered to be independent. This may hinder our Board of Directors’ effectiveness in fulfilling the functions of the audit committee.

Currently, we have no separate audit committee. Our full Board of Directors functions as our audit committee and is comprised of four directors, one of whom has two votes and none of whom are considered to be "independent" in accordance with the requirements of Rule 10A-3 under the Exchange Act. An independent audit committee plays a crucial role in the corporate governance process, assessing the Company's processes relating to its risks and control environment, overseeing financial reporting, and evaluating internal and independent audit processes. The lack of an independent audit committee may prevent the Board of Directors from being independent from management in its judgments and decisions and its ability to pursue the committee's responsibilities without undue influence. We may have difficulty attracting and retaining directors with the requisite qualifications. If we are unable to attract and retain qualified, independent directors, the management of our business could be compromised.

Our Board of Directors, which does not have a majority of independent directors, acts as our compensation committee, which presents the risk that compensation and benefits paid to these executive officers who are board members and other officers may not be commensurate with our financial performance.

A compensation committee consisting of independent directors is a safeguard against self-dealing by company executives. Our Board of Directors acts as the compensation committee and determines the compensation and benefits of our executive officers, administers our employee stock and benefit plans, and reviews policies relating to the compensation and benefits of our employees. Although all board members have fiduciary obligations in connection with compensation matters, our lack of an independent compensation committee presents the risk that our executive officers on the board may have influence over their personal compensation and benefits levels that may not be commensurate with our financial performance.

12

Trading on the OTCQB may be sporadic because it is not a stock exchange, and stockholders may have difficulty reselling their shares.

Trading in stock quoted on the OTCQB is often thin and characterized by wide fluctuations in trading prices, due to many factors that may have little to do with our operations or business prospects. Moreover, the OTCQB is not a stock exchange, and trading of securities on the OTCQB is often more sporadic than the trading of securities listed on a quotation system like NASDAQ or a stock exchange like NYSE. Accordingly, you may have difficulty reselling any of the shares you purchase from the selling stockholders.

We cannot guarantee that an active trading market will develop for our common stock.

There currently is not an active public market for our common stock and there can be no assurance that a regular trading market for our common stock will ever develop or that, if developed, it will be sustained. Therefore, purchasers of our common stock should have long-term investment intent and should recognize that it may be difficult to sell the shares, notwithstanding the fact that they are not restricted securities. We cannot predict the extent to which a trading market will develop or how liquid a market might become.

There may be future dilution of our common stock.

If we sell additional equity or convertible debt securities, those sales could result in additional dilution to our stockholders. Holders of our Series A-1 Preferred Stock have the right to convert their shares into 31,375,000 shares of common stock and; the holder of the Series B Preferred Stock has the right to convert his shares into 4,000,000 common shares and Ervington, the sole holder of the Series C Preferred Stock has the right to convert its shares of Series C Preferred Stock into 120,000,000 shares of common stock. We also have warrants outstanding that are convertible into 6,339,498 shares of our common stock.

Recent accounting changes may make it more difficult for us to sustain profitability.

We are a publicly traded company, and are therefore subject to the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), which requires that our internal controls and procedures comply with Section 404 of the Sarbanes-Oxley Act. We expect compliance to be costly and it could impact our results of operations in future periods. In addition, the Financial Accounting Standards Board now requires us to follow the accounting standards on share based payments. Under this rule, companies must calculate and record in their statement of operations the cost of equity instruments, such as stock options or restricted stock, awarded to employees for services. We expect that we will use stock options to attract, incentivize and retain our employees and will therefore incur the resulting stock-based compensation expense. This will continue to adversely affect our operating results in future periods.

Maintaining and improving our financial controls and the requirements of being a public company may strain our resources, divert management’s attention and affect our ability to attract and retain qualified board members.

As a public company, we are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act and the rules and regulations of an exchange or the OTCQB. The requirements of these rules and regulations will likely continue to increase our legal, accounting and financial compliance costs, make some activities more difficult, time-consuming or costly and may also place undue strain on our personnel, systems and resources.

The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and effective internal control over financial reporting. Significant resources and management oversight are required to design, document, test, implement and monitor internal control over relevant processes and to, remediate any deficiencies. As a result, management’s attention may be diverted from other business concerns, which could harm our business, financial condition and results of operations. These efforts also involve substantial accounting related costs.

We have identified material weaknesses in our internal controls, and we cannot provide assurances that these weaknesses will be effectively remediated or that additional material weaknesses will not occur in the future. If our internal control over financial reporting or our disclosure controls and procedures are not effective, we may not be able to accurately report our financial results, prevent fraud, or file our periodic reports in a timely manner, which may cause investors to lose confidence in our reported financial information and may lead to a decline in our stock price.

Our management is responsible for establishing and maintaining adequate internal control over our financial reporting, as defined in Rule 13a-15(f) under the Exchange Act. We have identified material weaknesses in our internal controls with respect to our financial statement for the year ended December 31, 2014. Our management discovered insufficient controls over review and accounting for certain complex transactions and a lack of segregation of duties.

The design of monitoring controls used to assess the design and operating effectiveness of our internal controls is inadequate.

We have begun to take actions that we believe will substantially remediate the material weaknesses identified. In response to the identification of our material weaknesses, we are in the process of expanding our finance and accounting staff. However, we cannot assure you that our internal control over financial reporting, as modified, will enable us to identify or avoid material weaknesses in the future.

13

We have never paid dividends and have no plans to pay dividends on our common stock in the future.

Holders of shares of our common stock are entitled to receive such dividends as may be declared by our Board of Directors. To date, we have paid no cash dividends on our shares of our preferred or common stock and we do not expect to pay cash dividends in the foreseeable future on our common stock. Our Series C Preferred Stock accrues dividends at the rate of 4% per annum of the stated price which initially is $3.277777778 payable annually in arrears on December 31 of each year. In addition, our Series B Preferred Stock accrues dividends at the rate of 8% per annum of the stated price which initially is $10.00 payable annually in arrears on December 31 of each year. Other than dividend payments on the preferred stock we intend to retain future earnings, if any, to provide funds for operations of our business. Therefore, any return investors in our preferred or common stock may have will be in the form of appreciation, if any, in the market value of their shares of common stock.

Our stock price may be volatile or may decline regardless of our operating performance.

The market price of our common stock may fluctuate significantly in response to numerous factors, many of which are beyond our control, including:

· price and volume fluctuations in the overall stock market;

· changes in operating performance and stock market valuations of other technology companies generally, or those in our industry in particular;

· the public’s response to our press releases or other public announcements, including our filings with the SEC;

· announcements by us or our competitors of significant technical innovations, acquisitions, strategic partnerships, joint ventures or capital commitments;

· introduction of technologies or product enhancements that reduce the need for our products;

· market conditions or trends in our industry or the economy as a whole;

· the loss of key personnel;

· lawsuits threatened or filed against us;

· future sales of our common stock by our executive officers, directors and significant stockholders; and

· other events or factors, including those resulting from war, incidents of terrorism or responses to these events.

We may issue preferred stock with greater rights than our common stock.

Our Certificate of Incorporation authorizes the Board of Directors to issue up to 10 million shares of preferred stock, par value $.001 per share. The preferred stock may be issued in one or more series, the terms of which may be determined by the Board of Directors at the time of issuance without further action by stockholders, and may include voting rights (including the right to vote as a series on particular matters), preferences as to dividends and liquidation, conversion and redemption rights and sinking fund provisions. Any preferred stock that is issued may rank ahead of our common stock, in terms of dividends, liquidation rights and voting rights that could adversely affect the voting power or other rights of the holders of our common stock. In the event of such an issuance, the Preferred Stock could be utilized, under certain circumstances, as a method of discouraging, delaying or preventing a change of control of our company. Any delay or prevention of a change of control transaction or changes in our Board of Directors or management could deter potential acquirers or prevent the completion of a transaction in which our stockholders could require substantial premium over the then current market price per share. We currently have 3,137,500 Series A-1 Preferred Stock outstanding, 40,000 Series B Preferred Stock outstanding and have 4,500,000 Series C Preferred Stock outstanding. The Series C Preferred Stock has the right to annual dividends in preference to all other preferred stock and the common stock and the Series B Preferred Stock is also entitled to an annual dividend. The Series A-1, B and C Preferred Stock all have liquidation preferences over the common stock. In addition the vote of a majority of the Series C Preferred Stock will be required for the (i) merger, sale of substantially all of our assets or our recapitalization, reorganization, liquidation, dissolution or winding up, (ii) redemption or acquisition of shares of our common stock other than in limited circumstances, (iii) declaration or payment of a dividend or distribution with respect to our capital stock, (iv) making any loan or advance, (v) amending our Certificate of Incorporation or Bylaws, (vi) authorizing or creating any new class or series of equity security, (vii) increasing the number of authorized shares for issuance under any existing stock or option plan, (viii) materially changing the nature of the business, (ix) incurring any indebtedness, (x) engaging in or making investments not authorized by the Board of Directors, (xi) acquiring or divesting a material amount of assets (xii) selling, assigning, licensing, pledging or encumbering our material technology or intellectual property, and (xiii) entering into any corporate strategic relationship involving payment, contribution or assignment by us or to us of any assets. The vote of two-thirds of the Series A-1 Preferred Stock is also required to take certain actions similar to those set forth above.

14

If we fail to meet the new eligibility requirements of the OTC Market Group, we will no longer be eligible to have our common stock quoted on the OTCQB.

If we fail to maintain a minimum bid price of $.01 per share one day per each thirty consecutive days, our stock will no longer be eligible to be traded on the OTCQB and will be traded on the pink sheets. Effective May 1, 2014, the OTC Market Group implemented new eligibility standards for companies traded on the OTCQB that will be gradually phased in over a one year period. Investors of companies that do not meet the eligibility requirements will not have the benefit of the additional disclosure

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds for the nine months ended September 30, 2015

There were no unregistered sales of equity securities during the quarter ended September 30, 2015 that were not previously reported.

Item 3. Defaults upon senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits

Regulation Number	Exhibit
10.1	Allocation Side Agreement between Novas Energy USA, Inc. Technovita Technologies Corporation and Novas Energy North America, LLC dated November 18, 2015.
31.1	Certification of the Chief Executive Officer and Chief Financial Officer, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of the Chief Executive Officer and Chief financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

15

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DATE: November 18, 2015	PROPELL TECHNOLOGIES GROUP, INC. (Registrant)
	By:	/s/ John W. Huemoeller II
		John W. Huemoeller II, President and Chief Executive Officer
		(Principal Executive Officer and Principal Financial Officer)

16

EX-10.1

Exhibit 10.1

Allocation SIDE AGREEMENT

This Allocation Side Agreement (“Agreement”) is made as of November 18, 2015, by and among Novas Energy USA, Inc. (“Novas USA”), Technovita Technologies Corporation (“Technovita”) and Novas Energy North America, LLC (the “JV Entity”).

WHEREAS, Novas USA and Technovita entered into a joint venture to Deploy the Vertical Technology in the United States and Canada, and in order to facilitate the joint venture, formed the JV Entity on June 5, 2015, and are the Members of the JV Entity;

WHEREAS, the JV Entity operating agreement was executed by Novas USA and Technovita on October 22, 2015, however, Technovita began operations on behalf of the JV Entity in August 2015 thereby accelerating capital contributions and incurring expenses for which NENA should be responsible;

WHEREAS, it was the understanding of Technovita and Novas USA that accelerated capital contributions would be applied to capital contribution obligations and that certain expenses incurred by Technovita on behalf of the JV Entity prior to October 22, 2015 would be paid by the JV Entity and the related revenue would be assigned to the JV Entity;

WHEREAS, the JV Entity Deployed the Vertical Technology in the month of August 2015 and began recognizing revenue for such Deployment in the month of September 2015; and

WHEREAS, Novas USA, Technovita, and the JV Entity desire allocate certain expenses and revenues associated with the JV Entity business to the JV Entity for a time period prior to the execution of the operating agreement.

NOW, THEREFORE, in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

1. JV Entity Expense Allocation. Novas USA, Technovita, and the JV Entity hereby jointly and severally agree to allocate to the JV Entity all expenses incurred by the Technovita or Novas during the period between August 1, 2015 and October 21, 2015 as set forth in Exhibits A, B, and C annexed hereto.

2. Pre-Operation Expense Allocation. Novas USA, Technovita, and the JV Entity hereby jointly and severally agree to allocate to the JV Entity expenses in the amount of $110,496.00 USD incurred during the month of August 2015, and the JV Entity shall immediately reimburse such amount to Technovita. If net revenue is less than $110,496.00 after 180 days following treatment of the Taylor 3-4 well, Technovita’s shall reimburse to the JV Entity an amount equal to the shortfall in net revenue.

3. JV Entity Revenue Allocation. Novas USA, Technovita, and the JV Entity hereby jointly and severally agree to allocate to the JV Entity all revenue recognized at any time for the Deployment of the Vertical Technology during the period between August 1, 2015 and October 21, 2015, and any revenue for which payment is in the future received by Technovita shall be deposited immediately with the JV Entity, and the JV Entity shall be entitled to all such allocated revenue upon receipt of payment by the recipient of the Vertical Technology Deployment.

4. Accelerated Initial Capital Contribution. Novas USA, Technovita, and the JV Entity hereby jointly and severally agree that all accelerated capital contributions by either Party prior to the execution of the JV Entity operating agreement will be applied to the respective Party’s capital contribution requirement as set forth in section 3.1 of the JV Entity operating agreement.

5. Initial Capital Contribution. Novas USA, Technovita, and the JV Entity hereby jointly and severally agree that the initial one million dollars of initial capital contribution has been satisfied by Technovita and Novas USA as a result of the following contribution schedule:

CONTRIBUTING ENTITY	PAYMENT DATE	PAYMENT AMOUNT
Technovita	August 21, 2015	$5,000.00
Technovita	August 25, 2015	$56,028.00
Technovita	September 15, 2015	$24,000.00
Technovita	September 29, 2015	$100,000.00
Technovita	October 26, 2015	$214,972.00
Novas USA	October 23, 2015	$600,000.00

6. Miscellaneous. This Agreement, and any documents referred to herein constitute the full and entire understanding and agreement among the parties with regard to the subjects hereof. Neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument referencing this Agreement and signed by the parties hereto. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of Texas, without giving effect to principles of conflicts of law. This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the parties that execute such counterparts, and all of which together shall constitute one instrument.

[SIGNATURE PAGE FOLLOWS]

-2-

IN WITNESS WHEREOF, the parties have executed this Agreement as of the day first written above.

NOVAS ENERGY USA, INC.
By:	/s/ John Huemoeller II
	Name: John Huemoeller II
	Title: President

TECHNOVITA TECHNOLOGIES CORPORATION
By:	/s/ Kenneth A. Stankievech
	Name: Kenneth A. Stankievech
	Title: Chief Executive Officer

NOVAS ENERGY NORTH AMERICA, LLC
By:	/s/ Kenneth A. Stankievech
	Name: Kenneth A. Stankievech
	Title: Chief Executive Officer

-3-

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER,

PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FONANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, John W. Huemoeller II, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Propell Technologies Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 18, 2015

/s/ John W. Huemoeller II

John W. Huemoeller II

President, Chief Executive Officer and Chief Financial Officer

(Principal Executive Officer and Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Propell technologies Group, Inc. (the "Registrant") on Form 10-Q for the period ending September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John Huemoeller, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

/s/ John W. Huemoeller II

John W. Huemoeller II

President, Chief Executive Officer and Chief Financial Officer

(Principal Executive Officer and Principal Financial Officer)

November 18, 2015

XML

ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Textual) - USD ($)				1 Months Ended
	Feb. 04, 2013	May. 06, 2008	Apr. 10, 2008	Nov. 01, 2015	Oct. 22, 2015
Technovita Technologies Inc [Member]
Organization and Description of Business [Line Items]
Payments to Acquire Interest in Joint Venture					$ 800,000
Percentage Of Interest Acquired In Joint Ventures					40.00%
Crystal Magic Inc [Member]
Organization and Description of Business [Line Items]
Sale of Stock, Number of Shares Issued in Transaction			180,000
Mountain Capital LLC [Member]
Organization and Description of Business [Line Items]
Sale of Stock, Number of Shares Issued in Transaction		41,897
Auleron 2005, LLC [Member]
Organization and Description of Business [Line Items]
Sale of Stock, Number of Shares Issued in Transaction		2,722
Novas Energy North America LLC [Member]
Organization and Description of Business [Line Items]
Payments to Acquire Interest in Joint Venture					$ 1,200,000
Payments To Acquire Interest In Joint Venture Tranche One					$ 600,000
Payments To Acquire Interest In Joint Venture Tranche Two				$ 300,000
Payments To Acquire Interest In Joint Venture Tranche Three				$ 300,000
Percentage Of Interest Acquired In Joint Ventures					60.00%
Share Exchange Agreement [Member]
Organization and Description of Business [Line Items]
Stock Issued During Period, Shares, New Issues	100,000,000
Number Of Shares Acquired Share Exchange Agreement	100,000,000

XML

SHORT-TERM CONVERTIBLE NOTES PAYABLE (Details Textual) - USD ($)		1 Months Ended
	Dec. 10, 2014	Feb. 20, 2015	Oct. 31, 2014
Short-term Debt [Line Items]
Debt Principal Amount		$ 107,000
Repayments of Convertible Debt		125,677
LG Capital Funding, LLC [Member]
Short-term Debt [Line Items]
Debt Principal Amount			$ 107,000
Proceeds from Convertible Debt			100,000
Debt Instrument, Convertible, If-converted Value in Excess of Principal			$ 7,000
Debt Instrument, Interest Rate, Effective Percentage			7.00%
Debt Instrument, Interest Rate During Period			8.00%
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger			62.00%
Debt Instrument, Convertible, Threshold Trading Days			10
Percentage of Redemption Penalty			150.00%
KBM Worldwide Inc [Member]
Short-term Debt [Line Items]
Debt Principal Amount	$ 84,000	84,000
Proceeds from Convertible Debt	80,000
Debt Instrument, Convertible, If-converted Value in Excess of Principal	$ 4,000
Debt Instrument, Interest Rate During Period	8.00%
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	58.00%
Repayments of Convertible Debt		$ 102,107
KBM Worldwide Inc [Member] | Minimum [Member]
Short-term Debt [Line Items]
Percentage of Redemption Penalty	110.00%
KBM Worldwide Inc [Member] | Maximum [Member]
Short-term Debt [Line Items]
Percentage of Redemption Penalty	135.00%

XML

ACCOUNTS PAYABLE - RELATED PARTIES (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Accounts Payable- Related parties [Line Items]
Accounts Payable, Related Parties, Current	$ 159,676	$ 0
Technovita Technologies Corp [Member]
Accounts Payable- Related parties [Line Items]
Accounts Payable, Related Parties, Current	108,510	0
Energy Conservation Management [Member]
Accounts Payable- Related parties [Line Items]
Accounts Payable, Related Parties, Current	47,610	0
Other [Member]
Accounts Payable- Related parties [Line Items]
Accounts Payable, Related Parties, Current	$ 3,556	$ 0

XML

COMMITMENTS AND CONTINGENCIES (Details 1) - Licensing Agreements [Member]	Sep. 30, 2015 USD ($)
Finite-Lived Intangible Assets [Line Items]
2015	$ 700,000
2016	1,000,000
2017	1,000,000
2018	1,000,000
2019	1,000,000
Capital Leases, Future Minimum Payments Due, Total	$ 4,700,000

XML

DERIVATIVE FINANCIAL LIABILITY (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Opening balance	$ 18,455	$ 237,799
Fair value adjustments to derivative financial liability	(18,455)	426,352
Closing balance	0	18,455
Short-term Notes with Variable Conversion Prices [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Increase (Decrease) in Derivative Liabilities	0	23,060
Conversion of Derivatives to Stock [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Increase (Decrease) in Derivative Liabilities	$ 0	$ (668,756)

XML

INTANGIBLES (Details 1) - Licensing Agreements [Member]	Sep. 30, 2015 USD ($)
Finite-Lived Intangible Assets [Line Items]
2015	$ 700,000
2016	1,000,000
2017	1,000,000
2018	1,000,000
2019	1,000,000
Total	$ 4,700,000

XML

DERIVATIVE FINANCIAL LIABILITY (Tables)

9 Months Ended

Sep. 30, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Liabilities at Fair Value [Table Text Block]

The movement in derivative liabilities is as follows:

	September 30,		December 31,
	2015		2014
Opening balance	$	18,455	$	237,799
Derivative financial liability arising on short-term notes with variable conversion prices		-		23,060
Conversion of derivative liability for stock issued at a discount		-		(668,756)
Fair value adjustments to derivative financial liability		(18,455)		426,352
	$	-	$	18,455

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]

The following assumptions were used in the Black-Scholes valuation model:

	Year ended
	December 31, 2014
Stock price over the period	$	0.17 – $0.23
Risk free interest rate		0.13% to 0.25	%
Expected life of short-term notes payable		9 to 14 months
Expected volatility		95.24% - 119.45	%
Expected dividend rate		0	%

XML

DERIVATIVE FINANCIAL LIABILITY (Details Textual)	Sep. 30, 2015 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Assets (Liabilities), at Fair Value, Net, Total	$ 224,442

XML

COMMITMENTS AND CONTINGENCIES (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015
Claims By Creditors	$ 372,090
Claims Against Long Term Liabilities	848,916
Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year	34,880
License Fees Waived Off		$ 200,000
Lease Agreement 1 [Member]
Sale Leaseback Transaction, Monthly Rental Payments	2,200
Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year	8,800
Lease Agreement 2 [Member]
Sale Leaseback Transaction, Monthly Rental Payments	3,260
Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year	$ 26,080

XML

ACCOUNTING POLICIES AND ESTIMATES (Policies)

9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

a) Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which we consider necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months and nine months ended September 30, 2015 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this quarterly report on Form 10-Q should be read in conjunction with our audited financial statements included in our annual report on Form 10-K as of and for the year ended December 31, 2014 as filed with the Securities and Exchange Commission (the “SEC”).

Significant accounting policies are described in Note 2 to the consolidated financial statements included in Item 8 of our annual report on Form 10-K as of December 31, 2014.

The preparation of unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to: the estimated useful lives for plant and equipment, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses, those related to revenue recognition and the allowance for doubtful accounts.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

All amounts referred to in the notes to the unaudited consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Consolidation, Policy [Policy Text Block]

b) Principles of Consolidation

The unaudited consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited consolidated financial statements. The entities included in these unaudited consolidated financial statements are as follows:

Propell Technologies Group, Inc. – Parent Company 

Nova Energy USA Inc. (wholly owned)

Novas Energy North America, LLC (60% owned)

Commitments and Contingencies, Policy [Policy Text Block]

c) Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

Fair Value of Financial Instruments, Policy [Policy Text Block]

d) Fair Value of Financial Instruments

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. 

The carrying amounts reported in the balance sheets for cash, accounts receivable, prepaid expenses, deposits, accounts payable, accrued liabilities, notes payable, and convertible notes payable approximate fair value due to the relatively short period to maturity for these instruments. The recorded derivative liabilities during the years ended December 31, 2014 was noted as subject to level III fair value measurements. The Company did not identify any other assets or liabilities that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance. 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

e) Risks and Uncertainties

The Company's operations will be subject to significant risk and uncertainties including financial, operational, regulatory and other associated risks, including the potential risk of business failure. The recent global economic crisis has caused a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

The Company’s operations are carried out in the USA and Mexico. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environment in the USA and Mexico and by the general state of those economies. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

New Accounting Pronouncements, Policy [Policy Text Block]

f) Recent Accounting Pronouncements

In August 2015, FASB issued Accounting Standards Update (“ASU”) No.2015-14, “Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date” defers the effective date ASU No. 2014-09 for all entities by one year. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in Update 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities should apply the guidance in Update 2014-09 to annual reporting periods beginning after December 15, 2018, and interim reporting periods within annual reporting periods beginning after December 15, 2019. All other entities may apply the guidance in ASU No. 2014-09 earlier as of an annual reporting period beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities also may apply the guidance in Update 2014-09 earlier as of an annual reporting period beginning after December 15, 2016, and interim reporting periods within annual reporting periods beginning one year after the annual reporting period in which the entity first applies the guidance in ASU No. 2014-09. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition.

In April 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs, to simplify presentation of debt issuance costs by requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The ASU does not affect the recognition and measurement guidance for debt issuance costs. For public companies, the ASU is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early application is permitted. This updated guidance is not expected to have a material impact on our results of operations, cash flows or financial condition.

Any new accounting standards, not disclosed above, that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

Segment Reporting, Policy [Policy Text Block]

g) Reporting by Segment

No segmental information is presented as the Company has disposed of its historical virtual trading store business which had minimal revenues. The Company is focusing on developing its Novas Energy, Plasma Pulse Technology for the petroleum industry.

Revenues to date are insignificant

Cash and Cash Equivalents, Policy [Policy Text Block]

h) Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2015 and December 31, 2014, respectively, the Company had no cash equivalents.

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. At September 30, 2015, the Company had cash balances of $12,568,839 which exceeded the federally insured limits by $11,717,660. At December 31, 2014, the balance did not exceed the federally insured limit

Receivables, Policy [Policy Text Block]

i) Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the nine months ended September 30, 2015 and the year ended December 31, 2014.

Inventory, Policy [Policy Text Block]

j) Inventory

The Company had no inventory as of September 30, 2015 or December 31, 2014

Property, Plant and Equipment, Policy [Policy Text Block]

k) Plant and Equipment

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

Description	Estimated Useful Life
Office equipment and furniture	2 years
Leasehold improvements and fixtures	Lesser of estimated useful life or life of lease
Plant and equipment	2 to 3 years
Plasma pulse tools	5 years

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

Intangible Assets, Finite-Lived, Policy [Policy Text Block]

l) Intangibles

All of our intangible assets are subject to amortization. We evaluate the recoverability of intangible assets periodically by taking into account events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired. Where intangibles are deemed to be impaired we recognize an impairment loss measured as the difference between the estimated fair value of the intangible and its book value.

i) License Agreements

License agreements acquired by the Company are reported at acquisition value less accumulated amortization and impairments.

ii) Amortization

Amortization is reported in the income statement on a straight-line basis over the estimated useful life of the intangible assets, unless the useful life is indefinite. Amortizable intangible assets are amortized from the date that they are available for use. The estimated useful life of the license agreement is five years which is the expected period for which we expect to derive a benefit from the underlying license agreements

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

m) Long-Term  Assets

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

Revenue Recognition, Policy [Policy Text Block]

n) Revenue Recognition

The Company records revenue when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the service is completed without further obligation, (3) the sales price to the customer is fixed or determinable, and (4) collectability is reasonably assured.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

o) Share-Based Payment Arrangements

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the unaudited consolidated statement of operations.

Income Tax, Policy [Policy Text Block]

p) Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2015, there have been no interest or penalties incurred on income taxes.

Earnings Per Share, Policy [Policy Text Block]

q) Net Loss per Share

Basic net loss per share is computed on the basis of the weighted average number of common shares outstanding during the period.

Diluted net loss per share is computed on the basis of the weighted average number of common shares and common share equivalents outstanding. Dilutive securities having an anti-dilutive effect on diluted net loss per share are excluded from the calculation (See Note 14, below).

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common shares at the average market price during the period.

Dilution is computed by applying the if-converted method for convertible preferred shares. Under this method, convertible preferred stock is assumed to be converted at the beginning of the period (or at the time of issuance, if later), and preferred dividends (if any) will be added back to determine income applicable to common stock. The shares issuable upon conversion will be added to weighted average number of common shares outstanding. Conversion will be assumed only if it reduces earnings per share (or increases loss per share).

Any common shares issued as a result of the issue of stock options and warrants would come from newly issued common shares from our remaining authorized shares

Comprehensive Income, Policy [Policy Text Block]

r) Comprehensive income

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. For the Company, comprehensive income for the periods presented includes net loss.

Related Party Transactions Policy [Policy Text Block]

s) Related parties

Parties are considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company, or own in aggregate, on a fully diluted basis 5% or more of the Company’s stock. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company shall disclose all related party transactions. All transactions shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a distribution to related party

XML

ACCRUED LIABILITIES AND OTHER PAYABLES (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Payroll liabilities	$ 42,317	$ 35,823
Accrued Royalties	14,653	4,603
License fees payable	200,000	200,000
Accrued Liabilities, Current, Total	$ 256,970	$ 240,426

XML

PREPAID EXPENSES (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Prepaid Expense [Line Items]
Prepaid Insurance	$ 23,125	$ 8,144
Expenses in excess of billings	72,308
Prepaid professional fees	36,286	4,417
Other	860	470
Prepaid Expense, Current, Total	$ 132,579	$ 13,031

XML

NET LOSS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:

	Nine Months		Nine months
	ended		ended
	September		September
	30, 2015		30, 2014
	(Shares)		(Shares)
Options to purchase shares of common stock		380,950		11,452,960
Restricted stock awards – unvested		8,750,000		-
Warrants to purchase shares of common stock		6,339,498		6,339,498
Series A-1 convertible preferred shares		31,375,000		38,875,000
Series B convertible preferred shares		4,000,000		7,500,000
Series C convertible preferred shares		120,000,000		-
Convertible long term notes		-		1,968,750
Convertible short term notes*		-		-
		170,845,448		66,136,208

* In the prior year convertible short term notes have variable conversion pricing dependent upon share prices prior to conversion

XML

NOTES PAYABLE (Details Textual) - Notes Payable, Other Payables [Member] - JAZ-CEH Holdings, LLC [Member] - USD ($)	1 Months Ended
	Feb. 20, 2015	Oct. 31, 2013
Debt Instrument, Face Amount		$ 105,000
Repayments of Short-term Debt, Total	$ 115,590

XML

NET LOSS PER SHARE (Details) - shares		9 Months Ended
		Sep. 30, 2015	Sep. 30, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		170,845,448	66,136,208
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		380,950	11,452,960
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		8,750,000	0
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		6,339,498	6,339,498
Series A Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		31,375,000	38,875,000
Series B Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		4,000,000	7,500,000
Series C Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		120,000,000	0
Notes Payable to Banks [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		0	1,968,750
Convertible Notes Payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	[1]	0	0

[1] In the prior year convertible short term notes have variable conversion pricing dependent upon share prices prior to conversion

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Details 1) - Employee Stock Option [Member] - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Beginning (in shares)	380,950	11,452,960
Share-based Payment Award, Options, Grants (in shares)	0	0
Share-based Payment Award, Options, Forfeited/Cancelled (in shares)	0	(11,072,010)
Share-based Payment Award, Options, Exercises (in shares)	0	0
Outstanding Ending (in shares)	380,950	380,950
Outstanding Beginning	$ 0.90	$ 0.30
Share-based Payment Award, Options, Grants - WeightedAverageExercisePrice	0	0
Share-based Payment Award, Options, Forfeitures/Cancelled - WeightedAverageExercisePrice	0	0.25
Share-based Payment Award, Options, Expirations - WeightedAverageExercisePrice	0	0
Outstanding Ending	0.90	0.90
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Beginning	0.51	0.25
Share-based Payment Award, Options, Forfeitures/Cancelled - WeightedAverageExercisePrice		0.25
Outstanding Ending	0.51	0.51
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Beginning	13.5	25
Share-based Payment Award, Options, Forfeitures/Cancelled - WeightedAverageExercisePrice		25
Outstanding Ending	$ 13.5	$ 13.5

XML

INTANGIBLES (Details Textual) - USD ($)	1 Months Ended		9 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Finite-Lived Intangible Assets [Line Items]
Amortization, Total			$ 52,500	$ 35,000
Licensing Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage Of Net Service Sales Paid As Royalty			7.50%
Obligated Initial License Fee		$ 150,000
Additional Obligated Amount	$ 200,000	$ 200,000
Termination of Interest Rate			100.00%
Licensing Agreements [Member] | UNITED STATES
Finite-Lived Intangible Assets [Line Items]
Royalty Expense			$ 500,000
Licensing Agreements [Member] | MEXICO
Finite-Lived Intangible Assets [Line Items]
Royalty Expense			$ 500,000

XML

PREPAID EXPENSES

9 Months Ended

Sep. 30, 2015

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Other Assets Disclosure [Text Block]

3 PREPAID EXPENSES

Prepaid expenses consisted of the following as of September 30, 2015 and December 31, 2014:

	September		December
	30, 2015		31, 2014
Prepaid insurance	$	23,125	$	8,144
Expenses in excess of billings		72,308
Prepaid professional fees		36,286		4,417
Other		860		470
	$	132,579	$	13,031

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Details 2) - Employee Stock Option [Member]	9 Months Ended
	Sep. 30, 2015 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Weighted Average Exercise Price | $ / shares	$ 0.90
Options Outstanding, Number Outstanding (in shares)	380,950
Options Outstanding Weighted Average Remaining Contractual life in years	4 years 8 months 12 days
Options Exercisable, Number Exercisable (in shares)	380,950
Options Exercisable, Weighted Average Exercise Price | $ / shares	$ 0.90
Options Exercisable, Weighted Average Remaining Contractual life in years	4 years 8 months 12 days
Exercise Price Range One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Weighted Average Exercise Price | $ / shares	$ 13.50
Options Outstanding, Number Outstanding (in shares)	3,480
Options Outstanding Weighted Average Remaining Contractual life in years	3 years 8 months 16 days
Options Exercisable, Number Exercisable (in shares)	3,480
Options Exercisable, Weighted Average Remaining Contractual life in years	3 years 8 months 16 days
Exercise Price Range Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Weighted Average Exercise Price | $ / shares	$ 12.50
Options Outstanding, Number Outstanding (in shares)	2,000
Options Outstanding Weighted Average Remaining Contractual life in years	5 years 14 days
Options Exercisable, Number Exercisable (in shares)	2,000
Options Exercisable, Weighted Average Remaining Contractual life in years	5 years 14 days
Exercise Price Range Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Weighted Average Exercise Price | $ / shares	$ 8.50
Options Outstanding, Number Outstanding (in shares)	500
Options Outstanding Weighted Average Remaining Contractual life in years	5 years 9 months
Options Exercisable, Number Exercisable (in shares)	500
Options Exercisable, Weighted Average Remaining Contractual life in years	5 years 9 months
Exercise Price Range Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Weighted Average Exercise Price | $ / shares	$ 5.00
Options Outstanding, Number Outstanding (in shares)	14,800
Options Outstanding Weighted Average Remaining Contractual life in years	6 years 14 days
Options Exercisable, Number Exercisable (in shares)	14,800
Options Exercisable, Weighted Average Remaining Contractual life in years	6 years 14 days
Exercise Price Range Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Weighted Average Exercise Price | $ / shares	$ 0.65
Options Outstanding, Number Outstanding (in shares)	36,924
Options Outstanding Weighted Average Remaining Contractual life in years	7 years 6 months
Options Exercisable, Number Exercisable (in shares)	36,924
Options Exercisable, Weighted Average Remaining Contractual life in years	7 years 6 months
Exercise Price Range Six [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Weighted Average Exercise Price | $ / shares	$ 0.63
Options Outstanding, Number Outstanding (in shares)	38,096
Options Outstanding Weighted Average Remaining Contractual life in years	2 years 9 months
Options Exercisable, Number Exercisable (in shares)	38,096
Options Exercisable, Weighted Average Remaining Contractual life in years	2 years 9 months
Exercise Price Range Seven [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Weighted Average Exercise Price | $ / shares	$ 0.51
Options Outstanding, Number Outstanding (in shares)	285,150
Options Outstanding Weighted Average Remaining Contractual life in years	4 years 6 months 14 days
Options Exercisable, Number Exercisable (in shares)	285,150
Options Exercisable, Weighted Average Remaining Contractual life in years	4 years 6 months 14 days

XML

PLANT AND EQUIPMENT (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Capital work in progress	$ 447,669	$ 18,482
Furniture and equipment	29,621	26,643
Total cost	808,791	376,626
Less: accumulated depreciation	(107,701)	(57,052)
Plant and equipment, net	701,090	319,574
Plasma pulse tools [Member]
Property, Plant and Equipment [Line Items]
Machinery and Equipment, Gross	310,374	310,374
Field equipment [Member]
Property, Plant and Equipment [Line Items]
Machinery and Equipment, Gross	19,627	19,627
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Machinery and Equipment, Gross	$ 1,500	$ 1,500

XML

ACCOUNTS PAYABLE - RELATED PARTIES (Tables)

9 Months Ended

Sep. 30, 2015

ACCOUNTS PAYABLE RELATED PARTIES [Abstract]

ACCOUNTS PAYABLE - RELATED PARTIES [Table Text Block]

Accounts payable to related parties includes the following:

	September 30, 2015		December 31, 2014
Technovita Technologies Corp.	$	108,510	$	-
Energy Conservation Management		47,610		-
Other		3,556		-
	$	159,676	$	-

XML

INTANGIBLES (Tables)

9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets Arising from Insurance Contracts Acquired in Business Combination [Table Text Block]

Intangibles consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	September 30,		December 31,
	2015		2014
License agreements	$	350,000	$	350,000
Website development		8,000		8,000
Total cost		358,000		358,000
Less: accumulated amortization		(113,000)		(60,500)
Intangibles, net	$	245,000	$	297,500

Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block]

The minimum commitments due under the license agreement for the next five years are summarized as follows:

	Amount
2015	$	700,000
2016		1,000,000
2017		1,000,000
2018		1,000,000
2019		1,000,000
	$	4,700,000

XML

DERIVATIVE FINANCIAL LIABILITY (Details 1) - Derivative Financial Instruments, Liabilities [Member]	12 Months Ended
	Dec. 31, 2014 $ / shares
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Fair Value Assumptions, Expected Dividend Rate	0.00%
Minimum [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Share Price	$ 0.17
Fair Value Assumptions, Risk Free Interest Rate	0.13%
Fair Value Assumptions, Expected Term	9 months
Fair Value Assumptions, Expected Volatility Rate	95.24%
Maximum [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Share Price	$ 0.23
Fair Value Assumptions, Risk Free Interest Rate	0.25%
Fair Value Assumptions, Expected Term	14 months
Fair Value Assumptions, Expected Volatility Rate	119.45%

XML

PLANT AND EQUIPMENT (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Property, Plant and Equipment [Line Items]
Depreciation	$ 50,649	$ 14,308

XML

ACCRUED LIABILITIES AND OTHER PAYABLES (Tables)

9 Months Ended

Sep. 30, 2015

Accounts Payable and Accrued Liabilities [Abstract]

Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Accrued liabilities consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	September 30, 2015		December 31, 2014
Payroll liabilities	$	42,317	$	35,823
Accrued Royalties		14,653		4,603
License fees payable		200,000		200,000
	$	256,970	$	240,426

XML

NOTES PAYABLE (Tables)

9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Notes Payables [Table Text Block]

Notes payable consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	Interest				September 30,		December 31,
Description	Rate			Maturity	2015		2014
Short-Term
Owl Holdings		-		-	$	3,000	$	3,000
JAZ-CEH Holdings, LLC		7.5	%	October 31, 2015		-		105,000
Accrued interest						-		9,489
Total JAZ-CEH holdings, LLC						-		114,489
Total Notes Payable					$	3,000	$	117,489

XML

ACCOUNTING POLICIES AND ESTIMATES

9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

2 ACCOUNTING POLICIES AND ESTIMATES

a) Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which we consider necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months and nine months ended September 30, 2015 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this quarterly report on Form 10-Q should be read in conjunction with our audited financial statements included in our annual report on Form 10-K as of and for the year ended December 31, 2014 as filed with the Securities and Exchange Commission (the “SEC”).

Significant accounting policies are described in Note 2 to the consolidated financial statements included in Item 8 of our annual report on Form 10-K as of December 31, 2014.

The preparation of unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to: the estimated useful lives for plant and equipment, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses, those related to revenue recognition and the allowance for doubtful accounts.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

All amounts referred to in the notes to the unaudited consolidated financial statements are in United States Dollars ($) unless stated otherwise.

b) Principles of Consolidation

The unaudited consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited consolidated financial statements. The entities included in these unaudited consolidated financial statements are as follows:

Propell Technologies Group, Inc. – Parent Company 

Nova Energy USA Inc. (wholly owned)

Novas Energy North America, LLC (60% owned)

c) Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed. 

d) Fair Value of Financial Instruments

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. 

The carrying amounts reported in the balance sheets for cash, accounts receivable, prepaid expenses, deposits, accounts payable, accrued liabilities, notes payable, and convertible notes payable approximate fair value due to the relatively short period to maturity for these instruments. The recorded derivative liabilities during the years ended December 31, 2014 was noted as subject to level III fair value measurements. The Company did not identify any other assets or liabilities that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance. 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.

e) Risks and Uncertainties

The Company's operations will be subject to significant risk and uncertainties including financial, operational, regulatory and other associated risks, including the potential risk of business failure. The recent global economic crisis has caused a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

The Company’s operations are carried out in the USA and Mexico. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environment in the USA and Mexico and by the general state of those economies. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

f) Recent Accounting Pronouncements

In August 2015, FASB issued Accounting Standards Update (“ASU”) No.2015-14, “Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date” defers the effective date ASU No. 2014-09 for all entities by one year. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in Update 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities should apply the guidance in Update 2014-09 to annual reporting periods beginning after December 15, 2018, and interim reporting periods within annual reporting periods beginning after December 15, 2019. All other entities may apply the guidance in ASU No. 2014-09 earlier as of an annual reporting period beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities also may apply the guidance in Update 2014-09 earlier as of an annual reporting period beginning after December 15, 2016, and interim reporting periods within annual reporting periods beginning one year after the annual reporting period in which the entity first applies the guidance in ASU No. 2014-09. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition.

In April 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs, to simplify presentation of debt issuance costs by requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The ASU does not affect the recognition and measurement guidance for debt issuance costs. For public companies, the ASU is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early application is permitted. This updated guidance is not expected to have a material impact on our results of operations, cash flows or financial condition.

Any new accounting standards, not disclosed above, that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

g) Reporting by Segment

No segmental information is presented as the Company has disposed of its historical virtual trading store business which had minimal revenues. The Company is focusing on developing its Novas Energy, Plasma Pulse Technology for the petroleum industry.

Revenues to date are insignificant.

h) Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2015 and December 31, 2014, respectively, the Company had no cash equivalents.

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. At September 30, 2015, the Company had cash balances of $12,568,839 which exceeded the federally insured limits by $11,717,660. At December 31, 2014, the balance did not exceed the federally insured limit.

i) Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the nine months ended September 30, 2015 and the year ended December 31, 2014.

j) Inventory

The Company had no inventory as of September 30, 2015 or December 31, 2014.

k) Plant and Equipment

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

Description	Estimated Useful Life
Office equipment and furniture	2 years
Leasehold improvements and fixtures	Lesser of estimated useful life or life of lease
Plant and equipment	2 to 3 years
Plasma pulse tools	5 years

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

l) Intangibles

All of our intangible assets are subject to amortization. We evaluate the recoverability of intangible assets periodically by taking into account events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired. Where intangibles are deemed to be impaired we recognize an impairment loss measured as the difference between the estimated fair value of the intangible and its book value.

i) License Agreements

License agreements acquired by the Company are reported at acquisition value less accumulated amortization and impairments.

ii) Amortization

Amortization is reported in the income statement on a straight-line basis over the estimated useful life of the intangible assets, unless the useful life is indefinite. Amortizable intangible assets are amortized from the date that they are available for use. The estimated useful life of the license agreement is five years which is the expected period for which we expect to derive a benefit from the underlying license agreements

m) Long-Term  Assets

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

n) Revenue Recognition

The Company records revenue when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the service is completed without further obligation, (3) the sales price to the customer is fixed or determinable, and (4) collectability is reasonably assured.

o) Share-Based Payment Arrangements

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the unaudited consolidated statement of operations.

p) Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2015, there have been no interest or penalties incurred on income taxes.

q) Net Loss per Share

Basic net loss per share is computed on the basis of the weighted average number of common shares outstanding during the period.

Diluted net loss per share is computed on the basis of the weighted average number of common shares and common share equivalents outstanding. Dilutive securities having an anti-dilutive effect on diluted net loss per share are excluded from the calculation (See Note 14, below).

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common shares at the average market price during the period.

Dilution is computed by applying the if-converted method for convertible preferred shares. Under this method, convertible preferred stock is assumed to be converted at the beginning of the period (or at the time of issuance, if later), and preferred dividends (if any) will be added back to determine income applicable to common stock. The shares issuable upon conversion will be added to weighted average number of common shares outstanding. Conversion will be assumed only if it reduces earnings per share (or increases loss per share).

Any common shares issued as a result of the issue of stock options and warrants would come from newly issued common shares from our remaining authorized shares.

r) Comprehensive income

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. For the Company, comprehensive income for the periods presented includes net loss.

s) Related parties

Parties are considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company, or own in aggregate, on a fully diluted basis 5% or more of the Company’s stock. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company shall disclose all related party transactions. All transactions shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a distribution to related party.

XML

SHORT-TERM CONVERTIBLE NOTES PAYABLE (Tables)

9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Short Term Convertible Notes payable [Table Text Block]

Short Term Convertible Notes payable consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	Interest		September 30,		December 31,
	Rate	Maturity	2015		2014
LG Capital Funding, LLC	8%	October 30, 2015		-		107,000
Unamortized debt discount and interest expense				-		(4,379)
Total LG Capital Funding, LLC				-		102,621
KBM Worldwide, Inc.	8%	September 12, 2015		-		84,000
Unamortized debt discount and interest expense				-		(3,512)
Total KBM Worldwide, Inc.				-		80,488
Total Short-Term Convertible Notes Payable			$	-	$	183,109

XML

ACCOUNTING POLICIES AND ESTIMATES (Details)	9 Months Ended
	Sep. 30, 2015
Office equipment and furniture [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	2 years
Leasehold improvements and fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	Lesser of estimated useful life or life of lease
Plant and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	2 years
Plant and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Plasma pulse tools [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years

XML

SHORT-TERM CONVERTIBLE NOTES PAYABLE (Details) - USD ($)		1 Months Ended	9 Months Ended	12 Months Ended
	Dec. 10, 2014	Oct. 31, 2014	Sep. 30, 2015	Dec. 31, 2014
Short-term Debt [Line Items]
Convertible Notes Payable, Current			$ 0	$ 183,109
LG Capital Funding, LLC [Member]
Short-term Debt [Line Items]
Debt Instrument, Interest Rate During Period		8.00%
KBM Worldwide Inc [Member]
Short-term Debt [Line Items]
Debt Instrument, Interest Rate During Period	8.00%
Convertible Notes Payable [Member] | LG Capital Funding, LLC [Member]
Short-term Debt [Line Items]
Debt Instrument, Maturity Date			Oct. 30, 2015
Debt Instrument, Interest Rate During Period			8.00%
Convertible Notes Payable Current Before Unamoritzed Debt Discount And Interest Expense			$ 0	107,000
Unamortized Debt Discount And Interest Expense			0	(4,379)
Convertible Notes Payable, Current			$ 0	102,621
Convertible Notes Payable [Member] | KBM Worldwide Inc [Member]
Short-term Debt [Line Items]
Debt Instrument, Maturity Date			Sep. 12, 2015
Debt Instrument, Interest Rate During Period			8.00%
Convertible Notes Payable Current Before Unamoritzed Debt Discount And Interest Expense			$ 0	84,000
Unamortized Debt Discount And Interest Expense			0	(3,512)
Convertible Notes Payable, Current			$ 0	$ 80,488

XML

JOINT VENTURE (Details Textual) - USD ($)	1 Months Ended			9 Months Ended
	Nov. 01, 2015	Oct. 31, 2015	Oct. 22, 2015	Sep. 30, 2015
Description Of Board Approval Required				Board approval is required to: (i) incur any indebtedness, pledge or grant liens on any assets or guarantee, assume, endorse or otherwise become responsible for the obligations of any other person, except to the extent approved or authorized in NENAs budget; (ii) make any loan, advance or capital contribution in any person, except to the extent approved or authorized in the budget; (iii) transfer any equipment necessary in the deployment of the Vertical Technology to any third party; (iv) enter into or effect any transaction or series of related transactions involving the sale of NENA or the sale, lease, license, exchange or other disposition (including by merger, consolidation, sale of assets or similar business transaction) by NENA of any assets in excess of $300,000; (v) appoint or remove NENAs auditors or make any changes in the accounting methods or policies of NENA (other than as required by GAAP); (vi) enter into or effect any transaction or series of related transactions involving the purchase, lease, license, exchange or other acquisition (including by merger, consolidation, acquisition of stock or acquisition of assets) by NENA of any assets and/or equity interests of any person and/ or assets in excess of $300,000; or (v) enter into or effect any commercial transaction or series of related commercial transactions involving anticipated liabilities or revenues of NENA in excess of $500,000 or that materially vary from NENAs existing strategy or business plan.
Subsequent Event [Member]
Joint Venture Agreement		$ 1,200,000
Payments to Acquire Interest in Joint Venture		$ 600,000	$ 800,000
Payments To Acquire Interest In Joint Venture Tranche One	$ 300,000
Payments To Acquire Interest In Joint Venture Tranche Two	$ 300,000
Subsequent Event [Member] | Parent Company [Member]
Percentage of Holding in Joint Venture			60.00%
Subsequent Event [Member] | Corporate Joint Venture [Member]
Percentage of Holding in Joint Venture			40.00%

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current Assets
Cash	$ 12,568,839	$ 40,844
Accounts receivable	9,391	5,892
Prepaid expenses and other current assets	132,579	13,031
Total Current Assets	12,710,809	59,767
Non-Current assets
Plant and Equipment, net	701,090	319,574
Intangibles, net	245,000	297,500
Deposits	2,200	2,200
Total non-current assets	948,290	619,274
Total Assets	13,659,099	679,041
Current Liabilities
Accounts payable	254,208	347,437
Accounts payable - related parties	159,676	0
Accrued liabilities and other payables	256,970	240,426
Notes payable	3,000	117,489
Short-term convertible notes payable, net	0	183,109
Derivative financial liabilities	0	18,455
Total Current Liabilities	673,854	906,916
Long Term Liabilities
Convertible notes payable, net	0	6,220
Total Long Term Liabilities	0	6,220
Total Liabilities	673,854	913,136
Stockholders' Equity (Deficit)
Preferred Stock Value		0
Common stock, $0.001 par value; 500,000,000 shares authorized, 268,558,931 and 260,169,499 shares issued and outstanding, respectively	268,559	260,169
Additional paid-in capital	25,458,468	9,914,303
Accumulated deficit	(12,845,919)	(10,412,155)
Total stockholder’s equity - controlling interest	12,888,786	(234,095)
Non-controlling interest	96,459	0
Total Stockholders' Equity (Deficit)	12,985,245	(234,095)
Total Liabilities and Stockholders' Equity (Deficit)	13,659,099	679,041
Series A Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred Stock Value	3,138	3,513
Total Stockholders' Equity (Deficit)	3,138	3,513
Series B Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred Stock Value	40	75
Total Stockholders' Equity (Deficit)	40	75
Series C Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred Stock Value	4,500	0
Total Stockholders' Equity (Deficit)	$ 4,500	$ 0

XML

INTANGIBLES (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
License agreements	$ 350,000	$ 350,000
Website development	8,000	8,000
Total cost	358,000	358,000
Less: accumulated amortization	(113,000)	(60,500)
Intangibles, net	$ 245,000	$ 297,500

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss attributable to the company	$ (2,433,764)	$ (3,549,947)
Less: loss attributable to non-controlling interest	(88,569)	0
Net loss	(2,522,333)	(3,549,947)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	50,649	14,308
Amortization expense	52,500	35,000
Amortization of debt discount	16,233	333,404
Equity based compensation	723,856	1,439,502
Stock issued for services rendered	70,000	302,347
Derivative financial liability	(18,455)	430,956
Gain on forgiveness of debt by issuer	0	(150,000)
Changes in Assets and Liabilities
Accounts receivable	(3,500)	(891)
Prepaid expenses and other current assets	(119,549)	(11,352)
Accounts payable	(93,229)	(19,981)
Accounts payable - related parties	159,676	0
Accrued liabilities	16,545	(14,547)
Accrued interest	(11,261)	39,834
Cash Used in Operating Activities	(1,678,868)	(1,151,367)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of plant and equipment	(432,165)	(139,227)
NET CASH USED IN INVESTING ACTIVITIES	(432,165)	(139,227)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds on issuance of Series C Preferred stock	14,750,000	0
Proceeds on issuance of Series B Preferred stock	0	750,000
Proceeds on common stock issued, net of expenses	0	946,110
Contribution from joint venture partner	185,028	0
Proceeds from notes payable and advances	125,000	160,000
Repayment of notes payable and advances	(421,000)	(461,948)
NET CASH PROVIDED BY FINANCING ACTIVITIES	14,639,028	1,394,162
NET INCREASE IN CASH	12,527,995	103,568
CASH AT BEGINNING OF PERIOD	40,844	28,423
CASH AT END OF PERIOD	12,568,839	131,991
CASH PAID FOR INTEREST AND TAXES:
Cash paid for income taxes	0	0
Cash paid for interest	48,130	130,753
NON-CASH INVESTING AND FINANCING ACTIVITIES
Licenses acquired not yet paid for	0	200,000
Conversion of debt to equity	12,789	794,150
Conversion of interest on debt to equity	$ 0	$ 102,397

XML

LONG-TERM CONVERTIBLE NOTES PAYABLE (Details Textual) - Notes Payable to Banks [Member]		9 Months Ended
	Feb. 06, 2015 USD ($) $ / shares	Sep. 30, 2015 $ / shares
Debt Instrument [Line Items]
Debt Instrument, Interest Rate During Period		6.00%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.02	$ 0.02
Debt Instrument, Periodic Payment, Principal	$ 11,250
Debt Instrument, Periodic Payment, Interest	1,539
Debt Instrument, Periodic Payment, Total	$ 12,789
Debt Instrument, Convertible, Number of Equity Instruments	639,432

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Tables)

9 Months Ended

Sep. 30, 2015

Stockholders' Equity Note [Abstract]

Restricted Stock Outstanding And Exercisable [Table Text Block]

The restricted stock granted and exercisable at September 30, 2015 is as follows: 

		Restricted Stock Granted				Restricted Stock Vested
				Weighted				Weighted
		Number		Average		Number		Average
Grant date Price		Granted		Fair Value per Share		Vested		Fair Value per Share
$	0.15		11,500,000	$			3,750,000	$
$	0.18		3,000,000	$			2,000,000	$
			14,500,000	$	0.16		5,750,000	$	0.16

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of all of our option activity during the period January 1, 2014 to September 30, 2015 is as follows: 

					Weighted
			Exercise		average
			price per		exercise
	Shares		share		price
Outstanding January 1, 2014		11,452,960	$	0.25 to 25.00	$	0.30
Granted		-		-		-
Forfeited/Cancelled		(11,072,010)		0.25 to 25.00		0.25
Exercised		-		-		-
Outstanding December 31, 2014		380,950	$	0.51 to 13.50	$	0.90
Granted		-		-		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding September 30, 2015		380,950		0.51 to 13.50		0.90

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

The options outstanding and exercisable at September 30, 2015 are as follows:

		Options Outstanding						Options Exercisable
				Weighted								Weighted
				Average		Weighted				Weighted		Average
				Remaining		Average		Number		Average		Remaining
Exercise		Number		Contractual		Exercise		Number		Exercise		Contractual
Price		Outstanding		life in years		Price		Exercisable		Price		life in years
$	13.50		3,480		3.71	$			3,480	$			3.71
$	12.50		2,000		5.04	$			2,000	$			5.04
$	8.50		500		5.75	$			500	$			5.75
$	5.00		14,800		6.04	$			14,800	$			6.04
$	0.65		36,924		7.50	$			36,924	$			7.50
$	0.63		38,096		2.75	$			38,096	$			2.75
$	0.51		285,150		4.54	$			285,150	$			4.54
			380,950		4.70	$	0.90		380,950	$	0.90		4.70

Schedule Of Share Based Compensation Warrants Activity [Table Text Block]

A summary of all of our warrant activity during the period January 1, 2014 to September 30, 2015 is as follows: 

					Weighted
			Exercise		average
			price per		exercise
	Shares		share		price
Outstanding January 1, 2014		375,000	$	0.30	$	0.30
Granted		5,964,498		0.15 to 0.25		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding December 31, 2014		6,339,498	$	0.15 to 0.30	$	0.24
Granted		-		-		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding September, 2015		6,339,498	$	0.15 to 0.30	$	0.24

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

The warrants outstanding and exercisable at September 30, 2015 are as follows:

		Warrants Outstanding						Warrants Exercisable
				Weighted								Weighted
				Average		Weighted				Weighted		Average
				Remaining		Average				Average		Remaining
Exercise		Number		Contractual		Exercise		Number		Exercise		Contractual
Price		Outstanding		life in years		Price		Exercisable		Price		life in years
$	0.30		375,000		3.08	$	0.30		375,000	$	0.30		3.08
$	0.25		1,751,667		3.74	$	0.25		1,751,667	$	0.25		3.74
$	0.15		525,500		3.74	$	0.15		525,500	$	0.15		3.74
$	0.25		1,508,333		3.84	$	0.25		1,508,333	$	0.25		3.84
$	0.15		577,499		3.85	$	0.15		577,499	$	0.15		3.85
$	0.25		968,166		3.85	$	0.25		968,166	$	0.25		3.85
$	0.25		633,333		3.90	$	0.25		633,333	$	0.25		3.90
			6,339,498		3.77	$	0.24		6,339,498	$	0.24		3.77

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Details Textual) - USD ($)	1 Months Ended					3 Months Ended		9 Months Ended
	Jul. 06, 2015	Jun. 30, 2015	Mar. 31, 2015	Feb. 19, 2015	Jun. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock, Shares Authorized						500,000,000		500,000,000		500,000,000
Common Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001		$ 0.001
Common Stock, Shares, Issued						268,558,931		268,558,931		260,169,499
Common Stock, Shares, Outstanding						268,558,931		268,558,931		260,169,499
Debt Conversion, Converted Instrument, Amount								$ 12,789	$ 794,150
Consulting Services Cost Fair Value								$ 70.000
Restricted Stock to be Vested in Future						920,714		920,714
Preferred Stock, Shares Authorized						10,000,000		10,000,000		10,000,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001		$ 0.001
Share-based Compensation, Total						$ 311,284	$ 619,125	$ 793,856	1,741,849
Restricted Stock or Unit Expense								$ 723,856	0
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock, Shares, Outstanding						13,000,000		13,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period								14,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period								5,750,000
Restricted Stock to be Vested in Future						1,000,000		1,000,000
Restricted Stock [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period								10,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period								3,750,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized								1,500,000
Restricted Stock [Member] | Chief Executive Officer [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period								750,000
Restricted Stock [Member] | Chief Executive Officer [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period								750,000
Restricted Stock [Member] | Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period								3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period			1,000,000					1,000,000
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized						5,000,000		5,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						100,000		100,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized								2,100,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance						380,950		380,950		380,950
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value						$ 0		$ 0		$ 0
Share-based Compensation, Total								$ 0	$ 1,439,502
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Issued for Services								500,000
Common Stock [Member] | Restricted Stock [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period								1,250,000
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding Intrinsic Value						$ 0		$ 0		$ 0
Series A-1 Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Stock, Shares Issued								31,375,000
Preferred Stock, Shares Authorized						5,000,000		5,000,000
Preferred Stock, Shares Issued						3,137,500		3,137,500
Preferred Stock, Shares Outstanding						3,137,500		3,137,500
Preferred Stock, Liquidation Preference Per Share						$ 0.08		$ 0.08
Preferred Stock, Voting Rights								the holders of at least 2/3 (66.6%) of the outstanding shares of the Series A-1 Shares, voting together separately as a class
Series A Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Stock, Shares Converted								375,000
Preferred Stock, Conversion Basis								10 Common shares for one Series A-1Preferred share.
Preferred Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001		$ 0.001
Preferred Stock, Shares Issued						3,137,500		3,137,500		3,512,500
Preferred Stock, Shares Outstanding						3,137,500		3,137,500		3,512,500
Preferred Stock Shares Designated						5,000,000		5,000,000		5,000,000
Series A Preferred Stock [Member] | Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Stock, Shares Issued								3,750,000
Series B Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Stock, Shares Issued								4,000,000
Conversion of Stock, Shares Converted								35,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001		$ 0.001
Preferred Stock, Shares Issued						40,000		40,000		75,000	75,000
Preferred Stock, Shares Outstanding						40,000		40,000		75,000
Proceeds from Issuance of Convertible Preferred Stock			$ 750,000					$ 3,500,000
Convertible Preferred Stock, Terms of Conversion								Each share of the Series B Shares is convertible at any time prior to the issuance of a redemption notice by the Company into such number of shares of Common Stock by dividing the Stated value ($10) of the Series B Shares by $0.10 and is subject to adjustment for dividends or distributions made in common stock, the issue of securities convertible into common stock, stock splits, reverse stock splits, or reclassifications of common stock. No adjustments will be made to the conversion rights or conversion price for any reorganization other than to be entitled to receive the same benefits as if the shares were converted immediately prior to such reorganization. No conversion will take place if the holder of the Series B Shares will beneficially own in excess of 4.99% of the shares of Common Stock outstanding immediately after conversion. As of the date hereof, each Series B Share converts into 100 shares of common stock.
Preferred Stock, Redemption Terms								The Company has the right, at any time after the date the Series B Shares have been issued, to redeem all or a portion of any Holder's Series B Shares at a price per Series B Share equal to the issue price per Series B Share multiplied by 120%
Preferred Stock, Dividend Payment Terms								Any dividend payable on a dividend payment date may be paid, at the option of the Company, either (i) in cash or (ii) in shares of common stock at an issue price of $0.10 per common share.
Undeclared Dividends								$ 82,455
Preferred Stock Shares Designated						500,000		500,000		500,000
Series B Preferred Stock [Member] | Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Stock, Shares Issued								3,500,000
Series C Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock, Shares, Issued	56,677,477			7,624,990
Common Stock, Shares, Outstanding	700,000			2,437,500
Debt Instrument, Convertible, Conversion Price						$ 0.12291665		$ 0.12291665
Conversion of Stock, Shares Converted	7,000,000			24,375,000
Preferred Stock, Shares Authorized						4,500,000		4,500,000		4,500,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001		$ 0.001
Preferred Stock, Shares Issued		2,974,576		1,525,424		4,500,000		4,500,000		0
Preferred Stock, Shares Outstanding						4,500,000		4,500,000		0
Proceeds from Issuance of Convertible Preferred Stock		$ 9,750,000		$ 5,000,000
Shares Issued, Price Per Share				$ 3.277777778		$ 3.277777778		$ 3.277777778
Preferred Stock Conversion Price Per Share				$ 0.15	$ 014			$ 26.67
Conversion of Stock, Amount Converted				$ 1,101,696	$ 1,355,085
Common Stock, Conversion Basis								at least 36,000,000 shares of our common stock on an “as converted” basis.
Preferred Stock, Dividend Rate, Percentage								4.00%
Dividends Payable, Current						$ 220,493		$ 220,493
Preferred Stock Shares Designated						4,500,000		4,500,000		4,500,000
Series C Preferred Stock [Member] | Criteria One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred Stock, Voting Rights								Upon the issuance of at least 1,500,000 shares of Series C Preferred Stock the holders of the Series C Preferred Stock, as a class, are entitled to elect either two directors holding one vote or one director holding two votes.
Series C Preferred Stock [Member] | Criteria Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred Stock, Voting Rights								Upon the issuance of an aggregate of 4,500,000 shares of Series C Preferred Stock, the holders of the Series C Preferred Stock are entitled to elect either three directors holding one vote each, one director holding three votes or two directors with one director holding two votes and another director holding one vote.
Series C Preferred Stock [Member] | Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock, Par or Stated Value Per Share				$ 0.001
Conversion of Stock, Shares Converted								120,000,000
Convertible Debt [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Debt Conversion, Converted Instrument, Amount								$ 12,789
Debt Instrument, Convertible, Conversion Price						$ 0.02		$ 0.02
Convertible Debt [Member] | Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Debt Conversion, Converted Instrument, Shares Issued								639,432

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

16 COMMITMENTS AND CONTINGENCIES

The Company disposed of its Crystal Magic, Inc. subsidiary effective December 31, 2013. In terms of the sale agreement entered into by the Company, the purchaser has been indemnified against all liabilities whether contingent or otherwise, claimed by third parties, this includes claims by creditors of the Company amounting to $372,090 and claims against long-term liabilities of $848,916. Management does not consider it likely that these claims will materialize and accordingly no provision has been made for these contingent liabilities.

The Company leases approximately 2,300 square feet of office space in Houston, Texas, the original term of the lease agreement terminated on January 31, 2014 with automatic renewals for six month periods unless 60 days written notice is given prior to renewal. The rental is $2,200 per month.

The future minimum lease installments under this agreement as of September 30, 2015 for the period October 1, 2015 to January 31, 2016 (the automatic renewal period) is $8,800.

The Company leases a loft space in Houston, Texas from a related party in terms of a lease agreement entered into on September 1, 2015 and expiring on May 31, 2016. The lease provides for automatic renewal on a month to month basis unless 60 days written notice is given to terminate the lease. The monthly rental is $3,260 per month.

The future minimum lease installments under this agreement as of September 30, 2015 for the period October 1, 2015 to May 31, 2016 is $26,080.

The future minimum operating lease commitments are as follows:

	Amount
2015		16,380
2016		18,500
	$	34,880

In terms of the license agreement commitments disclosed in note 5 above, the minimum commitments due under the amended license agreement entered into on January 30, 2013, for the next five years, are summarized as follows:

	Amount
2015	$	700,000
2016		1,000,000
2017		1,000,000
2018		1,000,000
2019		1,000,000
	$	4,700,000

We are currently in negotiation with the Licensor to waive the $200,000 license fee which was due on June 30, 2015, we are also renegotiating the terms of the minimum royalty payments due and expect these payments to be deferred and amended.

XML

EQUITY BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2015

Equity [Abstract]

Comprehensive Income (Loss) [Table Text Block]

Equity based compensation is made up of the following:

	Nine months		Nine months
	ended		ended
	September 30, 2015		September 30, 2014
Stock option compensation charge	$	-	$	1,439,502
Restricted stock award compensation charge		723,856		-
Stock issued for services rendered		70,000		302,347
	$	793,856	$	1,741,849

XML

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

Subsequent Events [Text Block]

18 SUBSEQUENT EVENTS

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to September 30, 2015 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements.

XML

RELATED PARTY TRANSACTIONS (Details Textual) - USD ($)	1 Months Ended		9 Months Ended
	Oct. 31, 2015	Mar. 31, 2015	Sep. 30, 2015
Related Party Transaction [Line Items]
Restricted Stock to be Vested in Future			920,714
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Labor and Related Expense			$ 180,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			10,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	1,250,000		3,750,000
Stock To be Granted Annually Per Agreement			750,000
Stock To be Vested Immediately In Termination of Agreement			5,000,000
Director [Member]
Related Party Transaction [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		1,000,000	1,000,000
Related Party Transaction, Amounts of Transaction			$ 5,000
Restricted Stock to be Vested in Future			1,000,000

XML

ORGANIZATION AND DESCRIPTION OF BUSINESS

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]

1 ORGANIZATION AND DESCRIPTION OF BUSINESS

a) Organization

Propell Technologies Group, Inc. (formerly known as Propell Corporation) (the “Company”), is a Delaware corporation originally formed on January 29, 2008 as CA Photo Acquisition Corp. On April 10, 2008 Crystal Magic, Inc. (“CMI”), a Florida Corporation, merged with an acquisition subsidiary of Propell’s, and the Company issued an aggregate of 180,000 shares to the former shareholders of CMI. On May 6, 2008, the Company acquired both Mountain Capital, LLC (doing business as Arrow Media Solutions) (“AMS”) and Auleron 2005, LLC (doing business as Auleron Technologies) (“AUL”) and made each a wholly owned subsidiary and issued a total of 41,897 shares of the Company’s common stock to the members of Mountain Capital, LLC and a total of 2,722 shares of the Company’s common stock to the members of AUL. In 2010 AUL and AMS were dissolved and the operations of CMI were discontinued. On February 4, 2013, the Company entered into a Share Exchange Agreement with Novas Energy (USA), Inc. (“Novas”) whereby the Company exchanged 100,000,000 shares of its common stock for 100,000,000 shares of common stock in Novas. After the consummation of the share exchange, Novas became a wholly owned subsidiary of the Company. As a result of the share exchange the shareholders of Novas obtained the majority of the outstanding shares of the Company. As such, the exchange is accounted for as a reverse merger or recapitalization of the Company and Novas was considered the acquirer for accounting purposes.

b) Description of the business

The Company, through its wholly owned subsidiary, Novas, is an innovative technology and services company whose aim is to radically improve oil production by introducing modern and innovative technologies. Novas has a unique Plasma-Pulse Treatment (“PPT”) technology, which is a new Enhanced Oil Recovery methodology and process that has been developed to be environmentally friendly, mobile, time efficient and extremely cost effective. We filed for patent protection of the PPT technology which is still pending. PPT has the potential to drive new and renewed revenue for energy producers and become a new standard for the entire petroleum industry.

On October 22, 2015, Novas Energy USA, Inc. (“Novas”), a wholly owned subsidiary of Propell Technologies Group, Inc. (the “Company”), entered into an operating agreement with Technovita Technologies USA, Inc. (the “Joint Venture Agreement”) through a newly formed Delaware limited liability company, Novas Energy North America, LLC (“NENA”), whereby Novas agreed to contribute $1,200,000 ($600,000 to be delivered on the effective date (October 22, 2015) of the Joint Venture Agreement, $300,000 on November 1, 2015 and $300,000 on the two month anniversary of the Effective Date) to the capital of NENA for 60% of the membership interests of NENA and Technovita agreed to contribute an aggregate of $800,000 to the capital of NENA for 40% of the membership interests of NENA. In terms of a side agreement entered into on November 18, 2015, the revenue and expenses incurred by Technovita prior to entering into the operating agreement, have been included in the joint venture and consolidated into the Company’s results effective September 1, 2015.

Subject to certain exceptions and pursuant to the terms of a sublicense agreement (the “Novas Sublicense Agreement”) that was entered into between Novas, NENA and Novas Energy Group Inc. (the “Licensor”), the licensor of Plasma Pulse Technology currently used by Novas and Technovita, NENA will be the exclusive provider of the Vertical Technology (as defined in the Joint Venture Agreement) to third parties in the United States. Subject to certain exceptions and pursuant to the terms of Sublicense Agreements (the “Technovita Sublicense Agreement”) that was entered into between Technovita, NENA and Licensor, NENA is the exclusive provider of the Vertical Technology to third parties in Canada. Notwithstanding the foregoing, both Novas and Technovita will retain the right to deploy the Vertical Technology on wells owned by Novas or Technovita in the United States or Canada, respectively. If either Novas or Technovita terminates the Sublicense Agreement with NENA and Licensor, the non- terminating party will receive 100% of the terminating member’s membership interest in NENA.

The business and affairs of NENA are to be managed by or under the direction of the Board of Directors, consisting of five (5) members, three (3) of whom shall be appointed by Novas and two (2) of whom shall be appointed by Technovita. Board approval is required to: (i) incur any indebtedness, pledge or grant liens on any assets or guarantee, assume, endorse or otherwise become responsible for the obligations of any other person, except to the extent approved or authorized in NENA’s budget; (ii) make any loan, advance or capital contribution in any person, except to the extent approved or authorized in the budget; (iii) transfer any equipment necessary in the deployment of the Vertical Technology to any third party; (iv) enter into or effect any transaction or series of related transactions involving the sale of NENA or the sale, lease, license, exchange or other disposition (including by merger, consolidation, sale of assets or similar business transaction) by NENA of any assets in excess of $300,000; (v) appoint or remove NENA’s auditors or make any changes in the accounting methods or policies of NENA (other than as required by GAAP); (vi) enter into or effect any transaction or series of related transactions involving the purchase, lease, license, exchange or other acquisition (including by merger, consolidation, acquisition of stock or acquisition of assets) by NENA of any assets and/or equity interests of any person and/ or assets in excess of $300,000; or (v) enter into or effect any commercial transaction or series of related commercial transactions involving anticipated liabilities or revenues of NENA in excess of $500,000 or that materially vary from NENA’s existing strategy or business plan.

The Joint Venture will provide NENA with access to Technovita’s experienced team, the ability to build one North American brand, the ability to leverage the strength of the combined entity expanding the Company’s geographic reach beyond the United States and into Canada.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock Shares Undesignated	0	4,500,000
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	268,558,931	260,169,499
Common Stock, Shares, Outstanding	268,558,931	260,169,499
Series A Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Liquidation Preference, Value	$ 251,000	$ 281,000
Preferred Stock Shares Designated	5,000,000	5,000,000
Preferred Stock, Shares Issued	3,137,500	3,512,500
Preferred Stock, Shares Outstanding	3,137,500	3,512,500
Series B Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Liquidation Preference, Value	$ 480,000	$ 900,000
Preferred Stock Shares Designated	500,000	500,000
Preferred Stock, Shares Issued	40,000	75,000
Preferred Stock, Shares Outstanding	40,000	75,000
Series C Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	4,500,000	4,500,000
Preferred Stock, Liquidation Preference, Value	$ 14,750,000	$ 0
Preferred Stock Shares Designated	4,500,000	4,500,000
Preferred Stock, Shares Issued	4,500,000	0
Preferred Stock, Shares Outstanding	4,500,000	0

XML

LONG-TERM CONVERTIBLE NOTES PAYABLE

9 Months Ended

Sep. 30, 2015

Debt Instruments [Abstract]

Mortgage Notes Payable Disclosure [Text Block]

11 LONG-TERM CONVERTIBLE NOTES PAYABLE

Long Term Convertible Notes payable consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	Interest			September 30,		December 31,
Description	Rate		Maturity	2015		2014
Notes payable		6%	November 19, 2017	$	-	$	11,250
Accrued interest					-		1,470
Unamortized debt discount					-		(6,500)
Total long-Term Convertible Notes Payable				$	-	$	6,220

The convertible notes payable consisted of notes issued to a number of private principals (“the Notes”). The Notes bore interest at the rate of 6% per annum and were due on November 19, 2017. The Notes were convertible into common stock at a fixed conversion price of $0.02 per share.

On February 6, 2015, the remaining convertible note with an aggregate principal amount of $11,250, inclusive of interest of $1,539, totaling $12,789 was converted into 639,432 common shares at a conversion price of $0.02 per share.

XML

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 18, 2015
Document Information [Line Items]
Entity Registrant Name	Propell Technologies Group, Inc.
Entity Central Index Key	0001434110
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	PROP
Entity Common Stock, Shares Outstanding		268,558,931
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3

XML

STOCKHOLDERS' EQUITY (DEFICIT)

9 Months Ended

Sep. 30, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

12 STOCKHOLDERS’ EQUITY (DEFICIT)

a) Common Stock

The Company has authorized 500,000,000 common shares with a par value of $0.001 each, and issued and outstanding 268,558,931 shares of common stock as of September 30, 2015.

The following common shares were issued by the Company during the nine months ended September 30, 2015:

i) an aggregate of 639,432 shares of Common Stock to convertible note holders upon conversion of an aggregate of $12,789 of long-term convertible notes, inclusive of interest thereon, at a share price of $0.02 per share;

ii) an aggregate of 3,750,000 shares of Common Stock were issued upon the conversion of 375,000 shares of Series A-1 Preferred stock in terms of a conversion notice received from a Series A-1 stockholder at a conversion factor of 10 Common shares for one Series A-1Preferred share.

iii)	an aggregate of 3,500,000 shares of Common Stock were issued upon the conversion of 35,000 shares of Series B Preferred stock in terms of a conversion notice received from the Series B stockholder at a conversion factor of 100 Common shares for one Series B Preferred share.
iv)	an aggregate of 500,000 shares of Common Stock were issued for consulting services which were valued at a fair market price of $70.000.

Included in the Common stock outstanding are 13,000,000 restricted shares of common stock issued as follows:

(a) An aggregate of 10,000,000 shares of restricted common stock were issued to our Chief Executive Officer in terms of an employment agreement entered into with him. These shares are restricted. As of September 30, 2015, 3,750,000 shares have already vested and a further 1,250,000 shares vested on October 1, 2015 with further vesting per quarter thereafter, these shares will be fully vested on October 1, 2016. These restricted shares were valued at the closing price of the common stock on February 4, 2015, the date of approval of the amended and restated employment agreement with our Chief Executive officer. Refer to the related party disclosure in note 15 below.

(b) An aggregate of 3,000,000 shares of restricted common stock were issued to our Director, John Zotos, in terms of a consulting agreement entered into with him. These shares are restricted and vested as to 1,000,000 shares on March 31, 2015, 1,000,000 on September 30, 2015 with the remaining 1,000,000 vesting on March 31, 2016. These restricted shares were valued at the closing price of the common stock on December 5, 2014, the date of approval of the consulting agreement with John Zotos. Refer to the related party disclosure in note 15 below.

Our Chief Executive Officer is also entitled to 1,500,000 shares of restricted common stock which has not been issued as yet. These shares will be issued upon vesting in two equal tranches of 750,000 shares of common stock on January 1, 2016 and January 1, 2017.

 

The restricted stock granted and exercisable at September 30, 2015 is as follows: 

		Restricted Stock Granted				Restricted Stock Vested
				Weighted				Weighted
		Number		Average		Number		Average
Grant date Price		Granted		Fair Value per Share		Vested		Fair Value per Share
$	0.15		11,500,000	$			3,750,000	$
$	0.18		3,000,000	$			2,000,000	$
			14,500,000	$	0.16		5,750,000	$	0.16

The Company has recorded an expense of $723,856 and $0 for the nine months ended September 30, 2015 and 2014, relating to the restricted stock awards and a further $920,714 will be expensed over the vesting period of the stock which takes place over the next fifteen months.

b) Preferred Stock

The Company has 10,000,000 authorized preferred shares with a par value of $0.001 each with 5,000,000 preferred shares designated as Series A-1 Convertible Preferred Stock (“Series A-1 Shares”), 500,000 preferred shares designated as Series B Preferred Stock and on February 19, 2015, the Company amended its articles of incorporation, designating the remaining 4,500,000 preferred shares as Series C Preferred Stock.

i) Series A-1 Convertible Preferred Stock

The Company has designated 5,000,000 preferred shares as Series A-1 Convertible Preferred Stock (“Series A-1 Shares”), with 3,137,500 Series A-1 Shares issued and outstanding which are convertible into 31,375,000 shares of common stock.

During the nine months ended September 30, 2015, holders of 375,000 Series A-1 shares converted their holdings into 3,750,000 shares of the Company’s Common Stock at a conversion ratio of 10 common shares to 1 Series A-1 Share.

The rights, privileges and preferences of the Series A-1 Shares are summarized as follows;

Conversion

Each Series A-1 Share has the following conversion rights:

(a) Each share of the Series A-1Shares is convertible into ten shares of Common Stock.

(b) There shall be no adjustment made to the conversion ratio of the Series A-1 Shares for any stock split, stock dividend, combination, reclassification or other similar event.

Company Redemption

The Series A-1 Shares are non-redeemable by the Company.

Voting Rights

Each holder of Series A-1 Shares is entitled to vote on all matters submitted to a vote of the stockholders of the Company and shall be entitled to that number of votes equal to the number of shares of Common Stock into which such holder’s shares of Series A-1 Shares could then be converted.

Dividends

Until such time that any dividend is paid to the holders of Common Stock, the holders of Series A-1 Shares shall be entitled to a dividend in an amount per share equal to that which such holders would have been entitled to receive had they converted all of the shares of Series A-1 Shares into Common Stock immediately prior to the payment of such dividend

Liquidation Preference

Each share of Series A-1 Shares is entitled to a liquidation preference of $0.08 per share

No Circumvention

The approval of the holders of at least 2/3 (66.6%) of the outstanding shares of the Series A-1 Shares, voting together separately as a class, is required for:

(a) the merger, sale of all, or substantially all of the assets or intellectual property, recapitalization, or reorganization of the Company;

(b) the authorization or issuance of any equity security having any right, preference or priority superior to or on a parity with the Series A-1 Shares;

(c) the redemption, repurchase or acquisition of any of the Company’s equity securities or the payment of any dividends or distributions thereon;

(d) any amendment or repeal of the Company’s Articles of Incorporation or Bylaws that would have an adverse effect on the rights, preferences or privileges of the Series A-1 Shares; and

(e) the making of any loan or advance to any person except in the ordinary course of business.

ii) Series B Convertible Preferred Stock

The Company has designated 500,000 preferred shares as Series B Convertible Preferred Stock (“Series B Shares”), with 40,000 Series B Shares issued and outstanding which are convertible into 4,000,000 shares of common stock.

The Company issued 75,000 Series B shares in March 2014 for gross proceeds of $750,000.

During the nine months ended September 30, 2015, the holder of 35,000 Series B shares converted his holding into 3,500,000 shares of the Company’s Common Stock at a conversion ratio of 100 common shares per Series B Share.

The rights, privileges and preferences of the Series B Shares are summarized as follows:

Conversion

The holders of the Series B Preferred Shares shall have conversion rights as follows:

(a) Each share of the Series B Shares is convertible at any time prior to the issuance of a redemption notice by the Company into such number of shares of Common Stock by dividing the Stated value ($10) of the Series B Shares by $0.10 and is subject to adjustment for dividends or distributions made in common stock, the issue of securities convertible into common stock, stock splits, reverse stock splits, or reclassifications of common stock. No adjustments will be made to the conversion rights or conversion price for any reorganization other than to be entitled to receive the same benefits as if the shares were converted immediately prior to such reorganization. No conversion will take place if the holder of the Series B Shares will beneficially own in excess of 4.99% of the shares of Common Stock outstanding immediately after conversion. As of the date hereof, each Series B Share converts into 100 shares of common stock.

(b) The conversion right of the holders of Series B Shares are exercised by the surrender of the certificates representing shares to be converted to the Company, accompanied by written notice electing conversion.

(c) No fractional shares of Common Stock or script will be issued upon conversion of Series B Shares. The Company will pay a cash adjustment in respect to such fractional interest based upon the fair value of a share of Common Stock, as determined in good faith by the Company’s Board of Directors.

(d) All shares of Common Stock issued upon conversion of Series B Shares will upon issuance be validly issued, fully paid and non-assessable. All certificates representing Series B Shares surrendered for conversion shall be appropriately canceled on the books of the Company and the shares so converted represented by such certificates shall be restored to the status of authorized but unissued shares of preferred stock of the Company.

Company Redemption

The Company has the right, at any time after the date the Series B Shares have been issued, to redeem all or a portion of any Holder's Series B Shares at a price per Series B Share equal to the issue price per Series B Share multiplied by 120%

Voting Rights

Each holder of Series B Shares is entitled to vote on all matters submitted to a vote of the stockholders of the Company and is entitled to votes equal to the number of shares of Common Stock into which Series B Shares could be converted, and the holders of shares of Series B Shares and Common Stock shall vote together as a single class on all matters submitted to the stockholders of the Company. 

Dividends

(a) The holders of the Series B Shares are entitled to receive cumulative dividends at the rate of eight percent per annum of the issue price per share, accrued daily and payable annually in arrears on December 31st of each year (“Dividend Date”). Such dividends accrue on any given share from the day of original issuance of such share. Such dividends are cumulative, whether or not declared by the Board of Directors, but are non-compounding.

(b) Any dividend payable on a dividend payment date may be paid, at the option of the Company, either (i) in cash or (ii) in shares of common stock at an issue price of $0.10 per common share.

(c) Nothing contained herein is deemed to establish or require any payment or other charges in excess of the maximum permitted by applicable law.

(d) In the event that pursuant to applicable law or contract the Company is prohibited or restricted from paying in cash the full dividends to which the holders of the Series B Shares are entitled, the cash amount available pursuant to applicable law or contract will be distributed among the holders of the Series B Shares ratably in proportion to the full amounts to which they would otherwise be entitled and any remaining amount due to holders of the Series B Shares will be payable in cash.

Liquidation Preference

In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of the Series B Shares are entitled to receive, prior and in preference to any distribution of any assets of the Company to the holders of any other preferred stock of the Company and subordinate to any distribution to the Series A-1 Shares, and prior and in preference to any distribution of any assets of the Company to the holders of the Common Stock, the amount of 120% of the issue price per share. In addition, the Series B holder has agreed to vote to subordinate the series B Preferred stock liquidation preferences to the Series C Preferred stock preferences.

No Circumvention

The Company may not amend its certificate of incorporation, or participate in any reorganization, sale or transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action for the purpose of avoiding or seeking to avoid the observance or performance of any of the terms to be observed or performed by the Company.

We have undeclared dividends on the Series B Preferred stock amounting to $82,455 as of September 30, 2015. If the dividends are paid in stock, the beneficial conversion feature of these undeclared dividends will be recorded upon the declaration of these dividends. The computation of loss per common share for the three months and nine months ended September 30, 2015 takes into account these undeclared dividends.

iii) Series C Convertible Preferred Stock

The Company has designated 4,500,000 preferred shares as Series C Convertible Preferred Stock (“Series C Shares”), with 4,500,000 Series C Shares issued and outstanding which are convertible into 120,000,000 shares of common stock (a conversion price of $0.12291665 per share).

On February 19, 2015, the Company entered into a Series C Preferred Stock Purchase Agreement (the “Purchase Agreement”) with Ervington Investment Limited, an entity organized under the laws of the Republic of Cyprus who is wholly owned by Greenleas International Holdings Ltd., which in turn is wholly owned by Harmony Trust Settlement, and closed the first tranche of a private placement offering under the Purchase Agreement, raising $5,000,000 in gross proceeds from the sale of 1,525,424 shares of our Series C Preferred Stock (“Series C Preferred Stock”) at a purchase price of $3.277777778 per share. The Company agreed to use the net proceeds of the offering for research and development, commercialization of new products, sales and marketing, repayment of debt, accounts payable and administrative expenses.

In terms of the Purchase Agreement, the Company sold to Ervington an additional 2,974,576 shares of Series C Preferred Stock for additional gross proceeds to us of $9,750,000 on June 30, 2015. The proceeds of the second closing are to be used by us for the acquisition, enhancement and maintenance of an oil field for deployment of our Plasma Pulse Technology.

We valued the beneficial conversion rights of the first tranche of Series C Convertible Preferred Stock issued on February 19, 2015 to be the right to the additional effective common shares as converted utilizing the opening market price of the common stock of $0.15 per share. Such computation valued the beneficial conversion rights to be $1,101,696 for purposes of presenting the net loss to common stock holders. We valued the beneficial conversion rights of the second tranche of Series C Convertible Preferred Stock issued on June 30, 2015, to be the right to the additional effective common shares as converted utilizing the open market price of the common stock of $.014 per share. Such computation valued the beneficial conversion rights to be $1,355,085 for purposes of presenting the net loss to common stockholders.

In connection with the Purchase Agreement, the Company also entered into an Investors’ Rights Agreement with Ervington (the “Investors’ Rights Agreement”). The Investors’ Rights’ Agreement provides that the Holders (as defined in the Investors’ Rights Agreement) of a majority of the outstanding Registerable Securities (defined therein as the shares of common stock and Series A-1 Convertible Preferred Stock (“Series A-1 Preferred Stock”) issued pursuant to the Secondary Stock Purchase Agreement (as defined below), the shares of Series C Preferred Stock issued pursuant to the Purchase Agreement and any common stock issued as dividends thereon or in exchange for such) are entitled to demand registration rights under certain circumstances and piggyback registration rights. In addition, the Investors’ Rights Agreement provides that Ervington (or its assignee) has the right to designate a person to be appointed as the Company’s Chief Executive Officer, a board observer right if a representative of Ervington or its affiliate is not a member of our board of directors and certain consultation rights if a representative of Ervington or its affiliate is not a member of our board of directors so long as it holds a majority of the Registerable Securities and at least 36,000,000 shares of our common stock on an “as converted” basis. Ervington and its affiliates also have a right of first refusal to acquire their pro rata share of any New Securities (as defined in the Investors’ Rights Agreement) which we propose to issue and sell.

In connection with the Purchase Agreement, Ervington also entered into a stock purchase agreement (the “Secondary Purchase Agreement”) with certain of our stockholders (the “Selling Stockholders”), pursuant to which the Selling Stockholders sold to Ervington an aggregate of 7,624,990 shares of our common stock and 2,437,500 shares of our Series A-1 Preferred Stock (representing 24,375,000 shares of our common stock on an as converted basis) at a purchase price of $.001 per share on the closing of the first tranche on February 19, 2015. In terms of the Secondary Purchase Agreement the Selling Stockholders also sold to Ervington on July 6, 2015, after the second closing an additional 56,677,477 shares of our common stock and 700,000 shares of our Series A-1 Preferred Stock (representing 7,000,000 shares of our common stock on an as converted basis) on the closing of the second tranche on July 6, 2015.

The Company also entered into a Stockholders Agreement with the Selling Stockholders and Ervington (the “Stockholders Agreement”) providing that until a Change of Control Transaction (as defined in the Stockholders Agreement), each person a party thereto shall vote all of such person’s shares of our common stock in favor of the designees appointed by Ervington and two additional directors appointed by two of the Selling Stockholders and Ervington agreed to vote its shares in favor of the two designees appointed by the two Selling Stockholders provided that the certain Selling Stockholders continue to own a certain threshold number of shares of our common stock or preferred stock convertible into our common stock. In addition, the Selling Stockholders granted Ervington certain drag along rights in the event of a Change of Control Transaction (as defined in the Stockholders Agreement) and Ervington and its affiliates were granted certain rights of first refusal.

In accordance with the terms of the Series C Preferred Stock Certificate of Designations (the “Series C Certificate of Designations”), Ervington appointed Ivan Persiyanov to serve as a director, holding two votes and Maria Damianou was appointed to serve as a director during July 2015, holding one vote.. In addition, James Fuller, Mark Kalow and Dan Steffens resigned from the Board of Directors effective upon the closing. In terms of the Series C Certificate of Designation.

In addition, as a condition to the consummation of the Purchase Agreement, the Company filed a Certificate of Designations to our Certificate of Incorporation with the Secretary of State of the State of Delaware setting forth the rights, preferences and privileges of the Series C Preferred Stock, our Bylaws were amended and restated and we entered into an Indemnification Agreement with Ivan Persiyanov.

The terms attached to the Series C Preferred Stock (“Series C Share”) are summarized below:

Conversion

Subject to adjustment for stock splits, stock dividends, reorganizations and recapitalizations and similar transactions, each Series C Share is currently convertible at the option of the holder into 26.67 shares of common stock.

Company Redemption

The Series C Shares are not subject to redemption by the Company.

Voting Rights

Generally, holders of Series C Shares will, on an as-converted basis, vote together with the common stock as a single class.  

Upon the issuance of at least 1,500,000 shares of Series C Preferred Stock the holders of the Series C Preferred Stock, as a class, are entitled to elect either two directors holding one vote or one director holding two votes. Upon the issuance of an aggregate of 4,500,000 shares of Series C Preferred Stock, the holders of the Series C Preferred Stock are entitled to elect either three directors holding one vote each, one director holding three votes or two directors with one director holding two votes and another director holding one vote.

Dividends

The Series C Shares accrue dividends at the rate per annum equal to 4% of the stated price (which initially is $3.277777778) payable annually in arrears on December 31 of each year in preference and priority to any payment of any dividend on our common stock, or any other class of preferred stock.

Liquidation Preference

In the event of our liquidation, dissolution or winding up and other liquidation events (as defined in the Series C Certificate of Designations), holders of Series C Shares are entitled to receive from proceeds remaining after distribution to our creditors and prior to the distribution to holders of common stock or any other class of preferred stock the (x) stated value (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) held by such holder and (y) all accrued but unpaid dividends  on such shares.

Anti-Dilution 

The Series C Shares are entitled to certain weighted average anti-dilution protection as specified in the Series C Certificate of Designations.

No Circumvention

The approval by holders of a majority of the Series C Shares, voting separately as a class, will be required for the following:

(i) merger, sale of substantially all of our assets or our recapitalization, reorganization, liquidation, dissolution or winding up;

(ii) redemption or acquisition of shares of our common stock other than in limited circumstances;

(iii) declaration or payment of a dividend or distribution with respect to our capital stock;

(iv) making any loan or advance;

(v) amending our Certificate of Incorporation or Bylaws;

(vi) authorizing or creating any new class or series of equity security;

(vii) increasing the number of authorized shares for issuance under any existing stock or option plan;

(viii) materially changing the nature of the business

(ix) incurring any indebtedness;

(x) engaging in or making investments not authorized by our board of directors;

(xi) acquiring or divesting a material amount of assets;

(xii) selling, assigning, licensing, pledging or encumbering our material technology or intellectual property;

(xiii) entering into any corporate strategic relationship involving payment, contribution or assignment by us or to us of any assets.

We have undeclared dividends on the Series C Preferred stock amounting to $220,493 as of September 30, 2015. The computation of loss per common share for the three and nine months ended September 30, 2015 takes into account these undeclared dividends.

c) Stock Options

i) Plan options

The Company’s Board of Directors approved the Company’s 2008 Stock Option Plan (the “Stock Plan”) for the issuance of up to 5,000,000 shares of common stock to be granted through incentive stock options, nonqualified stock options, stock appreciation rights, dividend equivalent rights, restricted stock, restricted stock units and other stock-based awards to officers, other employees, directors and consultants of the Company and its subsidiaries. After the reverse stock split in August 2012, a total of 100,000 shares were available for grant. Subsequent to the reverse split the Board of Directors approved an increase in the number of awards available for grant to 2,100,000 shares. The exercise price of stock options under the Stock Plan is determined by the Board of Directors, and may be equal to or greater than the fair market value of the Company’s common stock on the date the option is granted. Options become exercisable over various periods from the date of grant, and generally expire ten years after the grant date.

At September 30, 2015 and December 31, 2014, there were 380,950 Plan options issued and outstanding, respectively, under the Stock Option Plan.

The vesting provisions for these stock options are determined by the board of directors at the time of grant, there are no unvested options outstanding as of September 30, 2015. 

No options were issued during the nine months ended September 30, 2015.

In the event of the employees’ termination, the Company will cease to recognize compensation expense.

A summary of all of our option activity during the period January 1, 2014 to September 30, 2015 is as follows: 

					Weighted
			Exercise		average
			price per		exercise
	Shares		share		price
Outstanding January 1, 2014		11,452,960	$	0.25 to 25.00	$	0.30
Granted		-		-		-
Forfeited/Cancelled		(11,072,010)		0.25 to 25.00		0.25
Exercised		-		-		-
Outstanding December 31, 2014		380,950	$	0.51 to 13.50	$	0.90
Granted		-		-		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding September 30, 2015		380,950		0.51 to 13.50		0.90

Stock options outstanding as of September 30, 2015 and December 31, 2014 as disclosed in the above table, have an intrinsic value of $0 and $0, respectively.

The options outstanding and exercisable at September 30, 2015 are as follows:

		Options Outstanding						Options Exercisable
				Weighted								Weighted
				Average		Weighted				Weighted		Average
				Remaining		Average		Number		Average		Remaining
Exercise		Number		Contractual		Exercise		Number		Exercise		Contractual
Price		Outstanding		life in years		Price		Exercisable		Price		life in years
$	13.50		3,480		3.71	$			3,480	$			3.71
$	12.50		2,000		5.04	$			2,000	$			5.04
$	8.50		500		5.75	$			500	$			5.75
$	5.00		14,800		6.04	$			14,800	$			6.04
$	0.65		36,924		7.50	$			36,924	$			7.50
$	0.63		38,096		2.75	$			38,096	$			2.75
$	0.51		285,150		4.54	$			285,150	$			4.54
			380,950		4.70	$	0.90		380,950	$	0.90		4.70

The Company has applied fair value accounting for all share based payment awards since inception. The fair value of each option or warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model. There is no deferred compensation recorded upon initial grant date, instead, for employees, the fair value of the share-based payment is recognized ratably over the stated vesting period. For consultants, the fair value is recognized as expense immediately.

All options are fully vested and have been fully amortized as of September 30, 2015. The Company has recorded an expense of $0 and $1,439,502 for the nine months ended September 30, 2015 and 2014 relating to options issued.

(d) Warrants

A summary of all of our warrant activity during the period January 1, 2014 to September 30, 2015 is as follows: 

					Weighted
			Exercise		average
			price per		exercise
	Shares		share		price
Outstanding January 1, 2014		375,000	$	0.30	$	0.30
Granted		5,964,498		0.15 to 0.25		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding December 31, 2014		6,339,498	$	0.15 to 0.30	$	0.24
Granted		-		-		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding September, 2015		6,339,498	$	0.15 to 0.30	$	0.24

The warrants outstanding and exercisable at September 30, 2015 are as follows:

		Warrants Outstanding						Warrants Exercisable
				Weighted								Weighted
				Average		Weighted				Weighted		Average
				Remaining		Average				Average		Remaining
Exercise		Number		Contractual		Exercise		Number		Exercise		Contractual
Price		Outstanding		life in years		Price		Exercisable		Price		life in years
$	0.30		375,000		3.08	$	0.30		375,000	$	0.30		3.08
$	0.25		1,751,667		3.74	$	0.25		1,751,667	$	0.25		3.74
$	0.15		525,500		3.74	$	0.15		525,500	$	0.15		3.74
$	0.25		1,508,333		3.84	$	0.25		1,508,333	$	0.25		3.84
$	0.15		577,499		3.85	$	0.15		577,499	$	0.15		3.85
$	0.25		968,166		3.85	$	0.25		968,166	$	0.25		3.85
$	0.25		633,333		3.90	$	0.25		633,333	$	0.25		3.90
			6,339,498		3.77	$	0.24		6,339,498	$	0.24		3.77

The warrants outstanding have an intrinsic value of $0 as of September 30, 2015 and December 31, 2014, respectively.

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Net Revenues	$ 0	$ 0	$ 91,000	$ 85,008
Cost of Goods Sold	40,275	34,620	140,245	136,645
Gross Profit (Loss)	(40,275)	(34,620)	(49,245)	(51,637)
Consulting fees	90,229	53,181	309,896	140,405
Stock based compensation	311,284	619,125	793,856	1,741,849
Sales and Marketing	2,541	1,943	5,232	6,026
Professional Fees	243,635	65,898	625,699	200,931
General and administrative	309,561	228,455	600,557	574,844
Depreciation and amortization	33,833	23,959	103,149	49,308
Total Expenses	991,083	992,561	2,438,389	2,713,363
Loss from Operations	(1,031,358)	(1,027,181)	(2,487,634)	(2,765,000)
Other income	0	150,000	0	150,000
Amortization of debt discount and finance costs	(54)	(8,309)	(53,154)	(503,991)
Change in fair value of derivative liabilities	0	(33,345)	18,455	(430,956)
Other Operating Income (Expense), Net	(54)	108,346	(34,699)	(784,947)
Loss before Provision for Income Taxes	(1,031,412)	(918,835)	(2,522,333)	(3,549,947)
Provision for Income Taxes	0	0	0	0
Net Loss	(1,031,412)	(918,835)	(2,522,333)	(3,549,947)
Net loss attributable to non-controlling interest	88,569	0	88,569	0
Net Loss Attributable to Controlling Interest	(942,843)	(918,835)	(2,433,764)	(3,549,947)
Deemed preferred stock dividend	0	0	(2,456,781)	(1,604,335)
Undeclared Series B and Series C Preferred dividends	(157,786)	0	(302,948)	0
Net loss to common stockholders	$ (1,100,629)	$ (918,835)	$ (5,193,493)	$ (5,154,282)
Net Loss Per Share - Basic and Diluted (in dollars per share)	$ (0.00)	$ (0.00)	$ (0.02)	$ (0.02)
Weighted Average Number of Shares Outstanding - Basic and Diluted (in shares)	261,037,172	239,473,781	257,867,561	225,460,411

XML

ACCOUNTS PAYABLE - RELATED PARTIES

9 Months Ended

Sep. 30, 2015

ACCOUNTS PAYABLE RELATED PARTIES [Abstract]

ACCOUNTS PAYABLE - RELATED PARTIES [Text Block]

6 ACCOUNTS PAYABLE – RELATED PARTIES

Accounts payable to related parties includes the following:

	September 30, 2015		December 31, 2014
Technovita Technologies Corp.	$	108,510	$	-
Energy Conservation Management		47,610		-
Other		3,556		-
	$	159,676	$	-

Technovita Technologies Corp., is the 40% shareholder in the NENA joint venture which the Company entered into. This payable represents expenses paid on behalf of the joint venture by Technovita.

Energy Conservation Corp is a third party contractor associated with the joint venture.

XML

INTANGIBLES

9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets Disclosure [Text Block]

5 INTANGIBLES

Licenses

Novas licenses the “Plasma-Pulse Technology” (“the Technology”) from Novas Energy Group Limited, the Licensor, pursuant to the terms of an exclusive perpetual royalty bearing license it entered into in January 2013, which was amended on March, 2014 and further amended on December 23, 2014. The amended license agreement provides Novas with the exclusive right to develop, use, market and commercialize the Technology for itself and/or third parties, sublicense and provide services to third parties related to the Technology in the United States and Mexico including all of its states, districts, territories, possessions and protectorates. The amended license agreement also provides Novas with the right to design and have manufactured the apparatus and to make modifications and improvements to the Technology provided that the Licensor is provided a non-exclusive license to any such improvements and modifications and any patent rights of Novas related to the Technology. The license is limited to the United States and Mexico. It also provides that Novas will pay the Licensor royalties equal to seven and a half percent (7.5%) of Net Service Sales (as defined in the second amendment to the license agreement) and Non-Royalty Sublicensing Consideration (as defined in the second amendment to the license agreement) and provides for a minimum royalty payment of $500,000 per year from United States operations and $500,000 per year from Mexican operations; however, no minimum royalty payment is due prior to the three year anniversary of the license agreement for revenue derived from the United States operations and no minimum royalty is due prior to December 31, 2015 for revenue derived from Mexico. Revenue derived from operations in one territory can be used to satisfy obligations for minimum royalty payments in the other territory. All royalty payments made by Novas as well as sublicensing revenue paid by Novas to the Licensor are credited towards the minimum royalty payment. If the minimum royalty is not timely paid, the Licensor has the right to terminate the license with respect to a particular territory and if the minimum royalty payment for both territories is not paid, to terminate the license agreement. Novas was obligated to pay an initial license fee of $150,000 on or prior to June 30, 2014, this fee was subsequently waived by the Licensor with effect from July 30, 2014, an additional $200,000 was due to the Licensor on June 30, 2015, this amount, together with the minimum annual royalty amounts due in terms of the licensing agreement are currently under renegotiation with the Licensor, we expect the $200,000 to be waived and the minimum royalty payments to be amended and deferred. The Licensor is responsible for the cost of filing prosecuting and maintaining the patents and Novas is responsible for costs of obtaining marketing approvals. The Licensor has the right to terminate the license agreement upon Novas’ breach or default. If the Licensor dissolves, becomes insolvent or engages in or is the subject of any other bankruptcy proceeding then the technology and patent rights in the United States shall become our property.

Subject to certain exceptions and pursuant to the terms of the Novas Sublicense Agreement that was entered into on October 22, 2015, between Novas, NENA and the Licensor of the Plasma Pulse Technology currently used by Novas and Technovita, NENA will be the exclusive provider of the Vertical Technology (as defined in the Joint Venture Agreement entered into on October 22, 2015) to third parties in the United States. Subject to certain exceptions and pursuant to the terms of Sublicense Agreements (the “Technovita Sublicense Agreement”) that was entered into between Technovita, NENA and Licensor, NENA is the exclusive provider of the Vertical Technology to third parties in Canada. Notwithstanding the foregoing, both Novas and Technovita will retain the right to deploy the Vertical Technology on wells owned by Novas or Technovita in the United States or Canada, respectively. If either Novas or Technovita terminates the Sublicense Agreement with NENA and Licensor, the non- terminating party will receive 100% of the terminating member’s membership interest in NENA.

Intangibles consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	September 30,		December 31,
	2015		2014
License agreements	$	350,000	$	350,000
Website development		8,000		8,000
Total cost		358,000		358,000
Less: accumulated amortization		(113,000)		(60,500)
Intangibles, net	$	245,000	$	297,500

Amortization expense was $52,500 and $35,000 for the nine months ended September 30, 2015 and 2014, respectively.

The minimum commitments due under the license agreement for the next five years are summarized as follows:

	Amount
2015	$	700,000
2016		1,000,000
2017		1,000,000
2018		1,000,000
2019		1,000,000
	$	4,700,000

XML

JOINT VENTURE

9 Months Ended

Sep. 30, 2015

Joint Venture [Abstract]

Joint Venture [Text Block]

17 JOINT VENTURE

On October 22, 2015, Novas Energy USA, Inc. (“Novas”), a wholly owned subsidiary of Propell Technologies Group, Inc. (the “Company”), entered into an operating agreement with Technovita Technologies USA, Inc. (the “Joint Venture Agreement”) through a newly formed Delaware limited liability company, Novas Energy North America, LLC (“NENA”), whereby Novas agreed to contribute $1,200,000 ($600,000 to be delivered on the effective date (October 22, 2015) of the Joint Venture Agreement, $300,000 on November 1, 2015 and $300,000 on the two month anniversary of the Effective Date) to the capital of NENA for 60% of the membership interests of NENA and Technovita agreed to contribute an aggregate of $800,000 to the capital of NENA for 40% of the membership interests of NENA. In terms of a side agreement entered into on November 18, 2015, the revenue and expenses incurred by Technovita and the Company prior to entering into the operating agreement, have been included in the joint venture and consolidated into the Company’s results effective September 1, 2015.

Subject to certain exceptions and pursuant to the terms of a sublicense agreement (the “Novas Sublicense Agreement”) that was entered into between Novas, NENA and Novas Energy Group Inc. (the “Licensor”), the licensor of Plasma Pulse Technology currently used by Novas and Technovita, NENA will be the exclusive provider of the Vertical Technology (as defined in the Joint Venture Agreement) to third parties in the United States. Subject to certain exceptions and pursuant to the terms of Sublicense Agreements (the “Technovita Sublicense Agreement”) that was entered into between Technovita, NENA and Licensor, NENA is the exclusive provider of the Vertical Technology to third parties in Canada. Notwithstanding the foregoing, both Novas and Technovita will retain the right to deploy the Vertical Technology on wells owned by Novas or Technovita in the United States or Canada, respectively. If either Novas or Technovita terminates the Sublicense Agreement with NENA and Licensor, the non- terminating party will receive 100% of the terminating member’s membership interest in NENA.

The business and affairs of NENA are to be managed by or under the direction of the Board of Directors, consisting of five (5) members, three (3) of whom shall be appointed by Novas and two (2) of whom shall be appointed by Technovita. Board approval is required to: (i) incur any indebtedness, pledge or grant liens on any assets or guarantee, assume, endorse or otherwise become responsible for the obligations of any other person, except to the extent approved or authorized in NENA’s budget; (ii) make any loan, advance or capital contribution in any person, except to the extent approved or authorized in the budget; (iii) transfer any equipment necessary in the deployment of the Vertical Technology to any third party; (iv) enter into or effect any transaction or series of related transactions involving the sale of NENA or the sale, lease, license, exchange or other disposition (including by merger, consolidation, sale of assets or similar business transaction) by NENA of any assets in excess of $300,000; (v) appoint or remove NENA’s auditors or make any changes in the accounting methods or policies of NENA (other than as required by GAAP); (vi) enter into or effect any transaction or series of related transactions involving the purchase, lease, license, exchange or other acquisition (including by merger, consolidation, acquisition of stock or acquisition of assets) by NENA of any assets and/or equity interests of any person and/ or assets in excess of $300,000; or (v) enter into or effect any commercial transaction or series of related commercial transactions involving anticipated liabilities or revenues of NENA in excess of $500,000 or that materially vary from NENA’s existing strategy or business plan.

XML

EQUITY BASED COMPENSATION

9 Months Ended

Sep. 30, 2015

Equity [Abstract]

Comprehensive Income (Loss) Note [Text Block]

13 EQUITY BASED COMPENSATION

Equity based compensation is made up of the following:

	Nine months		Nine months
	ended		ended
	September 30, 2015		September 30, 2014
Stock option compensation charge	$	-	$	1,439,502
Restricted stock award compensation charge		723,856		-
Stock issued for services rendered		70,000		302,347
	$	793,856	$	1,741,849

XML

SHORT-TERM CONVERTIBLE NOTES PAYABLE

9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

9 SHORT-TERM CONVERTIBLE NOTES PAYABLE

Short Term Convertible Notes payable consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	Interest		September 30,		December 31,
	Rate	Maturity	2015		2014
LG Capital Funding, LLC	8%	October 30, 2015		-		107,000
Unamortized debt discount and interest expense				-		(4,379)
Total LG Capital Funding, LLC				-		102,621
KBM Worldwide, Inc.	8%	September 12, 2015		-		84,000
Unamortized debt discount and interest expense				-		(3,512)
Total KBM Worldwide, Inc.				-		80,488
Total Short-Term Convertible Notes Payable			$	-	$	183,109

LG Capital Funding, LLC

On October 31, 2014, the Company issued a note in the principal amount of $107,000 to LG Capital Funding, LLC (“LG”) upon receipt of $100,000 from LG. The terms of the note provided for an original issue discount of 7% amounting to $7,000 which was added to the face value of the note. The note carried an interest charge of 8% per annum. The note was convertible into common stock at any time, at the holder’s option, in whole or in part, at a conversion price equal to 62% of the lowest bid prices in the 10 trading days prior to conversion. The note had a maturity date of October 30, 2015. The holder was not entitled to exercise any conversion right that would result in the holder owning more than 9.9% of the Company’s common stock. The Convertible Note was redeemable by the Company within 180 days of the issuance date, after a 3 day notice period, in which notice period the holder could elect to exercise the conversion feature of the note, at a premium over the principal amount due of 10%, plus any interest earned thereon, subject to the holders approval. The conversion price of the note had anti-dilutive provisions which would increase the redemption penalty of the note to 150% of the principal outstanding plus accrued and unpaid interest thereon, or allow conversion immediately prior to the dilutive event taking place.

On February 20, 2015, the unsecured promissory note issued to LG in the principal amount of $107,000 was repaid for $125,677, inclusive of interest, original issue discounts and early settlement penalty accrued thereon. The Company has no further obligations under this note.

KBM Worldwide, Inc.

On December 10, 2014, the Company issued an unsecured convertible note to KBM Worldwide, Inc. (“KBM”) with a face value of $84,000, in exchange for $80,000 in cash, including an original issue discount of $4,000. The note was convertible into common stock of the Company and bore interest at the rate of 8% per annum, which interest was payable in cash or common stock, at the election of the holder, and had a maturity date of September 12, 2015. The conversion price, as well as the formula for determining the number of shares needed to repay the note and any interest thereon was 58% of the average of the lowest closing price for any three trading days during the last ten day trading period prior to conversion or payment of interest. The holder could only convert the note following the expiration of 180 days from the date of issuance, December 10, 2014. The holder was not entitled to any conversion right that would result in the holder owning more than 4.99% of the Company’s common stock. This note could be prepaid by the Company from the date of issuance to 180 days after issuance date at a prepayment penalty ranging from 110% to 135% of the balance outstanding, including interest thereon, dependent upon the age of the note.

On February 20, 2015, the unsecured promissory note issued to KBM on December 10, 2014 with a face value of $84,000 was repaid for $102,107, inclusive of interest, fees and an early settlement penalty accrued thereon. The Company has no further obligations under this note.

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Restricted Stock [Member]	9 Months Ended
	Sep. 30, 2015 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Granted - Number Outstanding (in shares)	14,500,000
Restricted Stock Granted - Weighted Average Fair Value per Share (in dollars) | $ / shares	$ 0.16
Restricted Stock Vested - Number Outstanding (in shares)	5,750,000
Restricted Stock Vested - Weighted Average Fair Value per Share (in dollars) | $ / shares	$ 0.16
Range Of Exercise Prices One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Granted - Number Outstanding (in shares)	11,500,000
Restricted Stock Vested - Number Outstanding (in shares)	3,750,000
Restricted Stock Vested -Grant Date Price (in dollars) | $ / shares	$ 0.15
Range Of Exercise Prices Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Granted - Number Outstanding (in shares)	3,000,000
Restricted Stock Vested - Number Outstanding (in shares)	2,000,000
Restricted Stock Vested -Grant Date Price (in dollars) | $ / shares	$ 0.18

XML

ACCRUED LIABILITIES AND OTHER PAYABLES

9 Months Ended

Sep. 30, 2015

Accounts Payable and Accrued Liabilities [Abstract]

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

7 ACCRUED LIABILITIES AND OTHER PAYABLES

Accrued liabilities consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	September 30, 2015		December 31, 2014
Payroll liabilities	$	42,317	$	35,823
Accrued Royalties		14,653		4,603
License fees payable		200,000		200,000
	$	256,970	$	240,426

XML

NOTES PAYABLE

9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Long-term Debt [Text Block]

8 NOTES PAYABLE

Notes payable consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	Interest				September 30,		December 31,
Description	Rate			Maturity	2015		2014
Short-Term
Owl Holdings		-		-	$	3,000	$	3,000
JAZ-CEH Holdings, LLC		7.5	%	October 31, 2015		-		105,000
Accrued interest						-		9,489
Total JAZ-CEH holdings, LLC						-		114,489
Total Notes Payable					$	3,000	$	117,489

Owl Holdings

The note payable advanced by Owl Holdings to the Company has no interest rate and is repayable on demand.

JAZ-CEH Holdings, LLC

In October 2013, Navies Energy USA, Inc., entered into an unsecured promissory note with JAZ-CEH Holdings LLC with a face value of $105,000. The note bore interest at 7.5% per annum and was due to mature on October 31, 2015.

On February 20, 2015, the note to JAZ-CEH Holdings, LLC, including interest thereon was repaid for a total amount of $115,590.

XML

DERIVATIVE FINANCIAL LIABILITY

9 Months Ended

Sep. 30, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives and Fair Value [Text Block]

10 DERIVATIVE FINANCIAL LIABILITY

Certain of the short-term convertible notes disclosed in note 9 above, had variable priced conversion rights with no fixed floor price and would re-price dependent on the share price performance over varying periods of time. This gave rise to a derivative financial liability, which was valued at $224,442 at inception of the convertible notes using a Black-Scholes valuation model. The value of this derivative financial liability is re-assessed at each financial reporting period, with any movement thereon recorded in the statement of operations in the period in which it is incurred or the convertible debt is converted into equity.

Upon repayment or conversion of the outstanding notes, the derivative financial liability is no longer required.

The movement in derivative liabilities is as follows:

	September 30,		December 31,
	2015		2014
Opening balance	$	18,455	$	237,799
Derivative financial liability arising on short-term notes with variable conversion prices		-		23,060
Conversion of derivative liability for stock issued at a discount		-		(668,756)
Fair value adjustments to derivative financial liability		(18,455)		426,352
	$	-	$	18,455

The following assumptions were used in the Black-Scholes valuation model:

	Year ended
	December 31, 2014
Stock price over the period	$	0.17 – $0.23
Risk free interest rate		0.13% to 0.25	%
Expected life of short-term notes payable		9 to 14 months
Expected volatility		95.24% - 119.45	%
Expected dividend rate		0	%

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Details 4) - Warrant [Member] - $ / shares	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercise Price Per Share			$ 0.30
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance	6,339,498	6,339,498	375,000
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Remaining Contractual Term	3 years 9 months 7 days
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Exercise Price	$ 0.24	$ 0.24	$ 0.30
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number	6,339,498
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Exercise Price	$ 0.24
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Remaining Contractual Term	3 years 9 months 7 days
Exercise Price Range One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercise Price Per Share	$ 0.30
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance	375,000
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Remaining Contractual Term	3 years 29 days
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Exercise Price	$ 0.30
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number	375,000
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Exercise Price	$ 0.30
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Remaining Contractual Term	3 years 29 days
Exercise Price Range Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercise Price Per Share	$ 0.25
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance	1,751,667
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Remaining Contractual Term	3 years 8 months 26 days
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Exercise Price	$ 0.25
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number	1,751,667
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Exercise Price	$ 0.25
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Remaining Contractual Term	3 years 8 months 26 days
Exercise Price Range Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercise Price Per Share	$ 0.15
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance	525,500
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Remaining Contractual Term	3 years 8 months 26 days
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Exercise Price	$ 0.15
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number	525,500
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Exercise Price	$ 0.15
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Remaining Contractual Term	3 years 8 months 26 days
Exercise Price Range Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercise Price Per Share	$ 0.25
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance	1,508,333
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Remaining Contractual Term	3 years 10 months 2 days
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Exercise Price	$ 0.25
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number	1,508,333
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Exercise Price	$ 0.25
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Remaining Contractual Term	3 years 10 months 2 days
Exercise Price Range Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercise Price Per Share	$ 0.15
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance	577,499
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Remaining Contractual Term	3 years 10 months 6 days
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Exercise Price	$ 0.15
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number	577,499
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Exercise Price	$ 0.15
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Remaining Contractual Term	3 years 10 months 6 days
Exercise Price Range Six [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercise Price Per Share	$ 0.25
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance	968,166
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Remaining Contractual Term	3 years 10 months 6 days
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Exercise Price	$ 0.25
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number	968,166
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Exercise Price	$ 0.25
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Remaining Contractual Term	3 years 10 months 6 days
Exercise Price Range Seven [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercise Price Per Share	$ 0.25
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance	633,333
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Remaining Contractual Term	3 years 10 months 24 days
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding, Weighted Average Exercise Price	$ 0.25
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number	633,333
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Exercise Price	$ 0.25
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable, Weighted Average Remaining Contractual Term	3 years 10 months 24 days

XML

EQUITY BASED COMPENSATION (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Stock option compensation charge	$ 0	$ 1,439,502
Restricted stock award compensation charge	723,856	0
Stock issued for services rendered	70,000	302,347
Share-based Compensation, Total	$ 793,856	$ 1,741,849

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Details 3) - Warrant [Member] - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Beginning (in shares)	6,339,498	375,000
Share-based Payment Award, Non-Option Equity Instruments, Granted	0	5,964,498
Share-based Payment Award, Non-Option Equity Instruments, Forfeited/Cancelled	0	0
Share-based Payment Award, Non-Option Equity Instruments, Exercised	0	0
Outstanding Ending (in shares)	6,339,498	6,339,498
Share Based Payment Award Non Option Equity Instruments, Outstanding In Period, Exercise Price Per Share		$ 0.30
Share Based Payment Award Non Option Equity Instruments, Grants, Exercise Price Per Share	$ 0
Share Based Payment Award Non Option Equity Instruments, Forfeited, Exercise Price Per Share	0	0
Share Based Payment Award Non Option Equity Instruments, Exercised, Exercise Price Per Share	0	0
Share Based Payment Award Non Option Equity Instruments Outstanding In Period,Weighted Average Exercise Price	0.24	0.30
Share Based Payment Award Non Option Equity Instruments Grants In Period,Weighted Average Exercise Price	0	0
Share Based Payment Award Non Option Equity Instruments ,Forfeited,Weighted Average Exercise Price	0	0
Share Based Payment Award Non Option Equity Instruments ,Exercised,Weighted Average Exercise Price	0	0
Share Based Payment Award Non Option Equity Instruments ,Outstanding,Weighted Average Exercise Price	0.24	0.24
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Payment Award Non Option Equity Instruments, Grants, Exercise Price Per Share		0.15
Share Based Payment Award Non Option Equity Instruments Outstanding In Period,Weighted Average Exercise Price	0.15	0.15
Share Based Payment Award Non Option Equity Instruments ,Outstanding,Weighted Average Exercise Price		0.15
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Payment Award Non Option Equity Instruments, Grants, Exercise Price Per Share		0.25
Share Based Payment Award Non Option Equity Instruments Outstanding In Period,Weighted Average Exercise Price	$ 0.30	0.30
Share Based Payment Award Non Option Equity Instruments ,Outstanding,Weighted Average Exercise Price		$ 0.30

XML

LONG-TERM CONVERTIBLE NOTES PAYABLE (Tables)

9 Months Ended

Sep. 30, 2015

Debt Instruments [Abstract]

Schedule of Long-term Debt Instruments [Table Text Block]

Long Term Convertible Notes payable consisted of the following as of September 30, 2015 and December 31, 2014, respectively:

	Interest			September 30,		December 31,
Description	Rate		Maturity	2015		2014
Notes payable		6%	November 19, 2017	$	-	$	11,250
Accrued interest					-		1,470
Unamortized debt discount					-		(6,500)
Total long-Term Convertible Notes Payable				$	-	$	6,220

XML

NOTES PAYABLE (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Short-term Debt, Total	$ 3,000	$ 117,489
Owl Holdings [Member]
Short-term Debt, Total	3,000	3,000
JAZ-CEH Holdings, LLC [Member]
Short-term Debt, Total	0	114,489
Short Term Borrowings Excluding Accrued Interest	0	105,000
Interest Payable, Current	$ 0	$ 9,489
Short-term Debt, Percentage Bearing Fixed Interest Rate	7.50%
Debt Instrument, Maturity Date	Oct. 31, 2015

XML

RELATED PARTY TRANSACTIONS

9 Months Ended

Sep. 30, 2015

Related Party Transactions [Abstract]

Related Party Transactions Disclosure [Text Block]

15 RELATED PARTY TRANSACTIONS

On February 4, 2015, we entered into an Amended and Restated Employment Agreement (the “Employment Agreement”) with John Huemoeller II, that superseded the Company’s prior Employment Agreement with Mr. Huemoeller that was previously entered into on December 5, 2014 (the “Prior Agreement”).

Under the Employment Agreement, which has a stated term of three (3) years, for his continued service as the Chief Executive Officer and President of the Company, Mr. Huemoeller will continue to receive the same annual base salary of $180,000 provided for under the Prior Agreement and will be entitled to bonuses at the discretion of the Company based on performance. The new Employment Agreement restated a previous grant to Mr. Huemoeller of 10,000,000 shares of the Company’s restricted stock. As of September 30, 2015, 3,750,000 shares have already vested and a further 1,250,000 vested on October 1, 2015, with further vesting taking place on each quarter anniversary commencing January 1, 2016 for another four (4) quarters. The restricted stock grant was in lieu of the options that had previously been granted to Mr. Huemoeller, which options were canceled on December 5, 2014. The Employment Agreement also provides that Mr. Huemoeller will receive a restricted stock grant of 750,000 shares of stock on an annual basis commencing January 1, 2016, which will vest upon issuance. In the event of a Change of Control (as defined in the Employment Agreement), termination without Cause (as defined in the Employment Agreement), termination due to disability (as defined in the Employment Agreement), death or termination by Mr. Huemoeller for Good Reason (as defined in the Employment Agreement), Mr. Huemoeller will receive: (i) a severance payment equal to two (2) months base salary together with payment of medical insurance or COBRA payments for two (2) months after termination; and (ii) all restricted stock grants that have been issued to Mr. Huemoeller will immediately vest. If Mr. Huemoeller terminates his employment at any time prior to January 1, 2016 Without Good Reason (as defined in the Employment Agreement) or is terminated for Cause (as defined in the Employment Agreement) then 5,000,000 of any restricted stock grants will immediately vest. The Employment Agreement also includes customary confidentiality obligations and inventions assignments by Mr. Huemoeller.

On December 5, 2014, the Company entered into a consulting agreement with John Zotos (“Zotos”), our director for a two year period. In terms of the agreement, Zotos will provide consulting services to the Company for a consideration of $5,000 per month and the grant of 3,000,000 restricted shares of which 1,000,000 vested on March 31, 2015, a further 1,000,000 vested on September 30, 2015 and the remaining 1,000,000 will vest on March 31, 2016. Early termination of the agreement by either party will result in immediate vesting of the remaining unvested shares. The Company will also reimburse the consultant for all out of pocket expenses incurred whilst performing his duties. The consulting agreement also includes customary confidentiality obligations and invention assignments by Mr. Zotos.

XML

PREPAID EXPENSES (Tables)

9 Months Ended

Sep. 30, 2015

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Other Assets [Table Text Block]

Prepaid expenses consisted of the following as of September 30, 2015 and December 31, 2014:

	September		December
	30, 2015		31, 2014
Prepaid insurance	$	23,125	$	8,144
Expenses in excess of billings		72,308
Prepaid professional fees		36,286		4,417
Other		860		470
	$	132,579	$	13,031

XML

ACCOUNTS PAYABLE - RELATED PARTIES (Details Textual)	Sep. 30, 2015
Accounts Payable- Related parties [Line Items]
Percentage of Shareholding by Investor in Joint Venture	40.00%

XML

ACCOUNTING POLICIES AND ESTIMATES (Details Textual) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2013
Accounting Policies and Estimates [Line Items]
Cash and Cash Equivalents, at Carrying Value, Total	$ 12,568,839	$ 40,844	$ 131,991	$ 28,423
Cash And Cash Equivalents At Carrying Value, Exceeding Federal Limits	11,717,660
Allowance for Doubtful Accounts Receivable, Recoveries	0	0
Inventory, Net, Total	0	$ 0
Plant and equipment are capitalized and depreciated	$ 1,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - 9 months ended Sep. 30, 2015 - USD ($)	Total	Noncontrolling Interest [Member]	Parent [Member]	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]	Series C Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2014	$ (234,095)	$ 0	$ (234,095)	$ 3,513	$ 75	$ 0	$ 260,169	$ 9,914,303	$ (10,412,155)
Balance (in shares) at Dec. 31, 2014				3,512,500	75,000	0	260,169,499
Conversion of notes and accrued interest thereon to common stock	12,789		12,789	$ 0	$ 0	$ 0	$ 640	12,149	0
Conversion of notes and accrued interest thereon to common stock (in shares)				0	0	0	639,432
Subscription for Series C Convertible Preferred Stock	14,750,000		14,750,000	$ 0	$ 0	$ 4,500	$ 0	14,745,500	0
Subscriptions for Series C Convertible Preferred Stock (in shares)				0	0	4,500,000	0
Conversion of Series A-1 preferred stock to common	0		0	$ (375)	$ 0	$ 0	$ 3,750	(3,375)	0
Conversion of Series A-1 preferred stock to common (in shares)				(375,000)	0	0	3,750,000
Conversion of Series B preferred stock to common	0		0	$ 0	$ (35)	$ 0	$ 3,500	(3,465)	0
Conversion of Series B preferred stock to common (in shares)				0	(35,000)	0	3,500,000
Restricted stock awards	723,856		723,856	$ 0	$ 0	$ 0	$ 0	723,856	0
Shares issued for services	70,000		70,000	$ 0	$ 0	$ 0	$ 500	69,500	0
Shares issued for services (in shares)				0	0	0	500,000
Contribution by joint venture partner	185,028	185,028	0	$ 0	$ 0	$ 0	$ 0	0	0
Net loss	(2,522,333)	(88,569)	(2,433,764)	0	0	0	0	0	(2,433,764)
Balance at Sep. 30, 2015	$ 12,985,245	$ 96,459	$ (12,888,786)	$ 3,138	$ 40	$ 4,500	$ 268,559	$ 25,458,468	$ (12,845,919)
Balance (in shares) at Sep. 30, 2015				3,137,500	40,000	4,500,000	268,558,931

XML

PLANT AND EQUIPMENT

9 Months Ended

Sep. 30, 2015

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment Disclosure [Text Block]

4 PLANT AND EQUIPMENT

Plant and Equipment consisted of the following as of September 30, 2015 and December 31, 2014:

	September		December
	30, 2015		31, 2014
Capital work in progress	$	447,669	$	18,482
Plasma pulse tool		310,374		310,374
Furniture and equipment		29,621		26,643
Field equipment		19,627		19,627
Computer equipment		1,500		1,500
Total cost		808,791		376,626
Less: accumulated depreciation		(107,701)		(57,052)
Plant and equipment, net	$	701,090	$	319,574

Depreciation expense was $50,649 and $14,308 for the nine months ended September 30, 2015 and 2014, respectively.

XML

LONG-TERM CONVERTIBLE NOTES PAYABLE (Details) - Notes Payable to Banks [Member] - USD ($)	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Notes payable	$ 0	$ 11,250
Accrued interest	0	1,470
Unamortized debt discount	0	(6,500)
Total long-Term Convertible Notes Payable	$ 0	$ 6,220
Debt Instrument, Interest Rate During Period	6.00%
Debt Instrument, Maturity Date	Nov. 19, 2017

XML

COMMITMENTS AND CONTINGENCIES (Details)	Sep. 30, 2015 USD ($)
Operating Leased Assets [Line Items]
2015	$ 16,380
2016	18,500
Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year	$ 34,880

XML

PLANT AND EQUIPMENT (Tables)

9 Months Ended

Sep. 30, 2015

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Table Text Block]

Plant and Equipment consisted of the following as of September 30, 2015 and December 31, 2014:

	September		December
	30, 2015		31, 2014
Capital work in progress	$	447,669	$	18,482
Plasma pulse tool		310,374		310,374
Furniture and equipment		29,621		26,643
Field equipment		19,627		19,627
Computer equipment		1,500		1,500
Total cost		808,791		376,626
Less: accumulated depreciation		(107,701)		(57,052)
Plant and equipment, net	$	701,090	$	319,574

XML

COMMITMENTS AND CONTINGENCIES (Tables)

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

The future minimum operating lease commitments are as follows:

	Amount
2015		16,380
2016		18,500
	$	34,880

Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]

In terms of the license agreement commitments disclosed in note 5 above, the minimum commitments due under the amended license agreement entered into on January 30, 2013, for the next five years, are summarized as follows:

	Amount
2015	$	700,000
2016		1,000,000
2017		1,000,000
2018		1,000,000
2019		1,000,000
	$	4,700,000

XML

NET LOSS PER SHARE

9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

14 NET LOSS PER SHARE

Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus common stock equivalents, including convertible preferred shares and convertible notes as well as the incremental shares that would be issued upon the assumed exercise of in-the-money stock options using the treasury stock method. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the nine months ended September 30, 2015 and 2014, all stock options, unvested restricted stock awards, warrants, convertible preferred stock and convertible notes were excluded from the computation of diluted net loss per share. Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:

	Nine Months		Nine months
	ended		ended
	September		September
	30, 2015		30, 2014
	(Shares)		(Shares)
Options to purchase shares of common stock		380,950		11,452,960
Restricted stock awards – unvested		8,750,000		-
Warrants to purchase shares of common stock		6,339,498		6,339,498
Series A-1 convertible preferred shares		31,375,000		38,875,000
Series B convertible preferred shares		4,000,000		7,500,000
Series C convertible preferred shares		120,000,000		-
Convertible long term notes		-		1,968,750
Convertible short term notes*		-		-
		170,845,448		66,136,208

* In the prior year convertible short term notes have variable conversion pricing dependent upon share prices prior to conversion